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ABSTRACT 
 
Provision of NHS hospital pharmacy services has historically been delivered during 
typical ‘office’ hours. During these hours most pharmacy departments provide a 
medicines information (MI) service where any healthcare professional can ask for 
medicines advice. Outside of these hours questions are handled by an on-call 
pharmacist. This study aimed to investigate the provision of pharmacy services and 
medicines advice out of hours, from the perspective of pharmacists and other 
healthcare professionals, in NHS England.   
 
A mixed methods approach was used: an online survey of all Chief Pharmacists in 
England (2012: n=220) and semi-structured interviews of on-call pharmacists (2014: 
n=8) and doctors and nurses (2015: n=3 & n=4 respectively) in the East of England. 
The online survey provided information about the provision of on-call pharmacy 
services in England, documentation of calls handled, and provision of relevant training. 
Semi-structured interviews generated 19 themes, grouped into 5 meta themes: 
documentation, individual’s knowledge and experience, information accessibility, use of 
service, and awareness of service. 
 
On-call pharmacy services were provided by most hospitals, predominantly by less 
senior staff with limited years’ experience. Documentation of questions was variable, 
and less than half of Trusts had a documentation policy. Documentation by on-call 
pharmacists was found to be affected by their knowledge and experience, if they had 
any concerns about the enquirer’s understanding, the time the call was received, and 
remuneration and Information Technology (IT) issues. Both Chief Pharmacists and on-
call pharmacists identified that training mainly consisted of operational issues, with on-
call pharmacists believing a greater role could be played by MI staff in this training. 
Drug administration and ‘medication safety check’ were the main types of medicines 
advice questions sought out of hours. Chief Pharmacists stated on-call pharmacy 
services were well advertised but doctors and nurses seemed unaware of its provision 
and means of access; on-call pharmacists perceived this to be due to a lack of 
promotion. Access to information out of hours, particularly patients’ drug and clinical 
information, by on-call pharmacists was a barrier to providing medicines advice.  
 
This is the first insight into the national landscape of on-call pharmacy services. There 
is a clear role for MI services to support on-call pharmacy services, and national 
standards should be developed for provision, information accessibility, documentation 
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and training. National pharmacy policy makers could also consider structured training, 
repeated on a regular basis, for all on-call pharmacists.  
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CHAPTER 1 INTRODUCTION 
The first section of this chapter introduces the background to this research including 
the researcher’s personal motivation for undertaking this study. This is followed by a 
critical evaluation of the literature relevant to this research. The chapter concludes by 
outlining the research aim and objectives relevant to this study.  
 
1.1 Background and personal motivation 
The provision of National Health Service (NHS) hospital pharmacy services has 
historically been delivered during typical ‘office’ hours, i.e. 9am – 5pm. This is 
increasingly at odds with the provision of services by other areas within hospitals, 
particularly general medical and nursing services. There is now an expectation that 
hospital pharmacy services should extend their opening times, and, although some 
have achieved this, most continue to only provide an on-call pharmacy service outside 
office hours. 1, 2  
 
During normal working hours most pharmacy departments provide a medicines 
information (MI) service where any healthcare professional can ask for medicines 
advice. This service is usually provided by pharmacists with particular skills in locating, 
assessing and interpreting information about medicines.3 These skills are mostly 
developed within the role which includes receiving regular feedback from peers. 
However, these skills can also be gained through attending a bespoke national training 
course and completing e-learning packages. 4, 5  
 
United Kingdom (UK) MI services are expected to operate to national standards during 
normal working hours, however there are no similar guidelines for on-call pharmacy 
services. 4 These national standards relate to how questions for medicines advice are 
handled, including: documentation; the resources available for use; risk management; 
and, training.   
 
Outside of normal office hours, an on-call pharmacist will field calls typically from other 
healthcare professionals from within their own organisation (although infrequently from 
external organisations), involving either the supply of medication or provision of 
medicines advice. On-call pharmacists are usually employees from the pharmacy 
department of that hospital: they could be any pharmacist, including the MI pharmacist, 
and usually participate on a rota basis. The knowledge, experience and training 
between these on-call pharmacists does vary. 6, 7 
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At a national level, most hospital Trusts have a dedicated MI centre, collectively 
referred to as UK Medicines Information (UKMi). 3, 4 The service handles over half a 
million enquiries each year during normal office hours. 3 High user satisfaction levels 
have historically been reported with the UKMi service, and more recently attempts have 
been made to determine patient outcomes based on UKMi advice. 8-15  
 
However, almost all UKMi research outputs have concentrated on enquiries received 
during normal office hours; very little is known about what happens outside these 
hours. This may, in part, be because on-call pharmacy services are not usually 
managed or staffed specifically by a hospital’s MI service, as outlined earlier. 16-18 
     
Since qualifying as a pharmacist I have worked in the NHS for nearly 20 years, the 
majority of which has been within hospital pharmacy. During this time, I have worked 
as a MI pharmacist for 10 years across two regional medicines services – one in a 
large acute teaching hospital, the other in a medium sized acute hospital. Both MI 
centres provided an excellent service during ‘office’ hours according to data from user 
satisfaction surveys.19 – 22 I have also worked as part of an on-call pharmacy service for 
approximately 5 years.  
 
I have personally undertaken service evaluations/developments and some research 
related to medicines advice out of hours as part of my NHS employment. 23-25 
Constraints on my time and limitations in my own research knowledge and skills meant 
that these have lacked the depth and rigour needed to draw any robust conclusions or 
recommendations. I believed that the need for MI by healthcare professionals did not 
stop when UKMi services closed because the care of hospital patients is 24 hours, 7 
days a week. The standard and quality of MI enquiry handling and documentation, 
usually related to an individual patient, should be no different according to the time of 
day or night that this might be needed but I considered that in practice, there may be a 
difference. Therefore, based on the body of research and my own experiences, as both 
a MI and an on-call pharmacist, I began to strongly believe that there was a need to 
understand how medicines advice is managed out of hours. I wanted to find out how 
on-call pharmacy services are provided across England and the support that 
pharmacists receive, what the information needs (if any) are of those that use the 
service, how frequently medicines advice is provided, and how such enquiries are 
handled. Rather than just focus on quantitative methods, I also wanted to explore the 
opinions and perceptions of the on-call pharmacists that provide this service, and of 
those who use it. This might lead to a better understanding of the views of those 
providing, and those using on-call pharmacy services. This research might then lead to 
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recommendations for on-call pharmacy services or identify future research. I hoped 
that through formal study, culminating in this PhD, these questions/ambitions could be 
answered in a robust way and lead to an improvement in on-call pharmacy services 
and ultimately to improved patient care.  
 
1.2 General overview 
Hospital pharmacy services historically only supplied medicines to patients treated by 
the organisation. However, as medicines became more complex (circa1960s) hospital 
pharmacy developed from its supply function to a more ‘clinical’ role. 26 Hospital 
pharmacists’ ‘clinical role’ involved them working in particular specialisms, e.g. 
medicine, surgery, trauma and orthopaedics, whilst reviewing the appropriateness of 
prescribing and advising clinicians accordingly.  A specialism within pharmacy that 
developed alongside this ‘clinical’ role was drug information. 
 
The term drug information was phased out in 2000 because ‘drug’ had become 
associated with drugs of abuse, and instead ‘medicine’ was adopted, and the service is 
now commonly known as MI. 27 Initially developed from two centres (London and 
Leeds) in 1969, today there are now approximately 200 ‘local’ and 14 ‘regional’ centres 
and are recognised as part of the Specialist Pharmacy Service (SPS). 28 Local centres 
are usually based in a hospital and provide a service to that organisation, whilst 
regional centres predominantly receive questions from primary care but also provide 
specialist services on medicines, for example medicines in lactation, pregnancy, renal 
disease and dental care.  Today, as previously described, these MI centres, collectively 
termed UKMi, provide a service during typical ‘office’ hours similar to other hospital 
pharmacy services. Healthcare professionals usually working in the same hospital can 
contact the MI service with questions about medication. In a hospital setting, these 
questions usually involve those seeking advice to support and influence clinical 
decisions about the care of individual patients. However, sometimes clinicians may 
seek evidence-based information relating to the general use of medicines.  
 
According to the Oxford Dictionary, ‘information’ is defined as facts provided or learned 
about something or someone. 29 MI has been defined as the provision of unbiased, 
evidence-based and critically evaluated information about medicines, in an attempt to 
improve patient care. 27 However, it is this researcher’s opinion that the term medicines 
advice is a more appropriate term to use. Advice is defined as guidance or 
recommendations offered with regard to prudent future action 29 and this better reflects 
practice and demonstrates it is not just facts that are provided. Medicines advice could 
15 
 
therefore be defined as the provision of guidance or recommendations based on 
unbiased, evidence-based and critically evaluated information about medicines, in an 
attempt to improve patient care. It is for this reason that the terms MI and medicines 
advice are used interchangeably throughout the thesis. In recent years, one regional 
UKMi centre has changed their name from a MI service to a Medicines Advice 
service.30 
 
MI services are typically provided by pharmacists, although a limited number employ 
pharmacy technicians and health science graduates. When MI staff receive a question 
or ‘enquiry’, they will first ensure that they have all the necessary background 
information from the enquirer. After agreeing a timeframe in which a response is 
needed, and how that would be communicated to them, a number of information 
sources are accessed by the member of MI staff to find information relevant to the 
enquiry. Once the information is collated, it is then critically evaluated allowing an 
answer/response to be formulated. This is then communicated to the enquirer either 
verbally or in writing as agreed. Throughout this process, all aspects of the enquiry 
answering process is documented using a bespoke database (MiDatabank).  
 
Depending on the complexity of the enquiry the MI service assign a complexity level, 1, 
2 or 3, to the enquiry. This is independent of the time taken to complete or the method 
used to communicate a response and does not have an impact on the urgency or the 
prioritisation of an enquiry. Level 1 questions are defined as ‘simple enquiries’ which 
can be answered using data from one or two standard sources. Level 2 and 3 
questions are defined as ‘complex’ enquiries: level 2 require the use of multiple and 
more specialist sources where the available evidence provides a reasonably clear 
answer or course of action; level 3 is defined as an enquiry in the absence of a clear 
answer or course of action from available sources where professional judgement is 
required to provide advice. This may require specialist evaluation of multiple sources 
and the evaluation of primary literature. 4  
 
1.3 NHS policy development affecting MI services 
In 2012, during the first year of this research, the NHS was in a relatively stable period. 
However, in recent years there have been a plethora of changes and policies 
developed by or on behalf of the NHS which had an effect on provision of pharmacy 
services and therefore potentially impacted on this study. Panel one identifies key 
policy documents up to January 2019, although the extent to which these will impact on 
UKMi is still yet to be fully understood. 
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Panel 1. Summary of key policy documents 
• NHS England. The Review of Specialist Pharmacy Services in England; May 
2014.  
• NHS England. NHS Five Year Forward View; October 2014.  
• Department of Health. 7-day NHS services; July 2015.  
• NHS England. Transformation of seven day clinical pharmacy services in acute 
hospitals; September 2016. 
• Lord Carter of Coles. Operational productivity and performance in English NHS 
acute hospitals:  Unwarranted variations; February 2016.  
• NHS England. The NHS Long Term Plan; January 2019. 
 
Since its conception in 1948, the NHS has undergone many structural re-organisations. 
In its current guise, the fundamental structure consists of primary, community, 
secondary and tertiary care. However, since the Health and Social Care Act was 
implemented from 1st April 2013, the NHS has become more complicated, with the 
introduction of Commissioners and Providers. 31 For example, in primary care, general 
practice and community pharmacies are Providers, with Clinical Commissioning 
Groups (CCGs) and Local Authorities being Commissioners. In secondary or tertiary 
care, the Providers are hospitals with NHS England, and CCGs being the 
Commissioners. These changes resulted in the abolition of Primary Care Trusts which 
had historically funded the majority of regional MI centres. This brought about 
uncertainty in the way in which MI services, predominantly regional services, were 
funded and led to the SPS Review in England (2014). 28  
 
The review, published in May 2014, made a number of recommendations about the 
organisation, commissioning, governance, accountability and leadership of SPS in 
England. The review made some key recommendations, the most significant for MI 
being that there should be four hubs (one per NHS region) and six spokes. As of early 
2019 this re-organisation of regional centres and services is in progress. Although not 
seen to date, this could mean closure of some regional centres, or their work 
subsumed by other centres. The impact of this report is however unlikely to have a 
substantial impact on ‘local’ MI services, although this is not the case for subsequent 
reports described. 
 
Greater integration of services is certainly something that the NHS is looking towards, 
as outlined in the Five Year Forward View published in October 2014. 32 This report set 
out the future of NHS services in England and stated that change was needed for the 
NHS to survive. It highlighted that the traditional divide between primary care, 
17 
 
community services, and hospitals is increasingly a barrier to the personalised and 
coordinated health services patients need.  
 
As a result, every local health and care system in England was asked to come together 
to create a Sustainability and Transformation Plan (STP) to take forward the 
implementation of the Five Year Forward View.  Of the 44 STPs developed, only a 
small number of STPs included pharmacy or medicines management services in their 
plans to encourage greater collaborative working within a sector, e.g. hospitals, and 
between sectors, e.g. hospital and primary care. However, the researcher is aware of 
organisations within STPs beginning to merge some MI centres and/or outsourcing 
them to other Trusts or regional MI centres.   
 
In 2015, the UK government also announced that it would implement a 7-day NHS 
service by 2020. 33 Whilst this has until recently focused on medical staffing, NHS 
England published its report entitled ‘Transformation of seven-day clinical pharmacy 
services in acute hospitals’ in September 2016. 34 Although this report focuses on 
developing and extending the clinical pharmacy service, it does not explicitly refer to 
infrastructure services including MI.   
  
In early 2016, Lord Carter of Coles published an independent report ‘Operational 
productivity and performance in English NHS acute hospitals: Unwarranted variations’. 
35  The significance of this was that all Trusts had to develop and implement a Hospital 
Pharmacy Transformation Programme (HPTP) by April 2017 and ensure that more 
than 80% of Trusts’ pharmacist resource is utilised for non ‘back office’ functions, 
namely direct medicines optimisation activities, medicines governance and safety 
remits (not explicitly defined). This has the potential to impact MI services if Trusts 
perceive these not to be a patient-facing activity. The researcher is aware of Trusts 
classifying their MI services as ‘back office’ and merging or outsourcing to other Trusts 
or regional MI centres in order to achieve the 80% cited in HPTPs. Although less likely, 
this could be applied to on-call pharmacy services. 36  
 
In 2019 the NHS Long Term Plan was published and whilst it does not specifically refer 
to MI services, it does include a vision for developing pharmacy roles, e.g. clinical 
pharmacists as part of primary care networks, and a more integrated NHS. 37 Both the 
effect of the SPS Review and the Lord Carter of Coles report on MI services may be 
mitigated by the recommendations of this latest plan, as pharmacists within primary 
care networks may require greater support. 
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In summary, these reports will affect the organisational structure of MI services 
because of required efficiencies. As the national landscape changes so that the health 
system becomes increasingly integrated, this may present opportunities as there may 
be a greater need for MI services. However, at the same time this may create 
challenges for MI services to operationally deliver and respond to further developments 
 
1.4 Literature Review 
The literature review relates to both the provision of MI services and on-call pharmacy 
services, both of which provide medicines advice during and outside normal working 
hours, respectively. 
  
In order to understand the provision of pharmacy services and medicines advice, the 
first part of this review has evaluated the literature for how such services are typically 
provided during normal working hours. The provision of medicines advice during 
normal working hours is usually undertaken by MI services as these are already well 
established and previously described (Section 1.2). The literature for MI has been 
summarised into three themes (Sections 1.4.2) to aid the reader in understanding the 
body of work published. The second part of this review evaluates the literature for on-
call pharmacy services, which includes the provision of medicines advice, and has also 
been summarised into three themes (Sections 1.4.4). Within the themes for MI and on-
call pharmacy services, the literature within the tables is presented chronologically to 
illustrate how it has changed with time.  Review articles are the exception and are 
therefore presented at the beginning of each theme where applicable. 
 
1.4.1 Search strategy 
The bibliographic databases Scopus, Embase and Medline were searched. In addition, 
the catalogue of available UKMi Practice Development Seminar poster abstracts were 
reviewed as this resource is not included within the bibliographic databases. For 
thoroughness, Regional MI Directors were also contacted for any studies relating to MI 
out of hours that they, or their regional UKMi research leads, were aware of that may 
not have been published. Furthermore, the National electronic Library for Medicines 
(NeLM) and UKMi website were searched for relevant publications (grey literature). 
 
The search terms chosen by the researcher, as outlined in Appendix 1 and 2, were 
used to identify the literature for hospital MI services or hospital on-call pharmacy 
services. These were the two areas that the researcher was particularly interested to 
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understand what had been published previously and the methods used. These search 
terms were broad and so when there was a high number of results, other keywords 
were combined to reduce the number of irrelevant hits whilst ensuring that relevant 
papers were not inadvertently excluded. For example, for one bibliographical database 
the search term ‘patient’ was used to avoid including studies that were about provision 
of MI services to patients. However, different combinations of search terms were used 
to minimise the likelihood of excluding relevant papers as outlined in Appendix 1 and 2. 
Using the thesaurus associated with each bibliographic database determined the most 
appropriate search term for the researcher to use, thereby enabling the use of 
controlled or standardised vocabulary. This was achieved as each bibliographic 
database has its own vocabulary for searching and so there can be subtle differences 
between bibliographic databases. For example, according to EMTREE the thesaurus 
associated with Embase, the correct search term to use for medicines information 
services was ‘Drug Information’. However when searching Medline, the thesaurus 
MeSH was used and the correct term for medicines information services was ‘Drug 
Information Services’. Identifying search terms using the associated thesaurus for each 
bibliographic database therefore ensured that the topics had standardised search 
terms or keywords assigned to them. To allow relevant articles to be located, the 
search term or keyword and all subheadings were ‘exploded. ‘Exploding’ a keyword in 
this way means that it minimises the risk of missing relevant information from the 
search because ‘narrower’ terms are included. Using the Medline search term ‘Drug 
Information Services’ as an example, the following illustrates its subheadings and what 
is included when the term is exploded: 
Panel 2. MeSH search terms for use within the bibliographical database 
Medline 
 
Drug Information Services+ 
Adverse Drug Reaction Reporting Systems 
Clinical Pharmacy Information Systems 
Prescription Drug Monitoring Programs 
 
An ‘exploded’ search term is illustrated by the prefix ‘ALL’ or ‘exp’ depending on the 
database used. For example (exp *DRUG INFORMATION/ OR exp *MEDICAL 
INFORMATION/) AND exp *HOSPITAL PHARMACY/ or (((ALL(medicines 
information)) OR (ALL(drug information)) OR (ALL(advice))) AND ((ALL(on call)) OR 
(ALL(on-call)) OR (ALL(emergency)))) AND (ALL(pharmacist)). 
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Where a search term was not available, free text or ‘all fields’ were used, for example 
“medicines information” or medicines information.af, respectively. These were chosen 
by the researcher based on the search term that would have been used had it been 
available or existed as a keyword in other bibliographical databases. This also meant 
that the likelihood of missing any relevant papers was further minimised.    
 
The exclusion criteria were defined before the search strategy. This excluded studies 
which did not relate to the provision of a hospital-based MI service, those involving 
hospital-based MI services which solely provided a service to primary care, the 
community setting or patients, or studies about patient medicines helplines specifically 
because they were not relevant to the provision of MI services to secondary healthcare 
professionals.  Opinion papers were also excluded  Only studies relating to MI or on-
call pharmacy services to healthcare professionals were included. Initially any paper 
which appeared related to these two services were included based on a review of the 
titles by the researcher. Following this first review, the abstracts of these studies were 
analysed by the researcher. Papers were only included if they related to the provision 
of MI or on-call pharmacy services to healthcare professionals.  
 
The references cited by those papers identified via bibliographic database searches 
were also reviewed. Where relevant, these additional studies were obtained. 
References within the systematic reviews included in this critical discussion were 
excluded from the researcher’s analysis to avoid duplication. However, any papers 
cited by the reviews which were relevant and applicable to highlight within the critical 
evaluation were referenced by including the lead author(s) name. Where there was 
more than one paper of note, these were stated in alphabetical order.  
 
The titles of publications generated from the search strategies for both MI services and 
on-call pharmacy services were first reviewed. The abstract of any that appeared 
relevant were then reviewed according to the inclusion and exclusion criteria previously 
described. As a result, papers were either accepted or rejected for inclusion within the 
literature review. The publications accepted for review were then reviewed to remove 
any duplicates. After this process was completed, a total of 23 papers (included 2 
reviews) were identified relevant to MI services (Section 1.4.2) and 15 for on-call 
pharmacy services (Section 1.4.4).  
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1.4.2 MI provision 
This initial part of the review evaluated the literature relating to MI provision during 
normal working hours and were summarised into the following three themes: 
 
a. MI service provision, i.e. operational aspects such as opening hours, services 
provided, staff handling enquiries, types of enquiries and enquirers.  
b. User satisfaction of MI services.  
c. Impact of MI services on patient care or patient outcome. 
 
Inevitably, there is some overlap between the studies included within these themes. 
For example, some of the literature about user satisfaction also included elements 
about the impact of MI services on patient care or outcome. Where this occurred, 
cross-reference is made within the critical evaluation completed in the relevant section. 
 
For each of the three themes, relevant studies are detailed and critiqued individually 
within a table format. This format was used to ensure that information was not 
inadvertently omitted and provide a consistent structure to displaying study information. 
The headings used were reference (including country of publication/relevance), the 
aims and objectives, type of study, what was the study about, outcome measure(s) and 
key findings/conclusions (relevant to this research). The information documented for 
each of these headings is the researcher’s analysis of the study/paper. A critical 
evaluation of the publications is provided after each table and general limitations 
associated with MI publications across all three themes is included in Section 1.4.3. 
 
Eleven papers about MI service provision were retrieved and are summarised in Table 
1 and critically evaluated in the text of the thesis.  Six of the 11 studies reviewed and 
summarised in Table 1 concentrated on service provision. Five additional studies 
reported on elements of service provision although this was not the primary purpose of 
the study as they had either focused on satisfaction or outcome. 
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Table 1. Publications relevant to MI service provision  
Reference 
(country) 
Maguire ME, D’Arcy PFD, Smith AMJ. From the drug information 
centres. A decade of drug information experience in Northern 
Ireland. Journal of Clinical and Hospital Pharmacy 1985; 10: 297 
– 302 (Northern Ireland) 38 
Aim & objectives Type of study What was the 
study about? 
Outcome 
measure(s) 
Outline 
development of 
combined Drug 
Information Service 
and Poison 
Information 
Service. 
Descriptive study of 
single regional MI 
centre in Northern 
Ireland. 
Staffing, enquirer 
type, enquiry 
category and time 
enquiries received.    
 
 
Data analysis of 
enquiry workload 
(1975 – 1984) 
handled by regional 
MI centre. Survey 
(1978-1981) of time 
enquiry received. 
Key Findings/ 
Conclusion 
Staffing included principal pharmacist, 3 staff pharmacists, rotational 
pharmacist, rotational pre-registration pharmacist, secretary. 
Pharmacists were the most frequent users (46%, n=4407/9615), 
followed by physicians (34%, n=3268/9615) and nursing staff (12%, 
n=1178/9615). Other healthcare professionals (defined as dentists, 
dieticians, laboratory staff) accounted for the remainder of enquirers 
(8%, n=762/9615). The three most common enquiry types received 
were pharmaceutical (not defined) (19%, n=1754/9168), 
availability/supply (18%, n=1671/9168) and administration/dosage 
(15%, n=1360/9168). Other types of enquiry received comprised of 
adverse effects (10%, n=903/9168) choice of 
therapy/indications/contraindications (9%, n=844/9168) 
pharmacology/pharmacokinetics (8%, n=707/9168), identification (6%, 
n=528/9168), interactions (3%, n=320/9168), poisoning (2%, 
n=164/9168). Enquiries categorised as ‘other’ accounted for 10% 
(n=917/9168). Over a third of enquiries were received between 2pm 
and 5pm (37%, n=1442/3870), followed by 30% (n=1144/3870) 
between 11am – 1pm and 24% (n=939/3870) between 9am – 11am, 
and 8% (319/3870) between 1pm and 2pm. Only 0.5% (n=20/3870) 
were received between 5pm and midnight and 0.2% (n=6/3870) 
between midnight and 9am the following morning. Two bulletins were 
circulated to hospital clinicians and GPs. 
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Reference 
(country) 
Maguire ME, D’Arcy PFD. Drug information services in four 
capital cities in the United Kingdom. ‘A tale of four cities’ – 
London (North East Thames), Cardiff, Belfast, Edinburgh. Journal 
of Clinical Pharmacy and Therapeutics 1988; 13: 207 – 212 (UK) 39 
Aim & objectives Type of study What was the 
study about? 
Outcome 
measure(s) 
Not clearly stated. 
Authors (note two 
same as study 
above) makes 
reference in the 
discussion section 
that one of the 
prime objectives 
was to gain 
information on the 
actual costs of a 
hospital pharmacy-
based UKMi 
service.  
Survey. 
 
Purposeful 
sampling of four 
hospital-based 
UKMi centres 
(London, Cardiff, 
Belfast, Edinburgh). 
Survey conducted 
in 1985.  
Service provision 
and population 
served, staff, 
available resources, 
enquiry workload 
and other services.  
 
 
Key Findings/ 
Conclusion 
Data for all centres was collected. All centres provided a service 
between 9am and 5pm Monday to Friday (one centre also provided a 
service on Saturdays). All provided voluntary emergency on-call cover 
and each of their hospital pharmacies provided a 24 hour service, 
although the nature of this service is not defined by the authors. The 
authors summarise the different staff groups that work within each 
centre and the total salaries paid per year. All centres were staffed by 
pharmacists. A list of computer hardware and software is provided 
and on-line resources accessible. The number of enquiries are 
provided by each centre (mean 2,249) and enquirer type is stated for 
three of the services; pharmacists being the largest users (58%, 50% 
and 43%), The cost of any enquiry at the four UKMi centres surveyed 
based on the time involved in this activity and staff salaries ranged 
from £5.36 - £10.80. 
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Reference 
(country) 
Rosenberg JM, Koumis T, Nathan JP, Cicero LA, McGuire H. 
Current status of pharmacist-operated drug information centers 
in the United States. American Journal of Health System 
Pharmacy 2004; 61: 2023 – 2032 (US) 40 
Aim & objectives Type of study What was the 
study about? 
Outcome 
measure(s) 
Identify the current 
provision of MI 
services in the US 
and Puerto Rico 
and compare the 
results to previous 
studies conducted 
in past 30 years. 
Postal survey of US 
and Puerto Rico MI 
services.  
 
Sent to 151 centres 
to complete 44 
multiple choice and 
‘fill in the blank’ 
questions.  
Information on 
service provision, 
resources and cost-
effectiveness, 
resources and 
training, and the 
impact of advice 
provided on 
prescribing.  
Identify trends in MI 
centre growth and 
development. 
Key Findings/ 
Conclusion 
A total of 81/119 (68%) MI service responses met inclusion criteria 
and were included in the analysis. Nearly half (48%, n=39/81) 
provided out-of-hours services with 72% (n=28/39) stating that this 
was provided by staff in the organisation’s pharmacy department. A 
small number (5%, n=4/81) provided a 24 hour MI service.  MI 
services were staffed by pharmacists (average 2.5 per centre). The 
most common type of enquiries reported were therapeutics (defined 
as therapeutic use and compatibility), adverse reactions, identification 
of US or foreign products, and dosage. These had remained 
unchanged from previous study results. Pharmacists (not 
differentiated between hospital and community) were the most 
frequent users of the service, followed by physicians and nurses. This 
finding was also consistent with previous study results. On average, 
82% of enquiries were received by telephone. A response was 
provided verbally in 70% and in writing in 10% of enquiries. The five 
most frequently reported resources considered useful by MI centres 
according to each category type, was provided. Micromedex 
Healthcare was reported as the most useful resource in answering 
93% (n=14/15) enquiry types. Half (50%, n=76/151) respondents 
reported being involved in experiential training. Other centres also 
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reported as being a Pharm.D. programme training site, an 
undergraduate pharmacy degree (no longer provided), programme 
training site and involved in MI fellowships. Just over half (51%, 
n=40/78) reported having a formal QA programme which primarily 
focused on enquiry answering, as per previous study result. The 
survey found that 52/77 (68%) of the responding organisations 
believed that physicians frequently altered their patients’ drug therapy 
as a result of the advice provided by the MI service. However, only 
18/52 (35%) organisations objectively measured this, primarily by 
enquirer follow up. Unfortunately, no details were given to assess this. 
Overall the authors conclude that the number of MI centres and MI 
pharmacists has declined since 1986 when the first survey was 
completed. 
Reference 
(country) 
Timpe M, Motl SE. Increased availability of information resources 
and the effects on the complexity of drug information requests 
asked to an academic center. Pharmacotherapy 2004; 24 (10): 1429 
(US) 41 
Aim & objectives Type of study What was the 
study about? 
Outcome 
measure(s) 
Determine the 
impact of increased 
availability of 
information 
resources on the 
number, type and 
complexity of 
enquiries handled 
by a MI service over 
a 9 year period.  
Retrospective  
analysis of  
documented  
enquiries handled. 
Enquiries received 
by a US MI service 
over a 9 year period 
(1995 – 2003).  
Number of 
enquiries handled, 
time spent 
answering each 
enquiry, the type 
and number of 
resources used and 
classification of the 
question. 
Key Findings/ 
Conclusion 
Number of enquiries decreased by a third, but the time spent 
answering an enquiry increased from a mean of 28 to 55 minutes. 
Enquiries involving primary literature searched and critical evaluation 
increased from 11% of total enquiries to 37% (p<0.0001). The time 
spent on literature search requests increased from an average of 70 
minutes to 104 minutes. The type of enquiry remained largely 
unchanged. Decrease in reference and monograph requests, product 
identifications and product availability. 
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Reference 
(country) 
Bertsche T, Hammerlein A, Schulz M. German national drug 
information service: user satisfaction and potential positive 
patient outcomes. Pharmacy World and Science 2007; 29: 167 – 
172 (Germany) 42 
Aim & objectives Type of study What was the 
study about? 
Outcome 
measure(s) 
Assess and explore 
user satisfaction of 
a single German 
drug information 
service and its 
impact on patient 
outcomes.  
Prospective survey Piloted survey sent 
by fax immediately 
after advice was 
provided to every 
healthcare 
professional that 
had contacted the 
MI service with a 
patient-related 
enquiry over 1 year. 
 
Route answer 
received, 
helpfulness 
regarding patient 
physician 
counselling, clarity 
& understanding of 
advice, timeliness 
of response, 
professional quality 
of the service, 
advice/counselling 
impact on patient 
outcome; any 
comments/suggesti
ons. 
Key Findings/ 
Conclusion 
A total of 1,639 enquiries were answered during the year, with the 
majority of enquirers being community pharmacists (95%). Most 
enquiries were answered by phone (69%), followed by fax (28%), 
postal mail (1%) and email (1%).  A total of 1,107 surveys were sent 
to enquirers and just under half returned a completed response (45%, 
n=455/1,017) all of which were included for analysis. Overall 
satisfaction ratings (rating 1=poor, 2=sufficient, 3=satisfactory, 
4=good, 5=very good) for study outcomes were 4.6 +/- 0.6 
(helpfulness regarding counselling patients and/or physicians), 4.6 +/- 
0.7 (timeliness of response), 4.7 +/- 0.5 (clarity of/understanding 
advice) and 4.7 +/- 0.5 (professional quality of service). In 42% cases 
(n=190/455), a potential positive patient outcome was reported. The 
remaining 58% stated unknown or no response was reported. 
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Reference 
(country) 
Fathelrahman AI, Awang R, Bashir AA, Taha IA, Ibrahim HM. User 
satisfaction with services provided by a drug information center 
in Sudan. Pharmacy World and Science 2008; 30 (6): 759 – 763 
(Sudan) 43 
Aim & objectives Type of study What was the 
study about? 
Outcome 
measure(s) 
Assessed 
satisfaction of 
enquirers that had 
previously used the 
MI service 
Retrospective Semi-structured 
telephone follow-up 
piloted 
questionnaire of 
randomly selected 
enquirers 
(n=423/3,308) over 
a 3 year period. No 
users were included 
more than once. 
General service, 
response time and 
communication of 
advice satisfaction 
Likelihood of 
contacting the 
service in the future 
Key Findings/ 
Conclusion 
All enquirers (except one) consented to participate (99.8%): 
pharmacists (36.1%), physicians (29.5%), members of the public 
(22.3%), students (7.5%) and other medical professionals (4.6%). 
Enquirers ranked their satisfaction as excellent or good for the 
following: general service (95.4%, n=399), time taken to answer the 
enquiry (86.5%, n=364) and communication of advice (defined as the 
way of asking questions, counselling, and answering different calls) 
(98.1%, n=413). The majority of enquirers would ‘probably’ call the 
service again (94.7%, n=397). 
Reference 
(country) 
Bramley D, Mohandas C, Soor S, Erskine D, Oborne CA. Does a 
medicines information service have a positive impact on patient 
care? Pharmaceutical Journal 2009; 282: 139 – 140 (England) 12 
Aim & objectives Type of study What was the 
study about? 
Outcome 
measure(s) 
Identified the 
proportion of 
enquiries involving 
patients, actions 
taken by enquirers 
as a result of 
Prospective survey. Patient-specific 
enquiries received 
from healthcare 
professionals by 2 
MI centres during a 
2 week period.  
The expected 
patient outcome 
(according to 
enquirer) at the time 
of contacting the MI 
service, the number 
of enquirers waiting 
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advice, impact on 
patient outcome. 
 
 
Healthcare 
professionals were 
asked by the MI 
staff at the time of 
the call (before 
advice given) three 
questions.  
Same healthcare 
professionals were 
then contacted 
between 7 and 28 
days later. 
for answer before 
proceeding with 
treatment and the 
action that they 
would take without 
access to MI 
service.  
Key Findings/ 
Conclusion 
A total of 40 patient-specific enquiries were from 17 (43%) 
pharmacists, 16 (40%) doctors, 6 (15%) nurses and 1 (3%) dentist. 
Most common enquiries were for information about choice of therapy, 
followed by drug administration or dosage, and adverse effects. 
The majority of enquirers (80%, n=32/40) were waiting for an answer 
from MI before proceeding. A quarter of enquirers (25%, n=12) stated 
that they would search the Internet if the MI service did not exist, 21% 
(n=10) would approach another member of the ward pharmacy team, 
19% (n=9) would ask another professional colleague, 19% (n=9) 
would look in books, 15% (n=7) would use other MI sources, 10% 
(n=5) would contact the drug manufacturer and 10% (n=5) mentioned 
other resources. At the time of the call, 14 enquirers (55%) predicted 
the patient would improve, 11 (38%) aimed to maintain the patient’s 
state of health, 4 (12.5%) stated prognosis was not known at this 
stage, and 2 (5%) thought the patient would deteriorate. 1 patient had 
died. A total of 32 (80%) follow-up telephone surveys were completed. 
Respondents indicated that 19 patients (59% of outcomes) matched 
the expected outcome, 3 (9%) had improved when it was expected 
that they would remain the same or deteriorate or the expected 
outcome was unknown and 6 (19%) remained the same when they 
had been expected to improve. Four outcomes (13%) were unknown. 
Of those followed-up, 30/32 (94%) had used the information or advice 
provided by MI.  
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Reference 
(country) 
McEntee JE, Henderson SL, Rutter PM, Rutter J, Davis HJ, Randall 
CJ. A survey of UK dental health professionals using a medicines 
information service: what questions do they ask and do they get 
useful answers? British Dental Journal 2011; 211 (1): 17 – 21 
(England) 44 
Aim & objectives Type of study What was the 
study about? 
Outcome 
measure(s) 
Assess what dental 
health professionals 
contacting a 
specialist regional 
MI service ask 
about, how advice 
provided to them is 
used, and whether 
they find the advice 
useful for patient 
care. 
Multiple choice, 
piloted 
questionnaire.  
Sent to 205 dental 
health professionals 
who had contacted 
the centre with an 
enquiry during a 6 
month period. 
Enquiry type, how 
advice was used by 
enquirer, service 
quality. 
Key Findings/ 
Conclusion 
A total of 151/205 (74%) questionnaires were returned. The majority 
(89%, n=135/151) were from general dental practitioners, i.e. from 
primary care. The most frequent type of question concerned 
antibiotics (32%). Enquiry categories not specific to antibiotics 
included choice of therapy (5%), adverse effects (5%), availability 
(4%), drug interactions (3%), drugs in pregnancy (3%), drug 
identification (3%) and dosage (2%). Enquiries were answered by 
telephone (89%), email (9%) or letter (2%). Nearly all enquirers (99%, 
n=144/145) considered that the advice received answered their 
question. Most used the advice provided (97%, n=146/151), for 
example in managing current patients or planning care (45%, 
n=65/144) of future patients. Of those who used information to inform 
current or future care of patients, nearly all (99%, n=141/142) 
considered the advice useful.  
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Reference 
(country) 
Bramley D, Innes AJ, Duggan C, Oborne A. The impact of 
Medicines Information enquiry answering on patient care and 
outcomes. International Journal of Pharmacy Practice 2013; 21 (6): 
393 – 404 (England) 10  
Aim & objectives Type of study What was the 
study about? 
Outcome 
measure(s) 
Assessed 
healthcare 
professionals’ 
opinions of the 
impact of MI advice 
on patients’ care 
and outcomes. 
Evaluated the views 
of independent 
clinicians on the 
impact. 
Prospective survey. During a 2 week 
period, MI centres 
(n=71) in Southeast 
England asked 
healthcare 
professionals 
contacting the 
service to 
participate in the 
study. Initial 
questionnaire was 
completed at the 
time of enquiry 
submission by 
enquirer. Enquirers 
contacted 2 weeks 
after receiving 
advice to complete 
follow-up 
questionnaire. 
Sample of enquiries 
(n=24) assessed by 
panel (3 medical 
consultants, 3 
senior clinical 
pharmacists). 
Impact of MI advice 
according to rating 
scales used by the 
enquirer and panel.  
Key Findings/ 
Conclusion 
35/71 (49%) MI centres participated in the study. Total of 179 sets of 
matching initial and follow-up questionnaires obtained. Hospital 
pharmacists/pharmacy staff (57%) were the most common enquirer, 
followed by hospital doctors (20%) and hospital /midwife/nursing staff 
(13%). Over half (54%) of enquirers used advice to check medication 
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safety, 44% to form part of their decision-making process, 30% to tell 
them the best plan of action and 22% to confirm a change in therapy 
was needed. The majority of enquirers (81%, n=145) who used the 
advice from MI rated the impact on patient care or outcome as 
positive: 19.6% (n=35) said it improved patient outcome and 61.5% 
(n=110) replied that their patients’ care was improved. Only 15.1% 
(n=27) reported no impact. No negative outcomes or cases of 
worsened patient care were reported. In 19.5% (n=35) of enquiries, MI 
pharmacists actively provided advice on issues that enquirers had not 
identified themselves. There was a trend for these enquirers to rate 
the impact of MI advice on their patients’ care more positively 
(P=0.057). No significant differences were found between enquirers’ 
professional roles and their impact rating of patient care or outcome 
(P=0.3). 
Reference 
(country) 
Alkhaldi N, Desborough J, Wright D, Wood J, House T. A five 
year review of patient focused medicine information queries at a 
large UK teaching Trust: assessing the trends, predicting the 
future. Journal of Pharmaceutical Care and Health Systems 2014; 
1: (3): 116 (England) 45 
Aim & objectives Type of study What was the 
study about? 
Outcome 
measure(s) 
Describe how the 
nature of MI 
enquiries has 
changed over time 
and to use this to 
predict how this 
may affect future 
demand. 
Retrospective 
analysis of 
enquiries at a single 
MI centre.  
 
 
All individual 
patient-based 
enquiries in the 
same two time 
points over a 5 year 
period (2006 to 
2010) were 
included.  
For each enquiry, 
origin, enquirer 
status, contact 
method, enquiry 
type, time taken to 
complete response, 
reply route, 
complexity of 
enquiry was 
collated.  
Key Findings/ 
Conclusion 
The authors found that enquiry numbers had increased by 50% over 
the study period, and the number of more complex enquiries had 
increased. The most common enquiry type received was 
administration (36%, n=583/1641), followed by choice of 
therapy/indication/contraindications (n=13%, n=211/1641), 
pharmaceutical (12%, n=203/1641) and availability/supply/formulary 
(12%, n=204/1641). Hospital pharmacists were the main user of the 
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service at both time points during the 5 year period (41%, 
n=654/1605). ‘Others’ were the next most frequent users of the 
service (33%, n=532/1605) and this group consisted of hospital 
nurse/midwife, primary care nurse/midwife, professionals allied to 
medicine, dentist and members of the public. Consultant (8%, 
n=127/1605), junior hospital doctors (7%, n=111/1605), Registrars 
(5%, n=80/1605) and GPs (4%, n=71/1605) are cited as the most 
common users after ‘Others’.  The authors reported that Level 2 and 3 
enquiries, and those enquiries received from dieticians, required more 
time to process. Enquiries classified as either administration or 
pharmaceutical enquiries took less time to answer than other enquiry 
types. 
Reference 
(country) 
Entezari-Maleki T, Taraz M, Javadi MR, Hajimiri MR, Eslami K, 
Karimzadeh I, et al. A two-year utilization of the pharmacist-
operated drug information center in Iran. Journal of Research in 
Pharmacy Practice 2014; 3 (4): 117 – 122 (Iran) 46 
Aim & objectives Type of study What was the 
study about? 
Outcome 
measure(s) 
Assess health 
services of a drug 
and poisons 
information service 
to enquirers during 
a 2 year period. 
Retrospective 
analysis.  
Enquiries received 
by a single MI 
service over a 2 
year period. 
Enquirer 
demographic, 
enquiry type, 
summary of 
question and 
answer, resources 
used, route by 
which answer was 
provided. 
Key Findings/ 
Conclusion 
A total of 110,310 calls were received during the two year period. Of 
these, 9.2% (10,118) were received from healthcare professionals and 
the remainder from the public. Pharmacists (40%, n=4025) were the 
most frequent users of the service, followed by general physicians 
(19%, n=1923) and nurses (11%, n=1144). Specialists (5%, n=470), 
sub-specialists (1%, n=56), and other healthcare professionals 
(undefined) 24% (n=2400) accounted for the remaining calls. The 
most common types of enquiries handled included therapeutic use of 
drugs (19.3%), drug identification (18.7%), drug availability (15.9%), 
adverse drug reactions (15.1%) and drug administration (7.6%). ‘Up 
To Date’, an evidence-based electronic clinical decision support tool, 
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was the most common resource used (35.5%) by call handlers when 
answering enquiries. The telephone was the most frequently used 
route when providing responses to enquirers (approx. 98%, p=0.001). 
 
Published work dates from the 1980s to present day and mainly originates from the US 
and UK. This is to be expected as these countries have the longest history of providing 
MI through established centres. Other parts of the world such as Brazil, Canada, 
Denmark, Germany, Norway and Sudan have developed MI services but have mainly 
reported on user satisfaction and the impact of MI advice on patient care or outcome 
(Table 2 and 3). As some of these publications report, to some extent, about MI service 
provision any relevant data has been included within Table 1 and in this critical 
discussion.10,12,42-44 Most studies were conducted at a single point in time, i.e. cross-
sectional, but two studies were longitudinal and focused on service provision over a 9- 
and 10-year period, 38,41 with a further study that looked at data over a 30-year period. 
40 The data generated from the combination of both longitudinal and repeated cross-
sectional studies allow trends/patterns in service provision over time to be identified. 
However, depending on the time period of the study it may mean that findings are no 
longer relevant to current practice. This is especially true over long time periods, for 
example in the survey where 30 years had elapsed. In such time periods practice and 
policy will have changed and is particularly true for organisations such as the NHS as 
these policy changes will impact on UKMi service provision and so findings of such 
studies need to be viewed alongside policy that may have affected organisational 
delivery of services (e.g. Carter 35). This is where cross sectional studies can be helpful 
as these snap shots provide data at a point in time and may be more appropriate 
where changes in practice are observed quickly due to implementation of policy.  
 
Two studies that focused primarily on service provision involved postal surveys of 
centres, 39,40 with the remainder undertaking analysis of workload data. 38,41,45,46 Whilst 
the methods reported may have changed over time, the types of data collected, and 
their findings, have largely remained the same. The studies summarised in Table 1 
primarily provided quantitative data and included information about the opening hours 
and time enquiries received, 38,39 staff working in MI centres, 38-40 the types of enquirers, 
10,12,38-40,42-45 and enquiries, 10,12,38,40-42,44,45  routes of communication, 40,42,44,46 resources 
used, 39-41 time spent handling an enquiry, 41,45 the training provided, 40 and the 
complexity of the enquiry. 45 These will now be discussed in more detail.  
 
Maguire et al and Rosenberg et al, were the only studies that provided information 
about opening times for UK and US MI services respectively. 39, 40 Both authors 
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reported low levels of non-standard working hours with Maguire et al finding just one 
UKMi centre open on a Saturday 39 and Rosenberg et al identified four US MI centres 
which provided a 24 hour MI service. 39 Both authors make the point that the hospital 
pharmacy provided a 24 hour service, i.e. on-call pharmacy service. It is unclear 
whether the authors were therefore implying that a MI service out of hours was 
therefore not required. 39, 40 Based on the limited published literature, it appears that MI 
services provide very little support outside of normal working hours. A more detailed 
discussion of on-call or pharmacy services and MI support out of hours can be found in 
Section 1.4.4. 
 
Pharmacists were frequently reported as the most common users of MI services 
(where data was available) irrespective of the study’s country of origin, followed by 
doctors and nurses. 10,12,38-40,42,43,45,46 The data is not unexpected as MI centres are 
usually provided by the pharmacy department and it is reasonable to assume that there 
is a greater awareness by pharmacists about the services MI provides.   
 
Only three studies, two UK and one US, have detailed the types of staff to work in MI 
centres. 38-40 The two UK studies published in the 1980s and therefore relatively dated, 
reported MI services were almost exclusively staffed by pharmacists. 38,39 These 
findings are now outdated and do not reflect the types of staff working in UKMi services 
today as previously described, i.e. pharmacists, pharmacy technicians and health 
science graduates. 47  
 
Studies have attempted to categorise the type of enquiry fielded, and whilst there is no 
universal categorisation choice of therapy, therapeutic use, drug availability and drug 
administration appear to be the most common enquiry types cited (where stated). 
12,38,40,44-46 Only one study, evaluating an Iranian MI service, linked the most common 
enquiry categories according to the type of enquirer. 46 Recording of enquiries handled 
by UKMi centres and the ability to readily report this data, has improved during the last 
15 years through the implementation of the bespoke MI enquiry answering database 
(MiDatabank). 48 This can be seen in the improved enquiry workload data reported by 
four UK studies since 2009. 10,12,44,45 MiDatabank is now available in other countries but 
none of the studies in Table 1 originate from these areas of the world. 48 It is not known 
if such enquiry answering databases (or similar) are used to document medicine advice 
calls out of hours. Therefore, if quantitative research methods were only used to 
determine the types of enquiries handled by on-call pharmacy services, this data may 
not be documented or if it is, recorded in the same way as MI services. For the 
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purposes of this research, qualitative methods may be an alternative approach to 
determine the types of enquiries handled by on-call pharmacy services.  
 
Little information was provided in the published studies as to the route of 
communication used by MI services for receiving enquiries. However, one study 
reported that most enquiries were received by telephone (82%). 40 The same US study 
also reported that 70% of its responses were provided orally (did not specify telephone 
or in person), 20% both oral and written and 10% in writing only. An Iranian study 
reported that nearly all MI service enquiry responses were made by telephone (98%). 
46 This is also reflected in a UK study in which most responses were provided by 
telephone (89%). However, email (9%) and letters (2%) were also used. 44 The use of 
telephone reflects an ease with which MI services can be accessed and enquirers can 
be contacted enabling information exchange and real-time clarification of any details if 
required. Both quantitative and qualitative research methods could be used to 
determine the routes used by healthcare professionals out of hours to seek medicines 
advice in the absence of MI services.  
 
Two studies (US, UK) reported information about the time taken for MI services to 
handle and process enquiries. 41,45 The US study gave details on an increased time to 
answer enquiries but no further details were provided. 41 A more detailed analysis of 
enquiries in the UK study reported that enquiries involving ‘complex’ cases such as 
drugs in pregnancy, adverse effects and drugs in breast milk took the most time to 
complete. In comparison, administration/dosage, pharmaceutical (medicines stability, 
formulation and compatibility) and availability/supply/formulary took the least time to 
complete. 45 This complexity was further elaborated on, with the mean time taken to 
provide a level 1 response (the simplest enquiries) being 32 minutes, compared to level 
2 (83 minutes) and level 3 (157 minutes). It is difficult to make any firm conclusions 
based on this published data from a single site but suggests that as the complexity of 
an enquiry increases, so does the time required to provide a response. Based on the 
researcher’s own experience, the nature of questions handled out of hours reflects 
those reported here, i.e. level 1 and 2, taking less time to complete. Qualitative 
research methods could be used to determine the complexity of enquiries handled out 
of hours by on-call pharmacy services.  
 
Information about the training provided by MI services is limited to one US study which 
reported that 50% of centres were involved in experiential training. 40 None of the other 
service provision publications summarised in Table 1 explored or evaluated the training 
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provided by MI centres. Based on the researcher’s own experience, UKMi services 
deliver training to a range of healthcare professionals including pharmacists, doctors 
and nurses to support the development of their MI skills.  
 
All publications that focused on service provision had some methodological limitations. 
For example, two studies did not clearly state their aims/objectives, or the methods 
used which makes it unclear whether the results reported was what the authors set out 
to find and how these data were generated. 38,39 Three studies did not fully report the 
data based on the stated aims which means the omission of some expected 
information. 38 41,45 This included for each of the MI services in the studies not reporting 
on the available resources, 38 the number of enquiries handled, 41 or a breakdown of 
enquirer origins. 45 It is therefore important that to ensure rigour in this research study, 
the aims, objectives, methods and results are clearly stated.  
 
In summary, studies evaluating the provision of MI advice showed that MI services are 
used by healthcare professionals, particularly pharmacists, during normal working 
hours. These provide some evidence about the level of service provision but due to the 
dates of publication and countries of study, these data are limited when compared to 
current UK practice. There are also difficulties establishing workload activity from the 
data because of a lack of universal enquiry categorisation. Based on the studies 
reported, quantitative methods will be used for this research to understand how on-call 
pharmacy services are provided by pharmacy departments across England and the 
workload handled, not restricting this to a single or small number of hospitals. This will 
increase the likelihood that the data generated is representative of hospital on-call 
pharmacy services in England. Quantitative methods will also be used to collect data 
on the staff providing on-call pharmacy services, the number of calls received, the 
enquirer type and the routes used to contact on-call pharmacists and what information 
is documented by the on-call pharmacist. However, studies which have reported 
workload data have based this on the enquiries that have been received and 
documented by MI services, and this may be an issue when determining the workload 
for on-call pharmacy services if there is a variation in documentation, as anticipated.  
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In this second section, 14 papers were retrieved which related to user satisfaction of MI 
services. This consisted of 5 cited in the reviews by Hands et al and Spinewine et al, 
and a further 9 publications through the search strategy employed and are summarised 
in Table 2. The specific studies referred to within the two reviews were by Baker and 
Gallo, Cardoni and Thompson, Moody, Pearson, and Repchinsky and Masuhara. 
These 13 papers are critically discussed in the text of the thesis. 
 
Table 2. Publications relevant to user satisfaction of MI services  
Reference 
(country) 
Hands D, Stephens M, Brown D. A systematic review of the clinical 
and economic impact of drug information services on patient 
outcome. Pharmacy World and Science 2002; 24: 132 – 138 (UK) 9 
Aim & objectives Type of study What was the 
study about? 
Outcome 
measure(s) 
Determine if MI 
services improve 
patient’s clinical 
outcomes to justify 
future investment in 
their provision and 
development. 
Systematic review  
In addition, a 
questionnaire was 
sent to all UKMi 
services which 
requested 
information on any 
relevant work 
carried out locally. 
Literature search 
from 1980 onwards.  
Questionnaires sent 
(n=244) to all MI 
services via 
regional MI centres 
(n=19) for 
information on 
relevant local work. 
Also sent to all UK 
Schools of 
Pharmacy Practice 
Research 
Departments. 
Establish clinical 
and economical 
impact of MI 
services on patient 
outcomes. 
Key Findings/ 
Conclusion 
Six published and one unpublished article met the assessment criteria 
according to the authors. Published studies included 5 retrospective 
analyses and 1 prospective evaluation; 2 of which were multi-centre 
and 4 single centre. Four studies assessed the impact of advice 
provided by a MI centre on patient care.  One study reviewed hospital 
mortality rates. Three of the studies were conducted in the UK, 2 in 
US and 1 in Canada. Studies included in the review were:  
 
38 
 
Stubbington et al: 3 month study using piloted questionnaire 
sampling doctors, nurses and pharmacists (n=161). Response rate 
(82%). A total of 125 respondents found information helped to prevent 
a potential adverse event (n=21); initiate new treatment (n=21); stop 
patient’s existing treatment (n=20); modify patient’s existing treatment 
(n=20); stop adverse event from getting worse (n=7); justify current 
therapy (n=16). Outcomes self-reported. No independent verification.  
Najabat et al: Enquiries (n=304) received from healthcare 
professionals during 1 month period.  Piloted questionnaire sent to 
each enquirer. Response rate 77% (n=234): 39% pharmacists, 32% 
doctors, 21% nurses. 224 (96%) said the information had been of use 
in some way. 138 (62%) cases where beneficial uses to patients 
identified. Benefits listed relate to patient management and not clear if 
these changes did have a positive impact on patient care. Outcome 
self-reported. No independent verification.  
Adams:  questionnaire sent to enquirers to 3 MI centres (hospital 
doctors (n=262) and hospital pharmacists (n=191)). Advice useful in 
subsequent management of 94% (n=394). Impact self-reported. 
Sample of questionnaire responses audited against medical records 
and corroborated in 92% of cases. A subsidiary study evaluated 
advice provided by a single MI centre. A total of 43 patients specific 
enquiries were available to follow-up, of which medical records could 
be obtained for 17 patients. In 15 (88%) of these, the questionnaire 
responses were corroborated by medical records.  
Bond et al: analysis of Medicare mortality rates and US Clinical 
Pharmacy Database across 1,209 hospitals. Analysed association 
between hospital mortality rates (adjusted for severity of illness) and 
clinical pharmacy services (including MI).  Where present (n=237 
hospitals), associated with 44 fewer deaths per hospital per year 
compared to those without MI service. Authors did not consider other 
patient outcomes. 
Cardoni and Thompson: A total of 491 enquiries, of which 350 were 
patient specific received during 4 month period. Enquirers followed-up 
by telephone by a member of the MI team. General and specific 
outcomes were identified. 329 (94%) were judged to have provided 
useful information and of these, 202 (58%) affected patient outcomes. 
Outcomes self-reported. No follow-up of patients.  
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Melnyk et al: Prospective evaluation of patient specific advice calls at 
single Canadian hospital (n=245/577). Enquiries were included if 
desired outcome could be identified, MI made a recommendation 
involving patient’s therapy and the enquirer was willing to participate 
(n=98/245). On completion of the enquiry, the MI pharmacist and 
enquirer identified possible desired outcomes (n=101) and agreed 
timeframe for follow-up. Desired outcomes included resolution of a 
therapeutic problem, reduction or elimination of symptoms, correction 
or slowing of the disease process, prevention of disease or symptoms, 
and optimisation of medicines administration. Approximately 1 – 2 
days after completion of the enquiry, a primary investigator (not 
defined) phoned the enquirer to confirm actual recommendation made 
by the MI service (n=230). Most of the recommendations (83.5%, 
n=192/230) made by the service were used by the enquirer. A panel 
(2 clinical pharmacists, 2 general medicine physicians) concluded that 
93 (94.9%) of the enquiries had been handled appropriately by the MI 
service. They found that 36 (46.8%) resulted in a positive patient 
outcome and in 24.7% cases a tangible outcome could not be 
measured if accepted interventions are evaluated, but the patient 
benefited from education about his/her therapeutic regimen. In 4% the 
patient experienced a negative outcome.   
Drolet & Repchinsky (unpublished): excluded as it related solely to 
community pharmacists.  
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Reference 
(country) 
Spinewine A, Dean B. Measuring the impact of medicines 
information services on patient care: methodological 
considerations. Pharmacy World and Science 2002; 24: 177 – 181 
(UK) 8 
Aim & objectives Type of study What was the 
study about? 
Outcome 
measure(s) 
Critical appraisal of 
papers assessing 
impact on patient 
outcome of passive 
information given to 
healthcare 
professionals by MI 
services. 
Review. Medline, EMBASE 
and the 
International 
Pharmaceutical 
Abstracts database 
(1970 – 2001) were 
searched.  
Identify key 
methodological 
issues 
 
Make 
recommendations 
for future research. 
Key Findings/ 
Conclusion 
Nine papers were identified: two studies undertaken in the UK, 5 in 
the US and 1 in Canada. Studies included in the review dated from 
1975 - 2000.  The studies included were: 
 
Pearson: US study which analysed random sample of requests from 
healthcare professionals (n=551) for accuracy, relevance, timeliness, 
adequacy and usefulness of information; also, use of information by 
the enquirer. Evaluation of these measures completed by 
multidisciplinary committee and enquirer survey. Physicians altered 
patient’s therapy mostly (56.4%), followed by pharmacists (40.8%) 
and nurses (35%). 
Cardoni and Thompson: see Hands (Table 2). 
Baker and Gallo: US study which assessed how advice provided by 
a MI service was used by enquirers (nurses, physicians and 
pharmacists) and user satisfaction. A random selection of enquirers 
(process not defined) were sent a questionnaire (n=77). Majority of 
respondents (91.1%) indicated that the information provided was 
frequently applied to patient care situations. Most of these arose 
regarding a specific patient (87%), and in 81% of these the 
information was applied. Respondents indicated that the information 
provided was most often used when starting a drug (31%), or when 
changing a schedule (18%), followed by discontinuation of a drug 
(5.5%) or changing the drug (3.7%). A fifth of respondents indicated 
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that the information did not change the planned use of a drug. Nearly 
all respondents agreed or strongly agreed that the response directly 
answered their question (91.6%), was clear (98.3%), was provided in 
a timely manner (98.3%) and provided enough information (93.3%).  
Repchinsky and Masuhara: Canadian study which analysed all 
requests from healthcare professionals (n=158) over a 4 week period 
for timeliness, accuracy, objectivity and completeness of the enquiry; 
also, use of information by the enquirer. Evaluation via enquirer 
survey.   
Golightly et al: all requests from healthcare professionals (n=11,424) 
over 2 years were analysed to determine the outcome (any beneficial 
effect on patient therapy) according to a physician. 
Moody: a random sample (method not stated) accounting for 10% of 
all requests from all physicians were analysed for correctness, 
completeness, timeliness and appropriateness of advice as evaluated 
by the Director of clinical services. 
Stubbington et al: see Hands (Table 2). 
Melnyk et al: see Hands (Table 2). 
Shah et al: UK study involving all patient-specific requests from all 
healthcare professionals (n=27) analysed for use of information, 
action taken, and patient outcome as assessed by the ward 
pharmacist.   
 
A number of factors are outlined by the authors of the review that they 
consider important when evaluating studies of MI services: study 
design, sampling, collecting and evaluating data, choice of endpoint 
measures, and validity. In conclusion, the authors make 7 key 
suggestions for future studies measuring the impact of MI services on 
patient care. 
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Reference 
(country) 
Schjott J, Pomp E, Gedda-Dahl A. Quality and impact of problem-
orientated drug information: a method to change clinical practice 
among physicians? European Journal of Hospital Pharmacy 
2002; 57 (12): 897 – 902 (Norway) 49 
Aim & objectives Type of study What was the 
study about? 
Outcome 
measure(s) 
Determined impact 
of MI advice on 
clinicians. 
Prospective survey. Structured postal 
questionnaire sent 
with written answer 
to enquirers who 
had contacted 
single MI centre 
over 18 months. 
Telephone 
enquiries excluded. 
Quality of written 
response 
(timeliness, 
relevance, 
‘adequately’ 
comprehensive, 
valuable references 
included) and 
impact of advice 
(change in clinical 
practice). 
Key Findings/ 
Conclusion 
A total of 117/163 (72%) physicians (hospital and GP) returned 
completed questionnaires. The assessment by enquirers of the quality 
of the written response was 96% (n=112) timeliness, 96% (n=112) 
relevance, 94% (n=110) adequately comprehensive and 85% (n=99) 
value references included. According to enquirers, 61% (n=71) 
reported that MI advice resulted in a change in clinical practice and 
30% (n=35) no change. A small number did not answer this question 
(9%, n=11/117).  
Reference 
(country) 
Bertsche T, Hammerlein A, Schulz M. German national drug 
information service: user satisfaction and potential positive 
patient outcomes. Pharmacy World and Science 2007; 29: 167 – 
172 (Germany) 42 
See Table 1. 
Reference 
(country) 
Fathelrahman AI, Awang R, Bashir AA, Taha IA, Ibrahim HM. User 
satisfaction with services provided by a drug information center 
in Sudan. Pharmacy World and Science 2008; 30 (6): 759 – 763 
(Sudan) 43 
See Table 1. 
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Reference 
(country) 
Basselin C, Ferreira E, Martin B, Touzin J, Morin C, Bussieres JF, 
et al. A survey on sources consulted by health care providers and 
on the satisfaction of the IMAGe service. Birth Defects Research 
Part A - Clinical and Molecular Teratology 2009; 85 (5): 494 
(Canada) 50 
Aim & objectives Type of study What was the 
study about? 
Outcome 
measure(s) 
Understand the 
information sources 
used by enquirers 
prior to contacting a 
Canadian teratogen 
information service, 
and enquirer’s 
satisfaction with the 
service.  
Prospective survey. 
 
 
Online survey 
(SurveyMonkey) 
sent to healthcare 
professionals who 
contacted the 
service during a 
single month. 
Enquirer and 
enquiry type, 
number and type of 
information 
resource consulted, 
enquirer service 
satisfaction. 
Key Findings/ 
Conclusion 
A total of 261 healthcare professionals completed an online survey 
(124 pharmacists, 97 physicians and 34 nurses, 6 other health care 
providers).  The majority (91%, n=238/261) had used the service 
before. Enquiries involved antidepressants (36%), antibiotics (22%) 
and antipsychotics (13%). Over three quarters of enquirers (76%, 
n=198/261) had consulted one information source prior to contacting 
the service. These had consisted of drug monographs (58%), 
reference books (46%), computer databases (30%) or Internet sites 
(27%). Half of the respondents (51%) had consulted at least two other 
information sources. Enquirers contacted the service because they 
had been unable to find information themselves (67%), the need for 
further information (43%) or they had difficulty interpreting the data 
they had found (29%). Nearly all (99%, n=258/261) were satisfied with 
the information received.  
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Reference 
(country) 
Frost Widnes SF, Schjott J. Drug use in pregnancy-physicians’ 
evaluations of quality and clinical impact of drug information 
centres. European Journal of Hospital Pharmacy 2009; 65 (3): 303 
– 308 (Norway) 51 
Aim & objectives Type of study What was the 
study about? 
Outcome 
measure(s) 
Assessed clinical 
impact of MI 
answers provided 
about medicines in 
pregnancy. 
Prospective survey. Structured 
postal/email 
questionnaire sent 
with written answer 
to doctors who had 
contacted 5 MI 
centres over 12 
months. 
Quality 
(satisfaction, 
importance for 
therapeutic 
decision, 
recommend the 
service to 
colleagues) and 
clinical impact of MI 
advice (Likert 
scale). 
Key Findings/ 
Conclusion 
Most questionnaires were returned (76%, n=123/162): 95% 
(n=117/123) were included and 6 were excluded). Respondents 
strongly agreed that they were satisfied with the answer (95%, 
n=111/117), the importance of the advice for therapeutic decision 
(78%, n=91/116) and would recommend the service to colleagues 
(96%, n=111/116). The clinical impact of the MI advice resulted in the 
starting/continuation (38%) or avoidance or discontinuation (29%) of 
treatment; was important for risk/befit assessment (11%); avoided 
termination of pregnancy (9%) or led to induced abortion (1%). A 
small number (8%) reported no clinical impact as a result of the MI 
advice. 
Reference 
(country) 
Hedegaard U, Damkier P. Problem-orientated drug information: 
physicians’ expectations and impact on clinical practice. 
European Journal of Hospital Pharmacy 2009; 65 (5): 515 – 522 
(Denmark) 52 
Aim & objectives Type of study What was the 
study about? 
Outcome 
measure(s) 
Assessed user 
satisfaction and 
Prospective survey. Structured postal 
(piloted) 
questionnaire sent 
Usefulness and 
clinical impact of MI 
advice.  
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clinical impact of MI 
advice. 
with written answer 
to doctors who had 
contacted a single 
MI centre with a 
patient specific 
enquiry over 12 
months. 
Key Findings/ 
Conclusion 
Most questionnaires were returned (93%, n=183/197): 97 (53%) 
worked as GPs, 86 (47%) in secondary care. During the 12 months, 
the service was used by some doctors once (85%, n= 134), twice 
(13%, n=20) and a small number three times (n=3). MI advice was 
used for patient information (79%, n=145), a change in therapy (45%, 
n=82), dissemination to colleagues (51%, n=93), for use for future 
patients (67%, n=123) or for personal interest (43%, n=78). In one 
case the information was not used. Doctors were completely or 
partially satisfied with the written answer (99.5%), timeliness of 
response (85.7%), ‘extent’ of the response (96.1%) and usefulness of 
the answer (96.8%).  
Reference 
(country) 
McEntee JE, Henderson SL, Rutter PM, Rutter J, Davis HJ. Utility 
and value of a medicines information service provided by 
pharmacists: a survey of health professionals. International 
Journal of Pharmacy Practice 2010; 18: 353 – 361 (England) 53 
Aim & objectives Type of study What was the 
study about? 
Outcome 
measure(s) 
Assess how advice 
provided to 
healthcare 
professionals from 
a specialist regional 
MI service was 
used and whether 
the advice provided 
was useful for 
patient care. 
Prospective survey. A pre-piloted 
questionnaire was 
sent to all 
healthcare 
professionals 2 
weeks after they 
had contacted the 
service with an 
enquiry during a 6 
month period to find 
out how advice 
used and its 
usefulness for 
patient care.  
Satisfaction with the 
service; how the 
advice provided 
was used; 
usefulness to 
patient care; and, 
general comments 
on the service. 
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Key Findings/ 
Conclusion 
Of the 672 questionnaires sent, a total of 459 (68%) were returned: 
144 (32%) dentists, 96 (21%) community pharmacists, 79 (17%) 
primary care pharmacists, e.g. prescribing advisors, 47 (10%) hospital 
pharmacists, 37 (8.2%) GPs and 2 (0.4%) hospital doctors. Most 
respondents (81%, n=350/430) used the advice for managing a 
current patient and 29% (n=125/430) for planning the care of future 
patients. A quarter used the advice for their own continuing 
professional development and 16% for training or teaching others. 
The majority (95%, n=376/396) found the advice provided useful with 
over half (51%, n=186/366) using it to check if current or proposed 
management of a patient was appropriate. Nearly all respondents 
were satisfied with how the service was provided (99%, n=455/459), 
456 able to contact the service at the first attempt, 455 were happy 
with the way their enquiry was initially handled and 456 confident that 
their question was understood. For those that did not need immediate 
advice, 92% (n=220/238) said a timeframe for a response had been 
agreed with them, 3% (n=8) said a timeframe had not been agreed 
with and 4% (n=10) were unsure. All but 7 respondents (n=98%, 
448/455) said the advice was provided in time to be helpful. General 
comments by 35% of respondents (n=116) included the helpfulness of 
staff, and 34% (n=112) commented on the good or excellent quality of 
the service. 
Reference 
(country) 
McEntee JE, Henderson SL, Rutter PM, Rutter J, Davis HJ, Randall 
CJ. A survey of UK dental health professionals using a medicines 
information service: what questions do they ask and do they get 
useful answers? British Dental Journal 2011; 211 (1): 17 – 21 
(England) 44 
See Table 1. 
Reference 
(country) 
Fischer MI, Tavares LA, Dal Pizzol TS. User’s satisfaction in a 
Brazilian Drug Information Center: evaluation under a new 
approach. Latin American Journal of Pharmacy 2012; 31 (8): 1138 
– 1142 (Brazil) 54 
Aim & objectives Type of study What was the 
study about? 
Outcome 
measure(s) 
Evaluated user 
satisfaction. 
Prospective survey. Piloted 
questionnaire of 
healthcare 
Access to 
information; 
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professionals who 
had contacted a 
single MI service 
over a 12 month 
period. 
quality and 
timeliness of 
information; 
likelihood to use 
again 
Key Findings/ 
Conclusion 
Based on sample size calculation, (43%, n=108/254) users were 
contacted to participate. Over two thirds (69%, n=74/108) completed 
the survey by phone (62%, n=46) and by email (38%, n=28). All were 
pharmacists. The service was rated as very easy to contact (72%, 
n=53) or easy to contact (28%, n=21). Information provided by the 
service was totally clear (53%, n=39), clear (42%, n=31) or somewhat 
clear (5%, n=4). Information was totally objective (35%, n=26), 
objective (53%, n=39) and somewhat objective (12%, n=9). Users 
were totally satisfied with the timelines of the response (50%, n=37) or 
satisfied (50%, n=37). The reply provided totally met the needs of the 
user (61%, n=45), partially (35%, n=26) or not really (4%, n=3). All 
respondents stated that they would use the MI service again. 
 
Studies about user satisfaction of MI services have been published over the last 40 
years (1975 – 2012) from Brazil, Canada, Denmark, Germany, Norway, Sudan, UK and 
US. 8,9, 42-44,49-54 All studies originated from a single MI site and probably reflects the 
relative ease with which it is possible to undertake such evaluations compared to a 
multi-site approach.  
 
Publications surveyed a range of healthcare professionals: nurses, 8, 50 physicians 
(medical or dental) 8, 43, 49 – 53, pharmacists, 8, 42, 43, 50, 53, 54 and other healthcare 
professionals 8, 43, 44, 50. One study also included members of the public and students. 43  
 
Studies used various selection strategies to recruit participants ranging from 
randomisation to including all users. With regards to numbers recruited this was, in 
part, due to the length of the study. Study duration varied from 1 month to 3 years. 8, 42-
44, 49-53 Just one study detailed a sample size calculation, but the desired number of 
users were not recruited. 54 
 
Surveys were conducted via telephone, 43, 54 post, 49, 44, 51, 52 fax, 42 email 54 or online. 8, 
50 Using the telephone to conduct satisfaction surveys removes user anonymity which 
may affect interviewees responses, compared to postal, fax, email and online surveys 
48 
 
which ensure user anonymity (depending on the design).  Parameters chosen to 
measure user satisfaction varied and included professional quality, 42 general 
satisfaction, 43, 53 ease of contact, 53, 54 enquiry handling, 53 confidence the question was 
understood 53 and whether the timeframe was agreed. 53 Other parameters included 
clarity of advice, 42, 54 helpfulness or usefulness of advice, 42, 44, 53 quality of response, 49 
timeliness of advice, 8, 43, 49, 52-54 communication of the advice 43 and if the advice 
answered the question. 8, 44, 52 In addition, advice being adequately comprehensive, 49 
usefulness of the response, 52 satisfaction with advice, 50-52 if the advice met the needs 
of the user, 54 extent of the response, 52 objectivity of the information, 54 if the advice 
contained enough information, 8 if the advice included references, 49 and whether the 
enquirer would use the MI service again, 43 were also used.  
 
Although there are similarities between these parameters, there is a lack of 
standardisation making it difficult to make comparisons between studies. However, in 
general, all studies report positive user satisfaction and the availability of these data 
over the time period (1975 – 2012) provides some reassurance in this regularly 
reported finding. 
 
Some of the publications which focused on user satisfaction of MI services had some 
methodological limitations: two studies had not previously piloted the survey to be 
used. 8, 50 This means that their reliability and validity is unknown which may call into 
question their findings. In addition to the different aspects of satisfaction measures 
used various methods for measuring satisfaction were employed. These included a 5-
point scale (1 is poor and 5 is very good), 42 a positively skewed 4-point scale 
(excellent, good, satisfactory, poor), 43 a weighted 4-point scale which varied 
depending on the question asked 54 and a questionnaire that required binary 
responses, i.e. yes or no. 53 The use of a positively skewed or a weighted scale to 
determine satisfaction with a MI service may lead to inaccurate or misleading results 
because the participant is presented with more ‘positive’ options to select from 
compared to ‘negative’ or neutral choices.  Binary choices as options for participants to 
report their satisfaction do not allow for any differentiation within a response. For 
example, if a user has slightly negative/positive feedback, but can only select from a 
yes or no option, this may not fully reflect their experience and lead to a superficial 
understanding. 
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In this third and final section, 12 papers about the impact of MI services on patient care 
or patient outcome, which included two reviews, were included for evaluation and are 
shown in Table 3.  
 
Table 3. Publications relevant to the impact of MI services on patient care or 
patient outcomes 
Reference 
(country) 
Hands D, Stephens M, Brown D. A systematic review of the clinical 
and economic impact of drug information services on patient 
outcome. Pharmacy World and Science 2002; 24: 132 – 138 (UK) 9 
See Table 2. 
Reference 
(country) 
Spinewine A, Dean B. Measuring the impact of medicines 
information services on patient care: methodological 
considerations. Pharmacy World and Science 2002; 24: 177 – 181. 
 (UK) 8 
See Table 2. 
Reference 
(country) 
Kinky DE, Erush SC, Laskin MS, Gibson GA. Economic impact of 
a drug information service. Annals of Pharmacology 1999; 33: 11 
– 16 (US) 55 
Aim & objectives Type of study What was the 
study about? 
Outcome 
measure(s) 
Determine what 
resources might be 
used in a typical 
healthcare 
encounter.  
Would additional 
resources have 
been used if a MI 
request had not 
been made.  
Retrospective 
analysis. 
Review of patient 
specific advice calls 
handled by a MI 
centre within a 
single US hospital 
during a 6 week 
period 
In addition, a panel 
reviewed these 
enquiries daily.  
Cost avoidance 
estimate of a MI 
service provided 
(using a model 
previously 
developed). 
Key Findings/ 
Conclusion 
A total of 570 enquiries from healthcare professionals were received, 
of which nearly a third (29%, n=163/570) were patient-specific. Just 
over half (51%, n=83/163) of the responses were considered to have 
insignificant or unmeasurable cost impact. The remainder (49%, 
n=80/163) of the responses were classified into outcomes of 
treatment failures (17%), new medical problems (25%), and treatment 
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failures with new medical problems (7%). With regards to severity, 86 
requests were considered to result in no economic value. However, 
80 questions did have potential cost savings. Of these, 3 were 
deemed to have potential cost savings ranked as signifying no harm 
or no potential cost savings. The remaining 77 requests were 
determined to have relevant potential cost savings but only 
represented 14% (77/570) of the total number of drug information 
questions answered during the study. During the six week period, 
potential cost savings were estimated to be approximately $195,000 
which extrapolated to one year, was predicted to save $1.7m. 
Reference 
(country) 
Schjott J, Pomp E, Gedda-Dahl A. Quality and impact of problem-
orientated drug information: a method to change clinical practice 
among physicians? European Journal of Hospital Pharmacy 
2002; 57 (12): 897 – 902 (Norway) 49 
See Table 2. 
Reference 
(country) 
Bertsche T, Hammerlein A, Schulz M. German national drug 
information service: user satisfaction and potential positive 
patient outcomes. Pharmacy World and Science 2007; 29: 167 – 
172 (Germany) 42 
See Table 1. 
Reference 
(country) 
Bramley D, Mohandas C, Soor S, Erskine D, Oborne CA. Does a 
medicines information service have a positive impact on patient 
care? Pharmaceutical Journal 2009; 282: 139 – 140 (England) 12 
See Table 1. 
Reference 
(country) 
Frost Widnes SF, Schjott J. Drug use in pregnancy-physicians’ 
evaluations of quality and clinical impact of drug information 
centres. European Journal of Hospital Pharmacy 2009; 65 (3): 303 
– 308 (Norway) 51 
See Table 2. 
Reference 
(country) 
Hedegaard U, Damkier P. Problem-orientated drug information: 
physicians’ expectations and impact on clinical practice. 
European Journal of Hospital Pharmacy 2009; 65 (5): 515 – 522 
(Denmark) 52 
See Table 2. 
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Reference 
(country) 
Alkhaldi N, Desborough J, Wright D, House T. What would you do 
without medicines information: a feasibility study to determine 
whether clinical outcomes resulting from the absence of an MI 
service can be elicited? International Journal of Pharmacy 
Practice 2013; 21 (Suppl 1): 34 (England) 13 
Aim & objectives Type of study What was the 
study about? 
Outcome 
measure(s) 
Determine if it was 
possible to identify 
the actions of 
enquirers in the 
absence of an MI 
service.  
 
Prospective. Healthcare 
professionals 
contacting a single 
MI service were 
asked before an 
answer was 
provided, what 
action they would 
take for the patient 
if MI were unable to 
provide an answer.  
Action that 
healthcare 
professional would 
take without advice 
from the MI service. 
Key Findings/ 
Conclusion 
Half of those who used the service during the study period (50%, 
n=30/60) agreed to participate in the study. This consisted of 
pharmacists (37%, n=11), doctors (30%, n=9), dieticians (7%, n=2) 
and nurses (27%, n=8). All respondents were unwilling to state their 
clinical action without an answer from the MI service. However, nearly 
a third stated that in the absence of MI they would look for the 
information themselves (30%, n=9). Other actions included asking a 
ward pharmacist (27%, n=8), calling the manufacturer (20%, n=6), 
seeking advice from colleagues (17%, n=5) and seeking advice from 
specialists (7%, n=2), e.g. consultant. 
Reference 
(country) 
Bramley D, Innes AJ, Duggan C, Oborne A. The impact of 
Medicines Information enquiry answering on patient care and 
outcomes. International Journal of Pharmacy Practice 2013; 21 (6): 
393 – 404 (England) 10  
See Table 1. 
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Reference 
(country) 
Innes AJ, Bramley DM, Wills S. The impact of UK Medicines 
Information services on patient care, clinical outcomes and 
medicines safety: an evaluation of healthcare professionals’ 
opinions. European Journal of Hospital Pharmacy 2014; 21: 222 – 
228 (UK) 11 
Aim & objectives Type of study What was the 
study about? 
Outcome 
measure(s) 
Determined the 
impact of UKMi 
advice on 
medicines safety, 
and patient care 
and clinical 
outcomes.  
Prospective survey. Same methodology 
used as described 
in the previously 
cited study. 14 A 
total of 1450 
healthcare 
professionals 
contacted MI 
services with a 
patient-related 
enquiry. A 
questionnaire was 
sent to 1367 
enquirers to identify 
how the advice was 
used and its impact 
on patient care. 
Impact of MI advice 
according to rating 
scales used by the 
enquirers and 
panel. 
Key Findings/ 
Conclusion 
A total of 62 (33%, n=189) MI services across England, Scotland and 
Wales were involved. Most enquirers (81%, n=1111/1367) needed 
advice from UKMi before proceeding with their patient’s treatment. 
Nearly all (98.8%, n=639/647) used the advice for their patient’s care. 
Most respondents self-reported that the advice had a positive impact 
on their patients (92%, n=597/647): 85% (n=547) on patient care or 
outcome; 77% (n=499) on medicines safety. The panel rated the 
impact of UKMi advice on medicines safety, and patient care and 
outcomes separately using a six point scale for 23/40 sample 
enquiries. Of these, the panel’s consensus rating of impact agreed 
with the enquirer’s rating within one rating scale point in 74% 
(n=17/23) cases for patient care/outcomes, and 83% (n=19/23) cases 
for medicines safety/risk, and of these there was full agreement in 
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53% (n=9/17 and n=10/19, respectively). The panel fundamentally 
disagreed with enquirer’s ratings for care/outcome in 4% (n=2/23) 
cases and for safety/risk in 17% (n=4/23) cases. 
Reference 
(country) 
Strobach D, Gruber AC, Mohler NC, Vetter-Kerkhoff C. Clinical 
impact of the hospital pharmacy drug information service: how 
does information on drug-drug interaction enquiries translate 
into clinical decisions? European Journal of Hospital Pharmacy 
2015; 22: 83 – 88 (Germany) 56 
Aim & objectives Type of study What was the 
study about? 
Outcome 
measure(s) 
Determined the 
impact of advice on 
clinical decision 
making by hospital 
physicians. 
Prospective. Structured 
telephone follow-up 
of physicians with 
patient-specific drug 
interaction enquiry 
to single MI centre 
(3 – 60 days after 
written answer had 
been provided) over 
12 months.  
Reason for enquiry 
(preventative, 
clinical problem, 
general test); 
severity (category 
1, 2 or 3); action 
taken as result of 
MI advice. 
Key Findings/ 
Conclusion 
A total of 127 drug interaction enquiries meeting inclusion criteria 
were included. Of these, 113 follow-up interviews were completed. 
Enquiries originated from paediatrics (30%), psychiatry (30) and 
general medicine (17%). Drug interaction enquiries were classified as 
preventative (63%, n=71), i.e. physician was checking for possible 
effect of medication change on drug regimen, a clinical problem (16%, 
n=18), i.e. unexpected side effect of TDM or treatment failure with 
interaction suspected cause, and a general test (21%, n=24), i.e. 
polypharmacy and interaction check for reassurance but no actual 
problem suspected. A fifth (20%, n=85) of enquiries were classified as 
category 1, i.e. clinically relevant drug interaction requiring action, 
50% (n=210) as category 2, i.e. clinically relevant drug interaction 
requiring observation, and 30% (n=125) as category 3, i.e. theoretical 
drug interaction. Total of 114/232 clinical actions were initiated 
following written MI advice to manage possible drug interactions as 
identified from follow-up interviews. These included starting a drug 
(n=34), monitoring of clinical parameter (n=22), discontinuation of, or 
not starting a drug (n=21), modification of therapy (n=15), specific 
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patient counselling (n=14), dosage modification (n=6) and additional 
actions (not specified) (n=2).Remainder (n=118) actions were taken 
for other reasons and not solely based on MI advice.   
 
Two publications in 2002 reviewed studies that focused on the impact of MI services on 
patient care or patient outcome. 8,9 Most studies conducted since these reviews have 
predominantly been published in the UK 10-13 but also the US, 55 Denmark, 52 Germany, 
42, 56 and Norway. 49, 51   
 
The two reviews, published by different UK authors, reflect the development of MI 
services in this country and recommendations from the authors for MI services to better 
demonstrate impact on patient care or outcome. Although both reviews were published 
at the same time and focused on the impact of MI services on patient care, only three 
of the same studies were cited in each (Cardoni and Thompson, Melnyk et al, 
Stubbington et al) and reflects the different inclusion and exclusion criteria used by the 
two reviews. 8,9 The review by Hands et al, aimed to establish the clinical and 
economical impact of MI services on patient outcome whereas Spinewine et al, 
identified methodological issues associated with publications that focused on assessing 
the impact of MI services on patient care. One paper (Drolet & Repchinsky) within the 
review by Hands et al, only included community pharmacists as enquirers of MI 
services. 9 Although this is noted within Table 3 for completeness, the details were not 
included as it met the exclusion criteria for this literature review.  
 
A total of 12 relevant publications were cited by these two reviews. The majority of 
these papers (n=11) surveyed enquirers about the impact of MI services although it 
was unclear from the review what methods were used for three of the studies. In eight 
of the nine studies published subsequent to the two reviews, enquirers were similarly 
surveyed using either questionnaire or telephone (or a combination of both). 10-13, 49, 52, 
56 Two of these eight studies surveyed enquirers used piloted questionnaires; for the 
remaining six studies this was not clear or not stated.  
 
One further paper cited by the reviews (Bond et al) undertook an analysis of US 
mortality rates and enquiries documented within a clinical pharmacy database from 
more than 1,000 hospitals. 9 This study found a lower rate of mortality for hospitals that 
had a MI service compared to those who did not. Although the authors adjusted for 
severity of illness, confounding variables did not seem to be taken into account which 
makes the reported results invalid.  
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Both reviews concluded that there were methodological limitations associated with the 
studies included in their respective reviews, which limited their usefulness, and both 
called for better designed studies to be undertaken to assess the impact of MI services. 
8,9 Since those reviews, there have been a number of publications which have 
attempted to do this. Over half of these studies published since the reviews included all 
healthcare professional enquirers and these typically consisted of pharmacists, doctors 
and nurses. 10-13, 42, 55 Remaining studies, all conducted in Europe, included doctors as 
enquirers only. 49, 51, 52, 56 Only including doctors in these types of studies may increase 
the likelihood that the impact can be better assessed because these healthcare 
professionals have traditionally been the prescribers and led the decision-making 
process for patient care. However, in recent years UK practice has evolved such that 
pharmacists, nurses and other healthcare professionals are now able to independently 
prescribe and manage aspects of patient care. However, none of the studies have 
completed subgroup analysis for these different healthcare professionals so it is not 
known if any were prescribers and if that affected the results.  
 
Data collection for these studies ranged from 2 weeks to 18 months. 12, 49 Data reported 
in the publications were generated from both longitudinal and repeated cross-sectional 
studies. For the reasons outlined previously, a cross sectional study can be helpful as 
the snapshot provides data at a point in time and would be more appropriate compared 
to a longitudinal study for this research study.  
 
Studies published since the reviews have reported on various outcome measures. 
These range from the actions taken in relation to the patient’s management as a result 
of MI advice, 49, 51, 56 what actions enquirers would take if MI advice was unavailable, 
12,13 the reasons enquirers were seeking advice and whether that received affected 
patient outcome. 10,11 These two latter studies also employed the use of a panel to 
assess a sample of enquiries to corroborate these findings. One study reported on the 
patient outcome predicted by enquirers at the time of seeking MI advice and whether 
this had changed once a response was received. 12  
 
When the MI service was unavailable, enquirers confirmed that they would seek out 
advice themselves. 12,13 This involved searching the internet, 12 contacting another 
member of the pharmacy team, 12,13 calling the manufacturer, 13 contacting a colleague, 
12,13 looking in books, 12 using other MI resources 12 or contacting specialists, e.g. 
consultants. 13 Both studies included a relatively high number of pharmacists (43% and 
37%), and some of these actions may not be taken by other healthcare professionals. 
56 
 
However, it is clear that in both studies healthcare professionals would contact another 
member of the pharmacy team or a colleague if the MI service was unavailable.  
 
There were many limitations associated with these studies. The first is that there was a 
lack of consistency in defining the terms patient care or patient outcome. One study by 
Bramley et al, has attempted to define patient care as, “Healthcare interventions 
intended to preserve or improve a patient’s mental or physical health”, and patient 
outcome as, “A change in the patient’s health status that could be a consequence of an 
intervention in the preceding healthcare.” 10 No other studies except that by Innes et al, 
which was co-authored by Bramley, have adopted these definitions. 11 Therefore the 
metrics used to measure the impact of a MI service on patient care or patient outcome 
varied between studies. Furthermore, the effect of MI advice on patient outcome was 
self-reported by enquirers and so the findings were subjective rather than objective. 
Four studies attempted to validate the results using other sources: three studies utilised 
a panel consisting of hospital doctors and pharmacists to assess a sample of enquiries. 
Despite these limitations making it difficult to draw firm comparisons, all the studies 
published since the reviews in 2002 reported positive results. 10-13, 42, 49, 51, 52, 56  
 
 
1.4.3 General limitations associated with MI provision publications 
Limitations were identified from the papers summarised in Tables 1 to 3. This section 
outlines these limitations and discusses their implications.  
 
The first limitation was that some studies were undertaken at a single site. It is difficult 
to generalise the results reported for one service to all MI services and across 
countries because individual MI service provision can vary. The second limitation was 
that participants self-selected to take part in studies across all three themes, 
irrespective of the method chosen. For example, when contacting a MI service with an 
enquiry participants were then contacted to take part in the research study. There is 
therefore a potential risk that those who chose to participate may have biased the 
results. The third limitation is that not all studies were piloted. It is important that any 
questionnaire used for research purposes is first piloted to ensure that it provides the 
types of data expected which helps increase the reliability of the data generated. 
Finally, all studies included at least one author from the MI service(s) that was being 
evaluated. This may have led to potential bias because the author’s views may have 
affected the interpretation of the results, although this may have been useful for the 
team of researchers because the author’s knowledge and understanding of the subject 
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matter may have aided the study design. This is an important consideration for this 
researcher to be aware of when undertaking this research considering his own role. 
 
1.4.4 On-call pharmacy services 
This second part of the review has evaluated the literature relating to on-call pharmacy 
services. After reviewing the literature and aims of the studies included, these were 
summarised into the following three themes: 
 
a. Extended hours pharmacy services, i.e. provision of a pharmacy service beyond 
normal working hours present within a hospital. 
b. On-call pharmacy services, i.e. provision of a pharmacy service that could be called 
upon outside normal working hours. 
c. Medicines advice out of hours, i.e. provision of, or related to the provision of MI 
services outside normal working hours.    
 
For each of the three themes, relevant studies are again detailed and critiqued 
individually within a table format. The rationale for this format and the headings used 
are the same as though outlined at the start of Section 1.4.2.  A critical evaluation of 
the publications is provided at the end of each section. 
 
In this first section, just two papers about extended pharmacy services were found and 
are shown in Table 4. 
 
Table 4. Publications relevant to extended hours pharmacy services  
Reference 
(country) 
Foster JJ, Rudall NL. Re-engineering out-of-hours pharmacy 
services for a new decade. Clinical Pharmacist 2010; Suppl 3: S23 
(England) 17 
Aim & objectives Type of study What was the 
study about? 
Outcome 
measure(s) 
Evaluation of a re-
engineered out-of-
hours hospital 
pharmacy service.  
Service evaluation 
in a single hospital. 
Electronic survey 
pre – and post-
implementation of 
Pre-implementation 
survey sent to 
nursing and medical 
staff. Post-
implementation 
Satisfaction of 
clinical activities 
during daytime, on-
call, and extended 
pharmacy services 
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extended pharmacy 
service to 
Emergency 
Admissions Unit 
(EAU). 
(after 4 months) 
sent to same 
groups with addition 
of Band 6 
pharmacists 
providing extended 
service. 
(0 very poor to 4 
excellent). 
 
 
Key Findings/ 
Conclusion 
A total of 35 responses were received from the pre-implementation 
survey. Day service provided was well received but a clinical 
pharmacy presence was also required out of hours. As a result, the 
authors developed considerations to include in an extended pharmacy 
service which were: participation in consultant post-take ward rounds, 
conducting medicines reconciliation processes, prescription 
monitoring including antibiotic review, offering advice to patients, 
supporting staff, and supplying discharge medications where there is 
a valid need for immediate discharge. A rota (compliant with the 
European Working Time Directive) was developed which ensured a 
clinical pharmacy presence 8am – 10pm. After 10pm, an on-call 
pharmacy service was provided until the following morning. A total of 
34 responses were received from the post-implementation survey. 
The authors stated that the results indicated a substantial 
improvement in the perceived quality of the out-of-hours service. A 
total of 91% respondents stated that extended hours had had a 
positive impact on their practice. The Band 6 pharmacists also 
experienced increased confidence, allowed integration into the MDT 
team and improved their clinical knowledge.  
Reference 
(country) 
Lewis P, Forster A, Magowan M, Butler G. Exploring the 
experiences and opinions of Pharmacists working in a 24/7 
hospital pharmacy service. International Journal of Pharmacy 
Practice 2015 (Suppl 2): 16 (England) 57 
Aim & objectives Type of study What was the 
study about? 
Outcome 
measure(s) 
Explore 
pharmacists’ 
experiences and 
opinions of working 
within a 24/7 
Survey of 
pharmacists 
working as part of a 
24/7 pharmacy 
Individual semi-
structured 
interviews.  
Participants 
recruited by email 
Advantages and 
disadvantages of 
24/7 pharmacy 
service. 
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hospital pharmacy 
service.  
service in a single 
hospital.  
and via a poster 
advertising the 
study to all 
pharmacists 
working as part of 
the service.  
Data analysed 
using Framework 
approach. 
Key Findings/ 
Conclusion 
The majority of pharmacists (81%, n=13/16) involved in the provision 
of the 24/7 pharmacy service were interviewed. Perceived advantages 
of the 24/7 service included directly improving patient care by the 
prompt supply of time critical medicines, completion of an accurate 
drug history on admission and prevention of adverse drug events. By 
having an onsite presence, with access to patient notes and a greater 
range of resources, pharmacists felt they were identifying more 
problems than would be possible when providing advice over the 
phone. In addition, integration within the MDT and unplanned 
interventions due to their physical presence on the ward was also 
reported as positive experiences. Disadvantages of the service 
included reliance on the service by nurses for non-urgent supplies of 
medicines ad delayed writing of discharge prescriptions.   
 
These two publications were UK-based 56, 57 and was not unexpected as UK clinical 
pharmacy services have, in recent years, been the subject of transformation to develop 
7 day working. 34 Both studies were undertaken at individual hospitals Foster et al, 
reported findings from a single clinical area, 56 whereas Lewis et al, appeared to 
evaluate a hospital-wide extended clinical pharmacy service. 57  
 
The first study used a quantitative research method to explore the views of healthcare 
professionals about extended clinical pharmacy services. 56 Although the response rate 
is not given and/or cannot be calculated, the study reports that doctors and nurses 
reported an improvement in service quality and impact on practice of the extended 
pharmacy service. Whilst there were a number of methodological issues with this 
study, surveying the users of an extended pharmacy service, and those involved in its 
provision enabled triangulation of the data generated from each professional group.  
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The second study used semi-structured interviews with pharmacists to explore their 
opinions about the provision of an extended clinical pharmacy service. 57 Although the 
numbers of pharmacists interviewed were small and limited to one hospital, the study 
reported advantages, as perceived by pharmacists, of an extended pharmacy service. 
The use of semi-structured interviews was more likely to have provided a greater depth 
and richness to the data generated in this study compared to if quantitative research 
methods had been used. Very little reference was made, or information provided about 
the effect of these extended clinical pharmacy services on the medicines advice 
seeking by healthcare professionals or the handling of such requests by pharmacists 
although these were not stated objectives of either paper.  
 
There were a number of methodological issues with these two studies. For example a 
4-point scale was used by Foster et al, to assess satisfaction with the extended clinical 
pharmacy service although it was unclear if this had been validated. 56 Furthermore, it 
was unclear if the survey by Lewis et al, was completed anonymously by 
respondents.57  
 
 
The section about on-call pharmacy services identified seven papers for review, are 
summarised in Table 5, and critically discussed in the subsequent text of the thesis. 
  
Table 5. Publications relevant to on-call pharmacy services 
Reference 
(country) 
Peak VJ, Greene SA, Hansen LA, et al. Twenty-four-hour clinical 
services provided by an on-call pharmacist. American Journal of 
Hospital Pharmacy 1986; 43: 1753-1754 (US) 58 
Aim & objectives Type of study What was the 
study about? 
Outcome 
measure(s) 
Determined the 
enquiry workload 
handled by a US 
hospital on-call 
pharmacy service. 
Descriptive study. Evaluation of the 
pharmacy on-call 
service during an 8 
month period.  
Number and types 
of enquiries 
received, enquirer 
type. 
Key Findings/ 
Conclusion 
The on-call pharmacy service was provided by a single pharmacist 
(taken in turn) resident within the hospital who could be contacted by 
bleep for consultation. All enquiries were recorded in a notebook each 
day. A total of 423 calls were received by the on-call pharmacy 
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service: 38% during the day (7am – 5pm), 52% in the evening (5pm – 
11pm) and 10% during the night (11pm – 7am). 
The authors state that enquiries were primarily from physicians both 
inside and outside the hospital, nursing staff and pharmacists at the 
base organisation. The authors categorised requests handled by the 
on-call pharmacy service as therapeutics (27%, n=116), dosing and 
pharmacokinetics (23%, n=96), miscellaneous (15%, n=64), drug 
administration (13%, n=53), drug distribution (9%, n=40), drug studies 
(n=19, 5%), nursing consultations (n=18, 4%) and narcotic distribution 
(n=17, 4%). An analysis of the enquiries indicated that 32% could be 
answered with basic references. Basic references were defined as 
those that are readily available to the resident. Most (68%) required 
extensive research which meant using any reference in the hospital’s 
MI centre or medical library, contacting a pharmaceutical company, or 
reviewing a patient’s chart. 
Reference 
(country) 
Pitner JK. Clinical pharmacy on-call service in a tertiary care 
hospital. Pharmacotherapy 1999; 19 (4): 530 (US) 59 
Aim & objectives Type of study What was the 
study about? 
Outcome 
measure(s) 
Determined the 
enquiry workload 
handled by a US 
hospital on-call 
pharmacy service.  
Descriptive study. Each pharmacy 
resident 
documented 
therapeutic drug 
monitoring and 
medicines advice 
provided during a 1 
year period. 
Number of 
enquiries handled; 
enquiry type; 
enquirer type. 
Key Findings/ 
Conclusion 
Data were evaluated for 42 weeks of the service: 259 patients with 
288 drugs were monitored, and 117 questions were handled. 
Questions were asked by physicians (n=70), pharmacists (n=33) and 
nurses (n=9). Most common MI enquiries involved drug dosing (n=50), 
followed by therapeutic use (n=25) and nutritional assistance (n=11).  
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Reference 
(country) 
McRobbie D, West T. Open all hours—running a resident 
pharmacy service. Hosp Pharm 2002; 9: 127 – 129 (England) 1 
Aim & objectives Type of study What was the 
study about? 
Outcome 
measure(s) 
Not stated. Descriptive. Described the 
workload 
associated with the 
pharmacy residency 
service out of hours 
(after 9pm 
weekdays and 3pm 
weekends) at a 
large, single NHS 
Trust.  
Workload data. 
Number and type of 
enquiries, and type 
of enquirer and 
clinical specialty.  
Key Findings/ 
Conclusion 
During a 12 month period, the pharmacy residency service handled a 
total of 11,716 calls out of hours from across two hospital sites. The 
majority of calls originated from the Emergency Department (27%), 
followed by General Surgery (22%) and cardiology (10%). Nearly a 
quarter (24%, n=2,781/11,716) of calls required advice, with the 
majority requests for supply of medication (59%, n=6,937/11,716) and 
a small number (6%, n=759/11,716) not recorded. The three most 
common types of medicines advice calls received by the service were 
dosage adjustment (30.5%, n=887), adverse drug reactions (30.5%, 
n=848) and therapeutic choice (12.6%, n=351). The remaining 
enquiry types accounted for 2.49% and 22.5% categorised as ‘other’. 
The most common users of the residency service were hospital 
nurses (63%, n=7,428/11,716), followed by medical staff (8%, n= 
951/11,716). Nearly a quarter (23%, n= 2,695/11,716) were not 
recorded. 
Reference 
(country) 
Heath EK, Welch SA, Costello N. On-call pharmacist enquiries 
and outcomes: an on-call database review, 2003–2012. Journal of 
Pharmacy Practice and Research 2014; 44: 201-204 (Australia) 60 
Aim & objectives Type of study What was the 
study about? 
Outcome 
measure(s) 
Determine the 
enquiry workload 
Retrospective 
analysis.  
Data recorded onto 
an Access 
Number of 
enquiries handled; 
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handled by an 
Australian hospital 
on-call pharmacy 
service. 
database between 
2003 and 2012. 
enquiry type; 
enquirer type. 
Key Findings/ 
Conclusion 
A total of 963 enquiries were received and documented, of which 94% 
(n=909) were drug based enquiries. The majority of calls were 
answered from home (74%, n=711/963) mostly received between 
5pm and 8am the following day. The most common ‘drug-based’ 
enquiry was about drug availability (59%, 540/909) and MI (26%, 
n=235/909). The majority of enquiries were answered using a 
reference source (54%, n=495/909) most commonly dispensing 
software (25%, n=124/495), followed by an on-call folder 
resource/database (22%, n=108/495) and other pharmacists (21%, 
n=102/495). Most enquiries were placed by nursing staff (74%, 
n=675/909) followed by doctors (n=18%, n=165/909). Of the 47 drugs 
involved in five or more enquiries, 64% (n=30/47) of these could be 
classified by ‘A PINCH High Risk Classification’. The most common ‘A 
PINCH’ subtype was antimicrobials (40%, n=12/30), followed by 
narcotic (17%, n=5/30) and chemotherapeutic agent (17%, n=5/30). 
Non-drug based enquiries involved issues with logistics of discharge 
medication, refrigerators and security alarms, most of which were 
handled from home (69%, n=37/54).  
Reference 
(country) 
Kapadia T, Kelly D, Singal R. Evaluating the out-of-hours 
residency pharmacy service at a large NHS Trust. International 
Journal of Pharmacy and Practice 2016; 24 (Suppl 3): 85 (England) 
61 
Aim & objectives Type of study What was the 
study about? 
Outcome 
measure(s) 
Evaluated on-call 
residency pharmacy 
service at a single 
hospital Trust.  
Retrospective. Data collected from 
calls (n=1386) 
made outside of 
normal working 
hours over a 6 
week period, 
categorised and 
themed. 
Understand nature 
of calls received by 
pharmacy out of 
hours.  
Assess pharmacy 
staffing levels 
between weekend 
and weekday 
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 services against 
workload. 
Key Findings/ 
Conclusion 
The average number of calls per week received by the residency 
pharmacy service was 255.  Medicines advice questions were 
responsible for 10% of the weekly calls, the remainder being for the 
supply of medication (78%). The remaining enquiries were 
categorised as ‘Other’ (not defined by the authors), accounting for 
12% of calls. Most calls were received on Mondays (n=40) and 
Fridays (n=50).  The weekday out of hours staffing provision to handle 
these calls was an average of 1.5 pharmacists and 0.4 technicians. 
This is against a weekend average of 1 pharmacist and 0.2 pre-reg 
pharmacist.  
Reference 
(country) 
Kilcullen N, O'Brady C. Do you need the on-call pharmacist? 
European Journal of Hospital Pharmacy 2016; 23: A159 – A160 
(Ireland) 62 
Aim & objectives Type of study What was the 
study about? 
Outcome 
measure(s) 
Quantified and 
identified the 
frequently occurring 
enquiries to the on-
call pharmacist and 
address any issues 
arising. 
Retrospective 
analysis. 
Review of on-call 
record forms 
(n=402) during a 9 
month period at a 
single hospital 
pharmacy 
department. Data 
entered into Excel 
spreadsheet. 
No. of questions 
related to supply 
and advice 
Medication involved 
in questions asked. 
Key Findings/ 
Conclusion 
A total of 295 requests involved supply and 141 for information (it is 
assumed that some record forms involved requests for both supply 
and advice). A total of 12% of requests for supply resulted in the 
pharmacist coming into the hospital. The top five medicines involved 
in out of hours requests were (in rank order): gentamicin, fentanyl, 
parenteral nutrition (PN), oxycodone and vancomycin. In addition to 
reviewing stock holding of fentanyl patches at ward level, supporting 
information for PN requests, and improvements to the gentamicin and 
vancomycin intravenous monographs, a flow chart “Do you need the 
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on-call pharmacist?” was developed in collaboration with nurse 
practice development to help improve provision of the service. 
Reference 
(country) 
Dunn J. On-call hospital pharmacy services: a perspective from 
NHS Tayside, Scotland. European Journal of Hospital Pharmacy 
2018; 25: 72 – 78 (Scotland) 18 
Aim & objectives Type of study What was the 
study about? 
Outcome 
measure(s) 
Described enquiries 
handled by a 
pharmacy on-call 
service.  
Described the 
activity of this 
service from April 
2015 – March 2016. 
Retrospective 
analysis. 
All enquiries 
received by on-call 
pharmacists 
throughout NHS 
Tayside (Scotland) 
during period and 
documented using 
a bespoke on-call 
pharmacy App. 
Data analysed 
using OpenOffice 
Calc. Activity of the 
service, users of the 
service, types of 
calls handled and 
how long calls took 
to answer. 
Number of calls and 
when received, 
enquirer and 
enquiry type and 
time calls took to 
answer. 
Key Findings/ 
Conclusion 
A total of 839 calls were received during the 12 month period with 
nearly half of all calls (46%, n=386/839) received over the weekend.  
Nurses were the most common user of the service (63%, n=527/839), 
followed by junior doctors (26%, n=220/839) and consultants (2%, 
n=18/839). The remainder consisted of a variety of staff working within 
and outside secondary care. Over half of calls were classified as 
either medicines supply or medicines advice 57% (n=477/839). 
Remaining calls were requests to dispense discharge prescriptions 
(18%, n=148/839), or advice on Total Parenteral Nutrition (TPN), 
therapeutic drug monitoring (TDM), or transferring or borrowing 
medicines from other departments or hospitals. Over a quarter of calls 
involved the security of the department or fridge temperature 
breaches (total 26%, n=214/839). It could be argued that advice on 
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TPN and TDM could be classified as MI requests. Most calls were 
handled within 30 minutes or less (82%, n=691/839), with nearly half 
of calls (49%, n=409/839) being resolved within 10 minutes. However, 
18% (n=148/839) required more than 30 minutes to resolve. The on-
call pharmacy service is provided mainly by Band 6 and 7 pharmacists 
and a very small number of Band 8a pharmacists.  
 
Four of the studies originate from the UK and Ireland, reflecting the development of 
hospital on-call pharmacy provision in these countries. 1,18,61.62 Three studies have been 
published from the US and Australia. 58-60 Overall, the studies were descriptive or 
retrospective in nature, with data derived from single organisations. 
 
The timeframe used for data analysis by each study varied and ranged from 6 weeks to 
10 years, 60,61 although three of the seven were conducted over 12 months. 1,18,59 As 
previously discussed, the data generated from studies conducted over a longer period 
of time, i.e. 10 years, may better reflect information about on-call pharmacy services 
over time and any changes to be observed which may identify trends/patterns. 
However, depending on the time period of the study it may mean that any historical 
findings are no longer relevant to current practice, particularly as practices can change. 
 
In five of the seven studies, data was generated about the different types of healthcare 
professionals who used on-call pharmacy services. Two US studies reported that 
doctors were the most frequent users, followed by either pharmacists or nurses. 58,59 
However, the remaining studies published from the UK and Australia all reported 
nurses as most likely to contact the on-call pharmacy service, followed by doctors. 
1,18,60 The lack of pharmacists as a user of the on-call pharmacy service in the UK and 
Australia reflects the provision of hospital pharmacy services in these countries.  
 
Three studies stated that the proportion of medication supply enquiries were higher 
compared with medicines advice. 60-62 These data reflect the researcher’s experience 
that on-call pharmacy services have typically focused on medicines supply rather than 
advice. The study by Dunn reported that more than half of the calls handled were about 
medicines supply or advice (57%) but did not differentiate between the two types. 18  
 
Therapeutic choice or use, and drug dosing appeared to be common enquiry types 
cited by studies published in the US and UK from the mid-1980s until 2002. 1,58,59 Other 
MI studies (Section 1.4.2) published since 2002 which provided information about the 
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types of enquiry categories might be drawn on for comparison for more up to date data. 
These studies reported that choice of therapy, therapeutic use, drug availability and 
drug administration were the most common enquiry types of enquiries handled by MI 
services. This suggests there are some similarities between the types of enquiries 
handled by on-call pharmacy services and MI centres. 
 
In summary, the published data is limited, derived from single organisations and has 
been generated using quantitative research methods. Reported results suggest that 
on-call pharmacy services handled a greater number of medicines supply questions 
compared to medicines advice. Nurses and doctors were the most frequent users 
generating questions about the therapeutic choice or use of a medicines and drug 
dosing.  
  
In the third and final section, seven papers about medicines advice out of hours were 
retrieved and summarised in Table 6, and critically discussed in the subsequent text. 
  
Table 6. Publications relevant to MI out of hours 
Reference 
(country) 
Auckland H, Belton R. UKMi 24/7: Audit of the quality of 
medicines information enquiries answered out-of-hours. 33rd 
UKMi Practice Development Seminar; 2007 Oct 31st; London 
(England) 63 
Aim & objectives Type of study What was the 
study about? 
Outcome 
measure(s) 
Assessed the 
quality of MI 
enquiries handled 
out of hours by on-
call pharmacists 
using national 
guidelines. 5 
Identified any 
learning for on-call 
pharmacists related 
to answering 
questions about 
Retrospective 
analysis. 
Enquiries answered 
out of hours during 
a 6 month period at 
a single large 
hospital were 
included and 
assessed using 
national enquiry 
answering 
standards by two 
experienced MI 
pharmacists. Any 
common learning 
Quality scores for 
enquiry 
documentation, 
analysis, search 
and answer 
recorded.  
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medicines out of 
hours. 
points were 
recorded during this 
assessment. 
Key Findings/ 
Conclusion 
A total of 75 enquiries were assessed with mean quality scores as 
follows: documentation 60% (UKMi Standard 100%), analysis of the 
enquiry 82% (UKMi Standard 100%), search coverage 54% (UKMi 
Standard 100%), and answer 87% (UKMi Standard 100%). The 
authors state that the quality of MI answers provided out of hours by 
on-call pharmacists is below that required during the day, although 
only one enquiry was considered to be unsafe. 
Reference 
(country) 
Emerson A. UKMi 24/7: What are the information needs of health 
professionals out-of-hours? 33rd UKMi Practice Development 
Seminar; 2007 Oct 31; London (England) 64 
Aim & objectives Type of study What was the 
study about? 
Outcome 
measure(s) 
Established 
whether there was 
a need to develop 
the UKMi service to 
support secondary 
care health 
professionals 
outside normal 
working hours.  
Prospective survey A questionnaire 
survey of doctors 
and nurses working 
out of hours at a 
single hospital in 
the South of 
England. 
 
Information needs 
of healthcare 
professionals 
working out of 
hours 
Key Findings/ 
Conclusion 
Of 465 staff surveyed (153 doctors, 312 nurses), 84 questionnaires 
were received (18% response rate). Healthcare professionals 
estimated that they needed to find MI between 1 – 5 times in an 
average shift out of hours (87%, n=73). Questions asked by 
healthcare professionals was most likely to be about adverse effects 
(62%, n=52), followed by drug administration, intravenous 
compatibility, drug interactions, and dose. Respondents usually 
sought information from paper-based resources (41.5%) or their peers 
(40.2%). The majority did not consider there were barriers to locating 
information about medicines out of hours (68%, n=57). However, of 
those that did consider there to be barriers, 83% (n=15) did not know 
where to look for information and 82% (n=14) found paper-based 
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resources missing from the ward. Knowing what resources were 
available and how up to date they were was also problematic. 
Questions involving intravenous medicines were considered more 
difficult to resolve out of hours (10.7%, n=9). Respondents suggested 
that they would prefer to be supported though improved links to 
validated online sources of information (67%, n=56), ready-made 
answers to frequently asked questions (62%, n=52) and improved 
access to the MI service (48%, n=40). 
Reference 
(country) 
Cheeseman M. Improving information governance for 
pharmacists working out of hours: involvement of a MI service. 
34th UKMi Practice Development Seminar; 2008 Sept 18 – 19; 
Warwick (England) 23 
Aim & objectives Type of study What was the 
study about? 
Outcome 
measure(s) 
Developed a 
bespoke toolkit to 
signpost on-call 
pharmacists to 
relevant information 
sources and ensure 
that any advice 
provided, was 
documented. 
Descriptive study. 
 
  
Evaluation of the 
toolkit 2 months 
after its 
implementation.  
Not stated. 
Key Findings/ 
Conclusion 
This author described that the toolkit (Emergency Duty Drug & MI 
(EDDI) pack) was based on national enquiry answering guidelines 
and quick question guide. It was designed to support the on-call 
pharmacist to record the minimum amount of information required to 
be documented when handling an enquiry. It also signposted the 
pharmacist to available resources and how these can be accessed. In 
addition, a separate paper record form was designed for each enquiry 
type most commonly received out of hours. This author states that 
after 2 months the most common enquiry type was drug 
administration. 
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Reference 
(country) 
Woods F. Extended Hours MI Service (paper for Welsh Chief 
Pharmacists meeting) [unpublished]; 2008 (Wales) 36 
Aim & objectives Type of study What was the 
study about? 
Outcome 
measure(s) 
Provide an out of 
hours MI enquiry 
answering service 
(pilot) and 
determine the 
workload, user 
satisfaction and 
quality of 
documentation 
against national 
guidelines. 
Service evaluation. Reviewed workload 
data after 3 months 
post 
implementation.  
A user satisfaction 
survey sent to 
enquirers who had 
used the service. 
Number, type, 
complexity of 
enquiries; time 
received; enquirer 
type; enquiry 
answering quality; 
user satisfaction. 
Key Findings/ 
Conclusion 
An experienced MI pharmacist was available by radio-pager in one of 
four MI centres across Wales. During the 3 month period, a total of 37 
calls were handled; most were received on a weekday evening (62%, 
n=23/37). Over half of the enquiries received were from hospital 
pharmacists (on-call, extended hours or weekend) (n=68%, n=25/37), 
followed by hospital nurses (14%, n=5/37), community pharmacy (8%, 
n=3/37), out of hours GP (5%, n=2/37), junior doctor (3%, n=1/37) and 
poisons unit (3%, n=1/37). The majority of enquiries handled out of 
hours were assigned as level 2 (83.8%, n=31), followed by level 1 
(13.5%, n=5) and level 3 (2.7%, n=1). A sample of on-call pharmacy 
documented enquiries (n=8) scored an average of 8/20 compared to 
extended hours MI service enquiries (n=3) which scored an average 
of 19/20.  Enquirers indicated via the user satisfaction survey 
(response rate 92%, n=22/24) that 76% were aware of the service, 
12% had previously used the MI service and 68% thought there was a 
need for an extended MI service.  
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Reference 
(country) 
Cheeseman M. The East Anglia Medicines Information out of 
hours project – results from a pilot study. 35th UKMi Practice 
Development Seminar; 2009 Sept 17 – 18; Edinburgh (England) 24 
Aim & objectives Type of study What was the 
study about? 
Outcome 
measure(s) 
Determine the types 
of MI enquiries 
handled by on-call 
pharmacists across 
the East Anglia 
region. Identify any 
pro-active MI that 
could be provided 
as a result. 
 
Prospective study 
(pilot). 
The titles of 
enquiries handled 
out of hours by 
hospital pharmacy 
departments (East 
Anglia) were 
collated on a 
weekly basis during 
a 3-month period.  
 
Data obtained was 
entered into a 
Microsoft Excel 
spreadsheet. 
Numbers of 
enquiries, enquiry 
type and the of 
medicines involved. 
Key Findings/ 
Conclusion 
All East Anglia MI centres participated in this study (n=11) but only 7.9 
services per week submitted data during the 3-month period (average 
72%).  A total of 195 enquiries were received, with questions involving 
administration/dosage accounting for two thirds of the enquiries (66%, 
n=127). The majority of enquiries (93%) involved an injectable 
medicine. The medicines most commonly involved in enquiries 
handled by pharmacists out of hours were antimicrobials (n=19), i.e. 
gentamicin and vancomycin. 
Reference 
(country) 
Cheeseman M. The on-call pharmacist’s bag – is there a different 
way? Clinical Pharmacist 2010; 2: 98 – 100 (England) 25 
Aim & objectives Type of study What was the 
study about? 
Outcome 
measure(s) 
Evaluation of an 
internal website for 
pharmacists at a 
single hospital to 
Retrospective 
survey. 
Pharmacists (n=30) 
at a single hospital 
were asked to 
complete online 
survey. 
Not stated by this 
author. 
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access information 
out of hours. 
Key Findings/ 
Conclusion 
Nearly two thirds of respondents completed the questionnaire (63%, 
n=19/30) and of these, 89% (n=17) had used the PRS at least once 
during the previous 6 months all of whom had found it easy to use. 
Most (88%, n=15/17) agreed or strongly agreed that information 
governance had improved considerably with the introduction of the 
internal website; the remaining two were undecided. Over two fifths 
(41%, n=7/17) had accessed the PRS outside of normal working 
hours and all had found the information they were seeking. Of these, 
five (86%) pharmacists had not needed to come into the hospital 
because they had been able to find and access information via the 
PRS. Three pharmacists said this had saved them from claiming for 
one hour of time worked; three had avoided claiming for two hours. 
 
 
Evidence related to medicines advice out of hours is limited, originating from the UK 
and consisting of ‘grey’ or unpublished literature. All of this literature has been led by 
UKMi pharmacists and perhaps reflects the explorative approach being taken to 
determine how MI services might support those working out of hours. The evidence 
includes analyses of documented medicines advice enquiries handled by on-call 
pharmacy services, 24, 63 evaluations of resources to support on-call pharmacists 
handling medicines advice enquiries, 23, 25 a survey of healthcare professionals MI 
needs when working out of hours, 64 and an evaluation of a dedicated out of hours MI 
service. 36  
 
Auckland et al, concluded that documentation by on-call pharmacists was poorer when 
compared to national standards. 63 However, the enquiries were assessed by two MI 
pharmacists, rather than independent assessors, and so there is a possible risk of bias 
as the reported findings could have been under or overstated. It is also not possible to 
generalise these findings to other on-call pharmacy services although Woods, as part 
of her service evaluation, also reported that the quality of documented enquiries by on-
call pharmacists compared to those by a dedicated MI pharmacist over a 3 month 
period was poorer compared to national standards. 36 However, the numbers of 
enquiries were small and not comparable between the two groups, i.e. three and eight 
enquiries. It is also not clear who assessed the quality of enquiry documentation as this 
may have also biased findings. 
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Work by Cheeseman investigating the types of enquiries fielded by the on-call 
pharmacy service across 11 hospital Trusts in East Anglia concluded that drug 
administration/dosage, using UKMi categorisation, was the most common enquiry type 
handled. 24 These enquiry types were similarly reported in a further evaluation by 
Cheeseman as part of an evaluation of a bespoke resource to support on-call 
pharmacists at a single site handling medicines advice enquiries. 23 Findings from a 
survey of doctors and nurses reported that their MI needs were most commonly about 
adverse effects, followed by drug administration, intravenous compatibility, drug 
interactions and dose. 64 There are similarities between these enquiry types and those 
reported to be handled during normal working hours (choice of therapy, therapeutic 
use, drug availability and drug administration) as reported in Section 1.4.2. It is not 
unexpected that medicine advice needs during normal working hours and out of hours 
should be comparable because patient care is 24 hours, 7 days a week.  
 
Only one paper aimed to determine where healthcare professionals sought information 
when working out of hours. 64 It is unclear how the survey questions were asked, but 
nurses and doctors reported that they would access paper-based resources or their 
peers when seeking MI out of hours; the on-call pharmacy service was not mentioned 
as a source of information.  
 
Just one study by Woods, has implemented and evaluated a dedicated on-call MI 
service. 36 This was conducted in Wales over a 3 month period, in addition to existing 
hospital on-call, extended and weekend pharmacy services. The most common 
enquirers were the hospital pharmacists, followed by nurses, community pharmacists, 
GPs, junior doctors and a poisons unit. It is not clear how the presence of this 
dedicated out of hours MI service was communicated, but it is likely that there was a 
greater awareness within the hospital pharmacy departments it was there to try and 
support.  
 
In summary, there is very limited published information about MI service provision or 
support out of hours.  
 
1.5 Research Aim and Objectives 
The literature reviewed provides information about how MI services are provided, 
including the types of enquirers, enquiries handled, and the routes of communication 
used. Users are generally satisfied with the service provided by MI centres and the 
advice received, is used in the management of patient care. In relation to on-call 
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pharmacy services, there is limited information about their provision emanating from 
single organisations. This data suggests that doctors and nurses seek medicines 
advice from on-call pharmacy services. There is a suggestion from the publications that 
there may be an issue with the consistency and quality of medicines advice enquiry 
documentation by on-call pharmacists. Whilst there is some limited information about 
the provision of extended pharmacy services, no data about the opinions and 
experiences of pharmacists providing out of hours services or those using these 
services exists.  
 
The overall aim of this study was to investigate the provision of pharmacy services and 
more specifically medicines advice out of hours, from the perspective of pharmacists 
and other healthcare professionals.   
 
For the research question to be adequately answered a number of elements needed to 
be considered and formed the objectives for the study. The objectives of the research 
were therefore to identify: 
 
1. how NHS England hospital pharmacies provide out of hours services. 
2. how NHS England hospital pharmacy out of hours services handle calls for 
medicines advice from secondary care health professionals. 
3. the perceptions of on-call pharmacists about the medicines advice they provide out 
of hours. 
4. how on-call pharmacists, nurses and doctors describe their MI needs out of hours. 
5. how on-call pharmacists, nurses and doctors access information when needing 
medicines advice out of hours. 
6. the perceptions of on-call pharmacists, nurses and doctors about the current 
provision of medicines advice by pharmacy out of hours services. 
7. the perceptions of on-call pharmacists about what would affect the documentation 
of medicines advice provided out of hours by on-call pharmacists.  
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CHAPTER 2 METHODOLOGY 
2.1 Introduction 
This chapter presents the philosophical and methodological approach for this research 
and outlines the rationale for the methods and data analysis used.  
 
2.2 Principles of research, theoretical perspective and methods 
The UK Policy Framework for Health and Social Care Research defines research as 
the attempt to derive generalisable or transferable new knowledge to answer or refine 
relevant questions with scientifically sound methods. 65 The four basic principles of any 
research undertaken include ontology/epistemology, theoretical perspective, 
methodology and the methods/techniques. 66 This section will outline these principles 
and put this research into context. 
 
Ontology is the study of being and is concerned with ‘what is’. 66 At its most basic level, 
ontology is the researcher’s beliefs about the nature of reality: what exists and what is 
true.  There are two opposing ontological beliefs: realism and relativism. The realist 
approach proposes that there is the existence of one truth and that this not does not 
change over time. The truth is discovered using objective methods and research 
findings can be generalised to other scenarios. In contrast relativism proposes that 
there are multiple truths or versions of reality and that these evolve over time. 
Qualitative research methods are typically used, and research findings are based on a 
particular context and cannot necessarily be generalised to other situations. 
Ontological beliefs dictate a researcher’s epistemological stance, i.e. how can reality be 
known, and there are two main approaches that can be taken which outline the 
relationship of the researcher with the research: positivism and constructivism.  
 
Positivists believe in an objective reality and that knowledge of this is obtained from 
direct observation or measurements of phenomenon. Constructivists believes that 
there are multiple truths and realities and that knowledge is created, or co-created, 
between a researcher and the participants. Both ontological and epistemological issues 
tend to merge together and both inform the theoretical perspective of the research. 66   
 
Initially, this researcher was not conscious that his approach to research was grounded 
in any theoretical stance or methodology. However, the researcher reflected on his own 
ontological and epistemological belief. These reflections were supported through the 
literature review process which showed that most researchers who have undertaken 
studies into MI and on-call pharmacy service provision have adopted a positivist 
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stance. These studies sought to identify the facts related to these services and so the 
methodology chosen for this research was initially informed by the researcher’s 
positivist belief. This researcher initially believed that there was one version of reality 
and this could be measured by using systematic methods typically employed in the 
natural sciences. That is, that the research objectives could be best met by attempting 
to find out what hospital on-call pharmacy services are provided across the NHS in 
England and how these services handle calls for medicines advice from healthcare 
professionals. In addition, the researcher would explore the opinions of on-call 
pharmacists and other healthcare professionals in a particular geographical area about 
a number of aspects related to the provision, access, needs and documentation of 
medicines advice out of hours. This approach would provide ‘the facts’ about how such 
services are provided and be generalisable across the NHS. Based on the researcher’s 
own experience as a MI and on-call pharmacist, it was his belief that there is likely to 
be variation with regards to both the provision and use of on-call pharmacy services, 
and how healthcare professionals seek MI out of hours. However, whilst this 
researcher may have set out as a positivist, he reflected that during the research 
process his belief had developed increasingly towards constructivism, accepting that 
there can be multiple versions of reality. This was supported by his approach of 
gathering information personally from on-call pharmacists to understand the context 
within which they work, generating subjective meanings from their experiences and 
interactions. 67 Further explanation is provided in Section 2.3.  
 
The methods chosen for research are influenced by the methodology, which in turn is 
influenced by the theoretical perspectives adopted and in turn by the researcher’s 
epistemological stance. 68 The methods that can be used to undertake research can be 
categorised into quantitative and qualitative. A quantitative research method can be 
defined as an approach for testing objective theories by examining the relationship 
among variables. These variables in turn can be measured, typically on instruments, so 
that numbered data can be analysed using statistical procedures. In contrast, a 
qualitative research approach is one for exploring and understanding the meaning 
individuals or groups ascribe to a social or human problem. 67 
 
In some circumstances, a mixed methods approach can be used. This approach is 
defined as an inquiry involving collecting both quantitative and qualitative data, 
integrating the two forms of data, and using distinct designs that may involve 
philosophical assumptions and theoretical frameworks. 67 The approach to this 
research study was to use a combination of quantitative and qualitative research 
methods because the combination was believed to provide a more complete 
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understanding of the provision of pharmacy services and medicines advice out of 
hours. The quantitative method provided factual information about the provision of on-
call pharmacy services whereas the qualitative approach provided an opportunity for a 
more in-depth exploration of the opinions and views of individuals. It also served to 
triangulate data from each of the methods used. The researcher believed that the use 
of a survey and semi-structured interviews undertaken sequentially would provide the 
necessary information to answer the research objectives.  
 
The next two sections discuss the chosen quantitative and qualitative methods, the 
rationale for their use and how the data generated was analysed. 
 
2.2.1 Quantitative research method and data analysis 
One of the most common quantitative research methods used is survey research. 
Survey research was believed to be the most appropriate methodology to use for the 
first part of this study because it enables objective information about a population, e.g. 
the number of hospital on-call pharmacy services, to be studied. In addition, this 
research method can include cross-sectional and longitudinal studies using structured 
data collection tools such as questionnaires consisting primarily of closed questions, 
and the information from a sample, if large enough, can be generalised more widely to 
a population. 
 
Therefore a survey of Chief Pharmacists was used to address research objectives one 
and two. Survey research can be undertaken using various modes and methods, such 
as postal mail, telephone, email and online. Online surveys have several advantages: 
shorter transmitting time, lower delivery cost, more design options, e.g. routing, and 
less data entry time. 69 There are disadvantages to online surveys which include losing 
participants who do not have Internet access and having low response rates that could 
lead to biased results.69 However, the researcher did not feel that these were applicable 
to Chief Pharmacists as a group because of the response rates previously reported. 
These studies, which surveyed Chief Pharmacists using postal questionnaires, have 
reported response rates ranging from 22 to 74%. 70-72 The researcher believed that 
using an online survey would provide comparable response rates, as reported for this 
target group in more recent studies. 73,74 It was therefore decided that an online survey 
would be used to ascertain how on-call pharmacy services were provided by hospitals 
in NHS England.  
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The online survey questions were initially generated by the researcher based on the 
presence and absence of information yielded by the literature review. They were also 
informed by the researcher’s own personal experiences from participating in the on-call 
pharmacy services of more than one acute hospital Trust. These experiences included 
the way the on-call pharmacy services were provided in these two organisations, the 
training he personally received, the volume and types of questions he handled and the 
way in which medicines advice questions were handled and documented. In addition, 
the researcher’s experiences as a MI pharmacist and the way medicines advice 
questions were expected to be handled during normal working hours also influenced 
these questions. Some examples of initial questions generated by the researcher are 
shown in Panel two. 
 
Panel 3. Examples of initial online survey questions 
• Does your pharmacy department provide an out of hours pharmacy service? 
• For whom is this service funded to provide an on-call service to? 
• Who participates in this service? 
• Are more complex advice calls handled differently to less complex calls? 
• How do on-call pharmacists document advice? 
 
These initial questions were then further developed by the researcher (Panel 3). This 
was achieved by reflecting on the information that would be provided in response to the 
questions and by referencing back to the literature to ensure that this data was not 
available already. Furthermore, very little information existed about the type of staff 
involved in the provision of on-call pharmacy services, particularly in the UK. Therefore 
the questions, “Does your department provide an on-call pharmacy service to 
secondary care healthcare professionals?”, and “Please indicate the number of 
pharmacists in each of the Agenda for Change banding that provide your on-call 
pharmacy service”, were developed. Whilst there was a suggestion within the ‘grey 
literature’ that there may be an issue with the documentation of enquiries by on-call 
pharmacists, it did not first describe how such questions were documented. Therefore, 
the question, “How is the medicines information advice provided by your on-call 
pharmacists to secondary healthcare professionals currently documented?”, was 
introduced. 
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Panel 4. Examples of initial online survey questions further developed 
• Does your department provide an on-call pharmacy service to secondary care 
healthcare professionals?  
• If response to the above question is NO: Please explain why your department 
does not provide an on-call pharmacy service to secondary care healthcare 
professionals. 
• Please indicate the number of pharmacists in each of the Agenda for Change 
banding that provide your on-call pharmacy service (you can tick more than one 
option)  
• How is the medicines information advice provided by your on-call pharmacists to 
secondary healthcare professionals currently documented?  
 
Once the initial questions were finalised, they were grouped into provisional themes 
according to the type of data that would be generated. The themes also helped with the 
sequence of questions within the survey and their routing (Panel 4). 
 
Panel 5. Provisional themes for online survey questions 
• Demographics • Advice 
• Delivery of on-call pharmacy services • Training 
• Types of services provided • Resources 
• Remuneration • Usage 
• Staffing • Evaluation of service 
• Documentation • Promotion of service 
 
The researcher then reviewed these finalised survey questions and their relevance to 
the research objectives of this study (Appendix 3). Any questions that could not be 
linked were removed. The answer option(s) that participants would be asked to select 
in the survey were developed and informed by the nature of the questions asked, e.g. 
closed questions, which required binary responses such as yes or no; information 
provided from the literature review; and, the researcher’s personal experiences or 
knowledge. For example, the options provided in response to the question about the 
number of beds in a Trust was based on researching the size of acute hospital and 
mental health Trusts and then grouping these into suitable bands. Another example 
was the options to select in response to a question about the number of calls for 
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medicines supply or advice handled out of hours. The likely workload handled by on-
call pharmacy services was based on the researcher’s own experiences and workload 
information from the literature review. For example, when the researcher worked in an 
acute hospital Trust (approximately 600 beds) an average of five medicines advice 
calls and thirty medication supply calls per week were handled. However, when the 
researcher worked in a large acute hospital Trust (approximately 1000 beds), a similar 
number of medication supply calls were handled each week but a higher number of 
medicines advice calls (approximately 12 per week).   Similarly, based on the published 
data summarised in the literature review (Section 1.4.4), there was a wide variation for 
how many enquiries on-call pharmacy services were reported to handle: between 4 
and 58 medicines advice calls, and between 8 and 230 medicines supply calls per 
week. Based on this information, the options used in the survey were chosen to be able 
to capture this variation in workload. A final example was the types of healthcare 
professionals that might use an on-call pharmacy service. The categories used within 
the survey were taken from those cited in the literature, e.g. doctors, nurses, and 
aligned to those used by UKMi services but amended to enable greater granularity, e.g. 
instead of hospital doctor, this was subdivided into senior hospital doctor and junior 
hospital doctor.   
 
In addition, the justification for including each question within the survey was 
documented (Appendix 3). The questions were then further refined by removing 
duplicates or any that overlapped. For example, the question, “Ideally, where should 
medicines information advice provided by on-call pharmacists to secondary healthcare 
professionals be documented?” was removed because the question, “How is the MI 
advice provided by your on-call pharmacists currently documented?” was already 
included. The researcher did not believe that the preceding question added any value. 
Once the questions were finalised, the provisional themes were further refined and 
finalised (Panel 5).  
 
Panel 6.  Final themes for online survey questions 
• Organisational demographics (questions 1 – 5) 
• Provision of on-call pharmacy service (questions 6 – 11, 38 - 41) 
• Documentation of medicines advice questions (questions 12 – 30) 
• Training provided to pharmacists to help them answer questions out of hours 
(questions 31 – 37)  
 
The majority of questions included within the online survey generated quantitative data.  
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A small number of open questions were included, and participants were able to enter 
free text responses. These data were analysed manually by the researcher, 
descriptively coded and then themed where appropriate. 
 
A number of techniques were used in this research to increase response rates to the 
online survey as described in a systematic review. 69 For example, a survey length time 
of less than 13 minutes was related to better response rates. 69 In order to achieve this, 
mainly closed, with minimal use of open questions, were included. All questions were 
kept simple, unbiased by avoiding words that might lead the Chief Pharmacist to a 
more positive or negative response, and not vague. Using closed questions would 
increase the likelihood of factual information being provided by Chief Pharmacists. 
 
Experimental studies have consistently proved the effects of pre-notification and 
reminders on response rates ranging from a modest to doubling the effect. 69 A postal 
letter was therefore sent to each Chief Pharmacist about a week before an email 
containing a link to the online survey. Attaching the online survey to the email was 
avoided because it has been suggested that this would adversely affect response 
rates. 69 The initial email was sent on a Sunday evening to ensure that when Chief 
Pharmacists accessed their email inbox on a Monday morning, it was more likely to be 
the first email they would see, i.e. top of their inbox. This would ensure that the email 
invitation was not ‘lost’ within the Chief Pharmacist’s inbox. A reminder postal letter 
was also sent to Chief Pharmacists a week later. Although the timeframe for 
completion of the survey was not stated in the postal letter/email or online survey, it 
was decided that a timeframe of 4 – 6 weeks was needed to maximise the opportunity 
for Chief Pharmacists to complete the survey. This timeframe was felt to be more than 
sufficient for Chief Pharmacists to complete the survey and would also account for any 
annual leave that they may have taken. Furthermore, this timeframe was aligned to 
other studies that included questionnaires or online surveys. 10, 11, 44, 53, 75  
 
In addition, the postal letter and emails were personally addressed to each Chief 
Pharmacist and included the University’s logo. Personalisation of invitations and online 
surveys sponsored by academic and government agencies/departments rather than 
those sponsored by commercial ones have been found to achieve higher response 
rates. 69  
 
With regards to the display or presentation of the online survey, a wide variety of 
technical issues have been examined in the extensive literature on survey methodology  
There is a long list of technical issues involved which include: display design; layout; 
82 
 
text format for questions and instructions; backgrounds; logos; graphics; progress 
indicators; navigational instructions; and, radio buttons, check boxes, drop-down 
boxes, and full list boxes. These issues were considered in the survey design used for 
this research. For example, the font used for questions was bold and larger than the 
text used for the options presented to the respondent. Furthermore, radio and check 
buttons were used throughout the survey to aid consistency for the respondent. With 
regards to online survey display designs, there are two main types: screen-by-screen 
and scrolling questionnaires. 69 Scrolling designs display all questions within one single 
web page and respondents need to scroll from the head to the bottom of that single 
webpage to view the whole questionnaire and give answers. A scrolling design requires 
less computer time and computer resources to contact with the web server because it 
only requires one single submission of the final responses. In addition, it provides 
richer context for respondents to respond because all questions are on one page. 69 
 
Screen-by-screen designs put one or several questions within one screen and 
respondents press the button of ‘‘next page” in order to proceed. It has been pointed 
out that the advantages of this design include allowing respondents to skip questions 
that are not applicable to them. 69 A screen-by-screen design was utilised for the online 
survey for Chief Pharmacists because it was anticipated by the researcher that a 
scrolling design would potentially reduce response rates. Furthermore, sequential 
questions were dependent on the respondents’ answers. For example, if a respondent 
answered ‘no’ to one question, then the next question could be different if another 
respondent had responded ‘yes’. There was a high degree of routing used within the 
online survey to ensure that depending on the response to a question, the next one 
shown was appropriate. For example, Chief Pharmacists were asked, “Do you have a 
standard Trust policy for the documentation of medicines information advice provided 
out of hours by pharmacists?” If they answered yes, they would then be presented with 
the following question, “What information does the policy state should be 
documented?” which required a free-text response. However, if the respondent had 
answered no, they would be presented with the following alternative question, “In your 
opinion, what information should be documented by on-call pharmacists when they 
provide advice out of hours to healthcare professionals?” and be presented with a list 
of answers to choose from. 
 
The researcher also decided to assign a unique identification number (UIN) to each 
Chief Pharmacist to use when completing the online survey. This would enable the 
researcher to identify which person had responded and if there were any duplicate 
responses (some organisations had more than one contact) and allow follow-up with 
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any Chief Pharmacist who had expressed an interest in participating in the second 
phase. Although this would mean that the respondents were not anonymous the ‘Key’ 
which detailed the contact details of each participant was kept and only known by the 
researcher. This key was stored on an encrypted and password protected USB drive 
held by the researcher. This was not considered an issue by the University ethics 
committee.  
 
The online survey was first piloted as it has been suggested that the best way to 
assess the quality of an online survey before its actual use is to pilot it with a small 
group of respondents in the real-life situation and then invite content or methodology 
experts to review the pilot results. 69 Research validity is defined as the extent to which 
a concept is accurately measured in a quantitative study 76 There are three major types 
of validity: construct, criterion and content. Construct validity refers to whether 
inferences can be drawn about test scores related to the concept being studied. In this 
research, factual information about the provision of on-call pharmacy services was 
being sought rather than assessing an individual’s knowledge. The researcher 
concluded that this type of validity was not relevant to this research. Criterion validity 
involves correlation of any other instrument that measures the same variable. There 
are few very published studies about on-call pharmacy services and therefore it was 
not possible to use this type of validity method. Finally, content validity involves the 
assessment of whether the instrument, e.g. online survey, adequately covers all the 
content that it should with respect to the variable. In other words, omitting to gather 
data on issues that are of importance will result in an instrument that lacks content 
validity. 77 A subset of this type of validity testing is face validity and this was applied to 
the survey used in this research. 76 Face validity is an assessment of whether the 
instrument, e.g. online survey, would be expected to collect the information accurately 
and effectively. 77 This type of validity testing was applied to the survey through its 
piloting. Reliability relates to the consistency of a measure. 76 A participant completing 
an instrument, such as an online survey, should have approximately the same 
response each time it is completed. Although it is not possible to give an exact 
calculation of reliability, an estimate of reliability can be achieved through different 
measures. The three attributes of reliability are homogeneity, stability and equivalence. 
76 The survey used for this research underwent no formal reliability testing.  
 
In order to potentially avoid reducing the number of Chief Pharmacists’ responses that 
could be included in the final data analysis, the online survey was therefore piloted with 
a small number of clinical and MI pharmacists. These were chosen to pilot the content, 
functionality and routing of the online survey and therefore the fact that they were not 
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the target group for the survey was not an issue. In addition to piloting the online 
survey and providing comments on its questions and functionality, e.g. routing, 
participants were also asked specifically to comment on a series of questions (Panel 
6). If the answer was ‘no’ to any of the questions in Panel six, participants were asked 
to email the researcher directly with their reasons.  
 
Panel 7. Pilot questions related to the online survey 
• Did they understand the information sheet/consent form attached to the email? 
• Did they understand the consent form at the start of the survey? 
• Did the survey work for them? i.e. technical functionality 
• Did they understand the questions asked within the survey? 
 
The remainder of this section discusses the types of data generated by the survey and 
its analysis. Quantitative data can be classified as either categorical or numerical and 
both were generated from this research. Categorical data can be further sub-classified 
as nominal or ordinal data and numerical data into discrete or continuous data. The 
online survey included closed questions that generated categorical data, both ordinal 
and nominal, and discrete numerical data. There is no obvious ordering of nominal data 
but there may be a natural order in some cases. For example, nominal data would 
include yes or no responses to the following online survey question, “Does your 
department provide an on-call pharmacy service to secondary care health 
professionals?” Ordinal data is one where the variables are natural and ordered. An 
example would be data generated in response to the online survey question, “Please 
rank the following healthcare professionals according to how often they use your 
on-call pharmacy service (rank 1 - 4, with 1 the greatest users and 4 the lowest users)”. 
Only discrete numerical data was generated from this research. Discrete numerical 
data are observations or responses to questions that can only take certain numerical 
values. An example would be the responses to the online survey question, “How many 
calls for medicines information advice are received during a typical week by the on-call 
pharmacy service?” The options for the respondent to choose are < 10, 11 - 20, 
21 - 30, 31 - 40, 41 - 50 and > 50. These data were categorised as ‘frequencies’ and 
exported from the online survey to the Statistical Package for Social Sciences (SPSS) 
Version 25. The data was then summarised as the proportion of the total number of 
‘frequencies’ in a category, e.g. number of hospitals providing an on-call pharmacy 
service (87.1%, n=101/116). 
 
Analysis of the categorical and numerical data generated was subject to cross-
tabulation where appropriate to explore the relationships within these data and 
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statistical tests applied using SPSS. When considering the statistical significance, the 
null hypothesis must be considered. The null hypothesis is a statement about a 
population that we try to reject with sample data. For example, that an on-call 
pharmacist will receive the same number of calls whether they are located at home or 
as part of a residency programme. Statistical tests are used to evaluate if the observed 
data could have been obtained if the null hypothesis were true. This probability is called 
the P value and for this research if this was equal to or smaller than 0.05, the less likely 
the null hypothesis was true. 78 
 
Two statistical tests – Pearson’s chi-squared (X2) and the Fisher’s exact test – could 
have potentially been used to analyse the categorical and discrete numerical data 
generated. The Pearson’s X2 test is used to assess how likely it is that an observed 
distribution is due to chance. When the null hypothesis is true, X2 has a chi-squared 
distribution and named accordingly. The X2 values are positive and its distribution has 
one degree of freedom. The number of degrees of freedom using the X2 test for a two 
way frequency table is the product (a-1) multiplied by (b-1), where ‘a’ is the number of 
rows and ‘b’ is the number of columns. Therefore, for a 2 x 2 table there would only be 
one degree of freedom and so the expected value of the chi-squared distribution when 
the null hypothesis is true is approximately the number of degrees of freedom. 78  
 
The distribution for the chi-squared test is based on a ‘large sample’ approximation, 
that is that 80% of the cells in the table should have expected frequencies greater than 
5, and all cells should have expected frequencies greater than 1. If any of the cells 
have a very small expected frequency, this would contribute significantly to the X2 
value. If the table has too many small expected frequencies then the frequencies in the 
rows and/or columns should be sensibly combined and the Fisher’s exact test, rather 
than the Pearson’s X2 test, is used instead. 78 In this research, because of the small 
sample sizes the Fisher’s exact test was more commonly used than the Pearson’s X2 
test to test the null hypothesis. This evaluated the probability associated with 2 x 2 
tables which have the same row and column totals as the observed data, making the 
assumption that the null hypothesis is true, i.e. the row and column variables are 
unrelated.  
 
The responses received to each of the survey questions were also exported from 
SPSS and tabulated using Microsoft Excel to provide a summary document showing 
the responses to each survey question.  
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2.2.2 Qualitative research method and data analysis 
Several different qualitative research methods can be used. These might include focus 
groups, observation, semi-structured, structured and in-depth interviews.  
 
Focus groups use a group of individuals to generate data and use a similar structure to 
face-to-face interviews. Group members are permitted to talk to one another, argue 
and ask questions, and is especially useful for finding out about shared experiences. 79 
Whilst on-call pharmacists, doctors and nurses work alone or in very small numbers as 
a team out of hours, they would have shared experiences. However, the usefulness of 
such an approach was not thought by the researcher to be appropriate to this work. 
Instead, the researcher was interested in the personal perspectives and opinions of the 
individual pharmacists, nurses and doctors. Had a focus group been used their own 
peers or other healthcare professionals may have potentially influenced their 
responses. Even with the most effective focus group facilitation,  some individuals may 
have been more vocal than others, and there may have also been a hierarchical 
influence within and between professions depending on the constitution of the focus 
groups. Therefore as it was important for this research to find out the experiences and 
opinions of these healthcare professionals as individuals without being influenced by 
others, focus groups were not used.  
 
Observation as a research method can involve organisational settings, behaviour, and 
interactions. This is particularly useful in studying quality issues as it allows 
researchers to uncover everyday behaviour rather than only relying on interview 
accounts. 79 Again, this method did not seem appropriate for this research because it 
explored the opinions of individuals and how medicines advice issues out of hours 
were handled rather than necessarily behaviours or interactions of individuals. The 
literature about the provision of medicines advice outside normal working hours is 
limited but based on published workload data and personal experience, the number of 
times on-call pharmacy services are used relative to pharmacy services during normal 
working hours is much less. Therefore the number of opportunities to observe nurses 
or doctors seeking information or contacting the on-call pharmacist is likely to have 
been very low. Furthermore, as some on-call pharmacists are based at home outside 
normal working hours, it would have been very difficult to observe these healthcare 
professionals. For these reasons, it would have been very difficult to use observation 
as a method.  
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Interviews are an alternative qualitative research method that can be used and can be 
conducted as semi-structured, structured or in-depth. Structured interviews use a 
formal schedule of questions which are adhered to and do not allow flexibility. In depth 
interviews enable the researcher to elicit more detail about an experience, attitude or 
issue. Semi-structured interviews use a loose structure of open-ended questions about 
a particular topic or range of topics. These questions explore the experiences and 
attitudes of the individual interviewed. In order to ensure that detailed information is 
gathered, interview methods require researchers with the necessary sensitivity and 
ability to establish rapport with respondents, use topic guides flexibly and follow up 
questions and responses. 79 For the purposes of this research, semi-structured 
interviews were felt to be the most appropriate method to use because it allowed the 
researcher to explore the opinions of on-call pharmacists by using a loose structure of 
open-ended questions. The researcher did not believe that this flexibility to explore 
opinions and views would be achieved with structured or in-depth interviews. Although 
the researcher’s personal experience of conducting semi-structured interviews was 
limited, he developed his understanding of how these should be prepared for, 
conducted, and potential sources of bias by reading educational material. This included 
but was not limited to information from the National Institute for Health Research. 80 
 
Individual face-to-face semi-structured interviews provided the most appropriate 
method for addressing research objectives 2 through 7, i.e. identifying the perceptions 
of on-call pharmacists, nurses and doctors and their information seeking behaviour. I 
felt that individual face-to-face semi-structured interviews provided an opportunity to 
hear the opinions of those individuals.  
 
The questions used within the interview schedule for on-call pharmacists were 
influenced by the responses to the online survey (Chapter 4). The data generated 
provided knowledge of how on-call pharmacy services were provided nationally 
enabling the development, targeting/focusing and influencing of the questions to be 
used within the semi-structured interview schedules. The interviews allowed opinions of 
pharmacists, doctors and nurses to be explored, which were hinted at by some of the 
responses received in the online survey. For example, the online survey asked whether 
training was provided specifically around medicines advice when working out of hours 
and whether this was refreshed. The semi-structured interviews explored this further – 
because the survey results indicated not much training was delivered and very little 
refresher training – to find out on-call pharmacists’ opinions about this. The online 
survey also confirmed that nurses and doctors were the most frequent users of the on-
call pharmacy service. This reinforced which professional groups were interviewed.  
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In addition, interview questions for on-call pharmacists, doctors and nurses were 
developed based on the findings from the literature review (Chapter 1, Section 1.4) and 
from the researcher’s personal experiences as an MI and on-call pharmacist. Initially 
the researcher listed the research objectives that linked to the interviews of on-call 
pharmacists, doctors and nurses and brainstormed questions. Where possible, 
interview questions for doctors and nurses were developed to ‘mirror’ those asked of 
on-call pharmacists. The interview questions for on-call pharmacists, doctors and 
nurses were then finalised by ensuring that each one met the research objectives 
(Appendix 4 and 5). The interview schedule for on-call pharmacists was piloted with 
two pharmacists and the questions used with doctors and nurses piloted with a single 
doctor. The pilot of the interview schedule to be used with doctors and nurses followed 
interviews conducted with on-call pharmacists. It was for this reason that a single pilot 
interview was conducted with a doctor only, as the questions mirrored those already 
used for on-call pharmacists. As a result, the researcher was more familiar with the 
questions and the interview process and so when the single pilot interview was 
completed and reviewed, there were no obvious reasons for not continuing to interview 
doctors and nurses. There were a number of reasons for undertaking the pilot 
interviews and these included: determining if the questions (and any follow-up) were 
understood by interviewees and appropriate responses generated; evaluating the 
researcher’s ability to conduct semi-structured interviews, e.g. developing rapport, 
appropriate use of body language, interview question technique; ensuring that the 
audio recording equipment functioned, the interview venue was appropriate, and that 
the interview was transcribed accurately. The latter was determined by verification of 
the transcript by the interviewee. No coding and thematic analysis of the interview 
transcripts was undertaken because this was outside the scope of the pilot interviews. 
It was decided that interviewees would be assigned a UIN and this was used when 
reviewing results to ensure that interviewees’ anonymity was maintained, but their 
professional role could still be identified. Interviews conducted with on-call pharmacists 
were given the pre-fix ‘OPh’ followed by a numerical number, e.g. OPh1; those 
conducted with doctors given the pre-fix Dr followed by a sequential numerical number, 
e.g. DR1; and, those conducted with nurses given the pre-fix Nr followed by a 
sequential numerical number, e.g. NR1.  
 
In order to maximise the likelihood of recruiting on-call pharmacists, doctors and 
nurses, different methods were used. For pharmacists, Chief Pharmacists had been 
asked at the end of the survey whether they would like to be participate in this next 
phase of the research study. Those Chief Pharmacists that had consented to being 
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approached again for the next phase of the research, were contacted for the email 
addresses of the on-call pharmacists within their departments. The postal addresses or 
telephone numbers of on-call pharmacists were not sought from Chief Pharmacists. 
This was because these routes of communication would have been too time-
consuming and complicated, and in the researcher’s opinion, not likely to result in 
improved recruitment rates for pharmacists. On-call pharmacists were contacted with a 
personally addressed email, to increase the likelihood of recruitment, and provided with 
information about the study. Positive, negative and no responses were documented 
onto a ‘tracker’ including agreed interview dates where applicable. 
 
The researcher did not believe it was appropriate to ask on-call pharmacists to recruit 
doctors and nurses when they were contacted for advice. This was because it would 
mean additional work for the on-call pharmacist when they are already handling calls 
during unsociable hours. Instead, doctors and nurses were recruited when they directly 
contacted the hospital pharmacy MI service during normal working hours with an 
enquiry. Nurses and doctors could be recruited irrespective of which route was used to 
contact the MI service, e.g. telephone, email. The time period of 4 – 8 weeks was used 
to enable sufficient recruitment of doctors and nurses by MI services based on 
unpublished workload data and the researcher’s own experience as a MI pharmacist. 
This recruitment method meant that only doctors and nurses who had previously used 
a MI service during normal working hours were included. In order to minimise the 
potential risk of bias from using this method of recruitment, the Medical Director (MD), 
Director of Nursing (DoN) and Research & Development (R&D) departments were 
contacted individually and asked to display or circulate a recruitment poster for doctors 
and nurses. This method would help to recruit doctors and nurses who had not 
previously used the hospital pharmacy MI service during normal working hours. 
 
The recruitment poster was developed to ensure it caught the attention of potential 
doctors and nurses interested in participating. This was achieved by the use of a 
border around the edge of a single A4 page and a bold, colourful image of medicines in 
the centre of the poster. The top of the poster included questions in a large font size to 
potential participants to ‘hook’ their attention. Underneath the image at the bottom of 
the poster, the aim of the research was stated. In addition, an explanation that 
participants would be required to take part one face-to-face interview, which would take 
no more than one hour to complete. The word ‘one’ was emphasised by use of 
capitals, bold and underline so that potential participants were given an indication of 
the commitment that they would need to make. The researcher’s academic email 
address was included at the bottom of the poster. 
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All semi-structured interviews were conducted within the East of England. This was for 
practical reasons, i.e. locality for conducting interviews was within a reasonable 
distance of where the researcher worked and lived. Interviews with on-call pharmacists 
were undertaken at a variety of Trusts in the East of England. However, the majority of 
interviews with nurses and doctors were conducted at the researcher’s base hospital. 
At this time the researcher had moved to his current role as Deputy Chief Pharmacist in 
a large teaching Trust and is aware that this may have influenced the departmental MI 
service to actively recruit nurses and doctors. It was also practically easier for the 
researcher to interview doctors and nurses at his base organisation, so this skewed the 
location of interviewees  
 
Qualitative analyses of the data attempted to preserve the textual form of the data 
gathered, e.g. interview transcripts were recorded verbatim, and to generate analytical 
categories and explanations. This can be done inductively—that is, obtained gradually 
from the data—or deductively—that is, with a theoretical framework as background, 
either at the beginning or part way through the analysis as a way of approaching the 
data. 79 Within this phase of the research a deductive analysis approach was initially 
taken to enable ideas and patterns or themes, to be generated from the interviews 
conducted with on-call pharmacists, doctors and nurses using a theoretical framework. 
The Framework method sits within a broad family of analysis methods often termed 
thematic analysis or qualitative content analysis and was developed in the UK during 
the late 1980s. The Framework method for thematic analysis provides an analytical 
process to the data which is systematic, comprehensive and transparent although it 
cannot accommodate highly heterogenous data. It is frequently used for the thematic 
analysis of semi-structured interview transcripts. 81 A suggested process for thematic 
analysis includes familiarisation with the data, e.g. transcribing, generating initial codes, 
searching for themes, e.g. collating codes into potential themes, defining and naming 
themes, e.g. checking if themes work in relation to the transcript and overall data set 
and producing the report, e.g. selection of supporting extract examples. 81  
 
All interviews were personally transcribed verbatim by the researcher from the digital 
audio recorder to Microsoft Word. Documentation of what the interviewee said used 
italic plain text, whereas italic bold text within square brackets was used for the 
interviewer, e.g. “…patients are allergic to lactose [Right].” Transcription included all 
non-verbal communication, e.g. laughter, pauses, sighing, and when it was unclear 
from the interview transcript the intention of the interviewee’s words, e.g. sarcasm. 
These were shown in the transcripts as non-italic text in square brackets, e.g. 
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[interviewee laughed]. If clarification was needed within the transcript because 
something the interviewee said was not obvious, then this was documented by the 
researcher within the transcript using non-italic, non-bold text in square brackets, e.g. 
“…and they [senior pharmacists] make a point…” This process was one of the first 
steps taken by the researcher to ensure data familiarity. The interview transcripts were 
then imported from Microsoft Word into NVivo Version 11. Using NVivo 11, each 
interview transcript was initially subjected to descriptive coding and an example of this 
is provided (Figure 1).  
 
Figure 1. Example of interview transcript descriptive coding 
 
 
Descriptive coding summarises in a word or short phrase the basic topic of a passage 
of qualitative data and is appropriate for analysing interview transcripts.  This type of 
coding leads primarily to a categorised inventory, tabular account, summary of index of 
the data’s contents, i.e. interview transcript. 82 Based on the researcher’s approach to 
descriptive coding and thematic analysis, it was decided not to complete this within 
NVivo, but rather complete this within Microsoft Excel. The codes documented in NVivo 
were then exported to Microsoft Excel to enable the systematic process of generating 
themes according to the interview schedule questions. Initially, the descriptive codes 
were categorised and then themed where there were similarities. This focused on what 
was said by interviewees rather than looking for relationships between the text and the 
way in which things were said. An example of this question-focused analysis is 
provided (Table 7). If there were any codes identified which were outside the interview 
schedule but of relevance, these were categorised accordingly, e.g. advantages of 
working during normal working hours.  
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Table 7. Question-focused analysis of interview transcripts  
Interview 
question 
Descriptive coding Category Theme 
What are the 
types of 
information or 
advice about 
medicines that 
you need to find 
when working out 
of hours? 
 
Safety check of dose 
calculation. 
Safety check of dose. 
Medication 
safety 
check. 
Reassurance that 
drug is safe to use in 
patient. 
Reassurance about 
safety of drug in 
patient. 
Ensuring right dose 
has been prescribed 
for patient. 
Double-check 
prescribed dose. 
Advice from 
pharmacist if nurse 
has concerns about 
use of drug in patient 
and raised these with 
medical team but 
overlooked. 
Double-check safety 
of drug in patient. 
 
One of the risks associated with the Framework method approach is that it can be too 
focused on process rather than outcome. In fact, when the themes generated from the 
Framework method approach were reviewed, it did not feel that the richness of the data 
had been captured. The researcher therefore decided to approach the themes again 
but without employing a question-focused analysis. The themes previously generated 
were re-reviewed to ascertain if there was any repetition or commonality amongst 
them. This involved removing the questions and approaching the analysis by 
considering the themes irrespective of question or the healthcare professional(s) that 
may have led to their generation. The majority of themes generated from this second 
round were different from the initial approach although there were some similarities, 
e.g. documentation. The transcripts were also re-visited by the researcher to determine 
if the themes generated from the second round were founded in this data, and this 
process was repeated several times and any new themes included. Once the 
researcher felt that the themes accurately reflected the data, the interview transcripts 
were re-read by the researcher to ensure that this was indeed the case. This process 
led to a finalised list of themes generated from the data. During this process a 
significant amount of reflexivity took place during this process and this is outlined in 
Section 2.3. 
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2.3 Reflexivity 
Reflexivity is a term derived from ethnomethodology used to describe the self-
organising character of all interaction so that any actions provides for its own context. 83 
The researcher is aware and sensitive to the ways in which he and the research 
process can shape the collected data, including the role of the researcher’s prior 
assumptions and experience, and the influence this might have on a study’s findings. 84 
 
The researcher has worked in the NHS for nearly 20 years as a hospital pharmacist, 
across four hospitals in the Southeast of England. During half of this time he has 
worked as a MI pharmacist and partly, as an on-call pharmacist. He therefore 
recognises that his experience and assumptions may have had an impact on this 
research. 
 
When Chief Pharmacists in England were contacted to complete the survey, the 
researcher’s name and university details were included. However, the researcher is 
aware that quite a few of them may have recognised him as an MI pharmacist working 
in a regional MI centre. However, although this may have helped with the response 
rate, it is unclear if this affected their responses to the survey questions. The 
researcher believes that the types of questions included in the survey were influenced 
by his previous roles. This may have introduced bias into the types of questions that 
were asked but he also feels it enabled him to include the types of areas that needed 
exploring. For example, he knew that documentation of advice provided out of hours 
was poor but needed evidence to support this as set out in the researcher’s personal 
motivation (Chapter 1, Section 1.1). The survey alluded to this but needed further 
exploration in the interviews. He is conscious that this may have potentially narrowed 
his focus on the areas that were explored. 
 
The researcher believed that semi-structured interviews would provide an opportunity 
to explore areas around medicines advice out of hours with interviewees that the 
survey did not allow, e.g. information needs, accessing information, barriers, 
documentation, training, support. Interviews with pharmacists were conducted in 
hospital pharmacy departments and the researcher is very aware that interviewees 
knew he was previously a MI pharmacist working in their regional/neighbouring 
regional centre (the researcher had now moved into a new role outside of hospital 
pharmacy). For example, some of these individuals were personally trained by the 
researcher in MI at the regional centre, or colleagues may have told them he used to 
be a MI pharmacist. This may have affected their responses and in particular their 
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interpretation of the questions focusing on MI or medicines advice. For example, when 
asking about MI or medicines advice in the context of out of hours, the researcher 
thinks that some interviewees answered this question in the purest sense of when 
medicines advice is provided by a traditional MI service. Some interviewees may have 
felt more relaxed when being interviewed; conversely some, may have felt more 
nervous and perceived there was an expectation of a “right” answer to the questions 
and tried to provide what they thought the researcher wanted to hear. The researcher’s 
approach was to put interviewees at ease explaining that they should answer questions 
honestly and that there was no right or wrong answer in an attempt to minimise my 
influence.  
 
Doctor and nurse interviewees knew that the researcher was a Deputy Chief 
Pharmacist (the researcher had now moved back into a new role within hospital 
pharmacy). This was because he contacted them using his work email address or 
when contacting potential interviewees using his University email address explained 
that he worked at the hospital to aid flexibility with dates and times for interview. During 
some of the interviews he also wore his identity badge showing he was the Deputy 
Chief Pharmacist. Whilst the researcher recognises that he was undertaking research 
in that context, he had to wear his identification badge whilst in his own hospital due to 
internal security requirements. This could have been avoided by removing the badge 
just prior to the interview but he believed this would have had little effect by that point. 
However, the researcher did not wear his identification badge when conducting 
interviews outside his organisation.  
 
During the semi-structured interview process, the researcher kept a diary to document 
any observations about the interviewee which would not have been evident in the audio 
transcript, e.g. body language, and the environment in which the interview was 
conducted. He kept a record of his thoughts/comments at the time or immediately after 
the interview as to how these might have affected the interviewee and/or their 
responses, and/or their effects on him as the researcher and reflected in this thesis. 
These reflections were important to consider during the research process and partly 
informed the reflexivity, pilot and discussion of results within this thesis. 
 
As a pharmacist trained in the natural sciences, the qualitative methods used in this 
research were unfamiliar to the researcher. The approach initially used, akin to the 
Framework method, was to code interview transcripts and generate themes. However, 
it was clear from the themes generated from this process that they were superficial and 
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did not reflect the richness of the data from the interviews. The researcher reflected on 
this and decided that he would approach the themes again, this time not restricting 
himself to a question-focused approach. Initially he struggled to understand how best to 
undertake this different method. However, in the end he realised that by removing any 
reference to the questions asked in the interviews and instead only focusing on the 
themes originally generated, this provided a clearer perspective. The researcher 
believed that this different approach could better reflect the data generated from the 
transcripts and enable broader connections to be made. During this process the 
researcher found it difficult to decide on the themes because he was concerned that he 
was missing important concepts. It is for this reason that he re-visited the themes again 
and again, checking back to the original research objectives to ensure that these were 
being answered. Once themes were finalised, he also re-read interview transcripts to 
ensure the themes reflected those coming out of the interviews. Eventually, a final set 
of themes were generated and the researcher felt happier that these better reflected 
the data within the transcripts. On a personal level, this researcher found this process 
very challenging because it was something he was not familiar with and doubted 
whether the process he was following would lead to valid results. This probably reflects 
the fact this was a new process for the researcher and for this reason, took significantly 
longer to analyse and theme the data compared to quantitative data analysis. 
 
At the start of this research process, this researcher had some experience of 
quantitative research methods and understood the value that these could provide. 
However, he had no experience of qualitative research methods and did not 
understand the benefits of these. However by undertaking a mixed methods approach, 
he has come to realise the value of qualitative research methods. In particular, the type 
of data generated from qualitative research methods provided a depth and richness 
which was not possible with quantitative methods. As a result, this researcher now 
appreciates and values both quantitative and qualitative research methods, and 
particularly how the two can complement and triangulate the findings from each. This is 
the first time qualitative research methods have been used to understand the provision 
of medicines advice out of hours.  
 
The final part of this section will discuss in more detail the impact of this researcher, as 
an expert, on this research. Firstly, this researcher was a MI pharmacist who had 
worked in this specialty for at least 10 years. It should be acknowledged that this 
experience has helped shape this research because of his knowledge and 
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understanding of the area. For example, the researcher had some knowledge of the 
research that had previously been undertaken focusing on MI provision, with a 
particular focus in recent years on patient care and outcomes. However, he was not so 
aware of what research had been published for on-call pharmacy services but based 
on his previous, limited evaluations had concluded that it was minimal. This knowledge, 
or assumed understanding by the researcher, of what had been published, contributed 
to his approach to the literature review. That is, the focus on the provision of both MI 
and on-call pharmacy services, and the themes for each. In turn, this knowledge of 
services together with the findings of the literature review helped shape the aim and 
objectives of this research. Previously undertaken practice-based research and service 
evaluations which focused on medicines advice out of hours sometimes meant that this 
researcher’s perceptions may have been influenced or pre-conceived. This is inevitable 
and unavoidable but by undertaking a rigorous research process, it is hoped that any 
bias may have been minimised. In addition, it was very important that the researcher as 
an expert, did not influence the findings from his own knowledge or assumptions based 
on experience. This was particularly relevant to the qualitative, rather than quantitative, 
data analysis because there was a greater risk of subjectivity. During this process, this 
researcher was determined not to influence the themes generated from the data but 
was very aware that this could happen unconsciously. Knowing how on-call pharmacy 
services operate in practice, and from his own experience, could have led to bias 
towards the generation of particular themes from the data, substantiating those 
experiences. However, because this researcher was conscious of this risk, this was 
one of the reasons why so much time was spent revisiting the themes ensuring that 
they reflected the interview transcripts as described earlier in this section. In fact, this 
was evident by the transition from using a process akin to the Framework method to an 
analysis which concentrated on the themes generated from the data irrespective of the 
questions asked and responses received.  
 
Finally, one of the most significant developments during this research process was the 
researcher’s own personal reflections about his perception of reality. As described in 
Section 2.2, he initially was not conscious that his approach to research was grounded 
in any theoretical stance or methodology. In fact, this researcher was completely 
unfamiliar with any of the concepts or terminology associated with research paradigms, 
and particularly qualitative methods. Although he initially came to believe that there 
was one version of reality, his belief later developed increasingly towards 
constructivism. He therefore accepted that there can be multiple versions of reality, for 
example that one pharmacist may perceive a question asked by a nurse or doctor as 
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‘simple’ whereas another pharmacist may believe the same question to be ‘complex’. 
The varied perceptions of these pharmacists appear to be grounded in their own 
knowledge and experiences based on their backgrounds, different training received 
and exposure to situations.  
These concepts were particularly challenging for this researcher to begin with, mainly 
because of his background in the natural sciences as a pharmacist. However, since 
undertaking this research he has a much greater appreciation and understanding of 
research paradigms. 
 
In summary, this reflection has helped the researcher understand the effect and 
influence he may have had on the research conducted and on individuals involved in 
this process.  
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CHAPTER 3 METHOD 
3.1 Introduction  
The first section of this chapter outlines the method used for the initial part of this 
research involving an online survey of Chief Pharmacists in England. The second 
section outlines the method used for the subsequent part of this research, which 
involved semi-structured interviews with on-call pharmacists, nurses and doctors. The 
rationale for both methods and their development has previously been described 
(Chapter 2).  
 
3.2 Online Survey 
According to the NHS Health Research Authority decision tool, this first phase of the 
research was deemed to be an evaluation of an existing service and therefore ethical 
approval was not sought from the National Research Ethics Service. 85 However, the 
researcher’s base organisation’s (a medium sized acute hospital NHS Trust) research 
office was notified of the study and ethical approval was still sought, and granted by 
The Behavioural Sciences Ethics Committee, School of Applied Sciences, University of 
Wolverhampton on 25th July 2012 (Appendix 6).   
 
Ethics approval was gained from the University of Wolverhampton and not the 
University of Central Lancashire because at the time of data collection the researcher 
was registered for study with the University of Wolverhampton, before transferring to 
the University of Central Lancashire.  
 
Piloting of the survey took place with nine pharmacists, three clinical and six MI 
pharmacists. Purposive sampling was used to identify participants, with the researcher 
approaching individuals who worked at his base organisation and those located in 
other hospitals using established professional networks. After initially approaching each 
individual informally to participate in the pilot, a formal email was then sent (Appendix 
7) together with a copy of the information sheet (Appendix 8). A copy of the online 
survey, hosted on Survey Monkey, is provided in Appendix 9. Participants were 
contacted in August 2012 and given two weeks to respond.  
 
All nine individuals completed the online survey and seven responded to the questions 
as outlined in Panel six.  Responses to the questions in Panel six were collated and 
manually entered into a Microsoft Excel spreadsheet (Table 8). Each response was 
reviewed and actions identified, documented and completed  
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Table 8. Participant responses to questions asked by the researcher for the 
pilot study 
Questions Responses 
Yes No Not 
Answered 
Did you understand the information 
sheet/consent form attached to this email? 
3 0 4 
Did you understand the consent form at the 
start of the survey? 
3  4 
Did the survey work for you? i.e. technical 
functionality 
2 a 1 4 
Did you understand the questions asked within 
the survey? 
1 1 b 5 c 
a. Two respondents gave the following information: Sort of - as part the consent form it states "you can 
choose to omit any question" as I did the questionnaire I tried to do this but it states certain answers 
are required; Yes NB. Question 27, gives a box for other-please specify, but there is not a blob for 
‘other’. 
b. One respondent commented “I was slightly confused by the description ‘secondary care’”. 
c. Although the question was not specifically answered, three respondents provided comments on the 
survey questions. 
 
Appendix 10 shows the comments received from participants about the online survey 
questions and its functionality, and the actions taken as a result. In addition, a number 
of general comments were received, and the actions taken as a result are shown in 
Appendix 11. The majority related to technical aspects of the survey, e.g. being able to 
partially complete the questions and then return at a later time, and consistency of 
wording within the survey or information sheet. Once any amendments were 
completed, no further piloting of the survey was undertaken. 
 
Following piloting, the online survey was distributed to all Chief Pharmacists. The 
contact details for Chief Pharmacists in NHS England were not publicly available in one 
place but were obtained from a database developed and maintained by the London 
Pharmacy Education and Training. Access to this data was freely granted to the 
researcher for the purposes of this study. All Chief Pharmacists of acute hospitals 
Trusts (n=164) and mental health Trusts (n=54) in NHS England were invited to 
participate in this study. A contact name and email address were not listed in this 
database for the Chief Pharmacist at three Trusts. For these, a postal survey was sent 
addressed to the ‘Chief Pharmacist’ rather than a named individual.  There were two 
Chief Pharmacists (joint post holders) listed for one acute hospital Trust and one 
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mental health Trust. For these organisations, both Chief Pharmacists were contacted. 
Therefore, in total 220 Chief Pharmacists were contacted. 
 
Initially a personalised letter (Appendix 12) with information sheet (Appendix 8) was 
posted (Monday 29th October 2012) to all Chief Pharmacists explaining the purpose of 
the study, with a link to the online survey hosted on Survey Monkey (Appendix 13). A 
personalised email containing the same information was then sent to every Chief 
Pharmacist on Sunday 4th November 2012.  A week later (Monday 12th November 
2012) a reminder letter (Appendix 12) was posted to all non-respondents. In addition, a 
reminder email was sent again to each non-respondent (16th November 2012). The 
survey was closed on Sunday 9th December approximately 6 weeks after the first letter 
was sent to Chief Pharmacists. 
 
Responses received were exported to SPSS Version 25. The data was then tabulated 
using Microsoft Excel to provide a summary document showing the responses to each 
survey question. Cross-tabulation, Pearson’s Chi-Square and the Fisher’s exact test 
using SPSS to determine statistical significance was also applied. Thematic analysis 
was used when ‘other’ was selected in response to survey questions. Further 
information about the quantitative and qualitative analysis undertaken has previously 
been described (Chapter 2, Section 2.2). 
 
3.3 Semi-structured interviews 
Like the first phase, this next part of the research was deemed a service evaluation 
according to the NHS Health Research Authority decision tool, and therefore ethical 
approval was not sought from the National Research Ethics Service. 85 Ethical approval 
was sought and granted on 11th November 2013 by The Behavioural Sciences Ethics 
Committee, School of Applied Sciences, University of Wolverhampton (Appendix 14).  
 
The researcher approached a Chief Pharmacist in the East of England on 16th January 
2014 seeking permission via email to pilot the interview schedule with on-call 
pharmacists working in that Trust (Appendix 15). This Chief Pharmacist had previously 
agreed to be contacted about this phase of research as described in Section 3.2. A 
reminder email was sent on 4th February 2014, followed by a telephone call on 28th 
February 2014. Subsequently, the Chief Pharmacist gave permission for the pilot to be 
conducted with on-call pharmacists at the Trust. The contact details of two individuals 
were provided by the Chief Pharmacist and the 4th April 2014 agreed as the date of the 
interviews. 
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The researcher contacted both individuals by email to ensure they were willing to 
participate in the interview. A copy of the information sheet (Appendix 16) was also 
provided. Interviews were conducted with each on-call pharmacist within the pharmacy 
department at the Trust on the same day, separated by a small break. Prior to the 
interview, each interviewee was asked to complete a consent form (Appendix 17). The 
questions used during the semi-structured interviews are shown in Panel seven. 
 
Panel 8. Interview schedule used in on-call pharmacist pilot interviews  
1. What do you think are the medicines information needs of doctors and nurses’ 
when working out of hours? How does this differ to normal working hours? 
2. How do you go about answering questions for medicines advice when working 
out of hours?  How does this compare to the same question being asked during 
normal working hours? What barriers (if any) do you face? 
3. What do you think about the way in which calls for medicines advice are handled 
out of hours by the pharmacy service? How does this compare to normal working 
hours?  
4. Is there anything that you would change about the way pharmacy departments 
provide medicines advice out of hours? What impact do you think 7 day working 
will have on the on-call pharmacy service? 
5. What do you document when you handle calls for medicines advice out of 
hours? How would this compare to normal working hours  
6. What affects what you document? Does this differ to normal working hours? 
7. If you did document medicines advice, what would affect what you use to 
document, e.g. paper- or electronic-based form. 
 
The interview schedule used for doctors and nurses was piloted initially with the first 
doctor interviewed on 15th May 2015, at their base hospital. A copy of the information 
sheet was provided (Appendix 18) and prior to the interview, the doctor was asked to 
complete a consent form (Appendix 17). Information about how doctors and nurses 
were recruited is provided in Chapter 2, Section 2.2.2. The interview schedule used 
can be found in Panel eight. 
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Panel 9. Interview schedule used in doctor pilot interview  
1. What are the types of information or advice about medicines that you need to find 
when working out of hours?  
(If the interviewee replies ‘don’t know’ or struggles to answer this question, I would 
prompt with: for example, have you ever needed some information/advice when 
you’ve been asked to prescribe a medicine for a patient? 
2. How does this compare to normal working hours? 
3. How do you access information on medicines when working out of hours?  
4. What sources would you typically use to find information on medicines out of 
hours? 
5. What barriers (if any) do you face when trying to access information on 
medicines out of hours? 
6. How does this (question 3, 3a and 3b) compare during normal working hours? 
7. Tell me what support does the pharmacy department provide you with during out 
of hours when you have questions related to medicines? 
a. Is there anything that you would change?  
b. How does this compare to normal working hrs? 
8. Do you have anything else you would like to tell me? 
 
All pilot interviews conducted with on-call pharmacists, doctors and nurses were audio 
recorded using a digital recorder. A reflective diary was completed by the researcher 
after each interview (Appendix 19). Each interview was transcribed into Microsoft Word 
by the researcher as soon as possible. Any identifying information provided by 
participants during the interview was anonymised. A copy of the transcript was returned 
to each participant by email for verification of accuracy. Interviewees were assigned a 
unique identification number (UIN). The ‘Key’ which detailed the contact details of each 
participant for each UIN was kept by and only known by the researcher. This key was 
stored on an encrypted and password protected USB drive held by the researcher.  
 
Interviews with on-call pharmacists took approximately one hour to complete (1 hour 11 
min and 1 hour 7 min), and the interview with a doctor took just over half an hour to 
complete (30 mins 6 seconds).  All interviewees verified the accuracy of the interview 
transcript and confirmed that the digital recording of the interview worked in practice 
and that the researcher accurately transcribed the audio recording. Thematic analysis 
of the transcript was not formally undertaken but responses given to questions were 
reviewed to determine if they provided information that met the research objectives. 
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A reflective diary kept by the researcher at the time of the interviews noted that a good 
rapport was quickly established with all interviewees. During the interviews the 
researcher mirrored the interviewee’s body language; no unusual body 
language/actions by the interviewees were noted during the interviews. The researcher 
attempted not to interrupt interviewees but was aware that this may have occurred on 
occasion with on-call pharmacists, and an example from a pilot interview transcript is 
provided below:  
 
[Researcher] OK, so in terms of normal working hours do they ask you for medicines 
advice questions which are not - do they ask you anything else apart from calculations 
and administration? 
[Interviewee] What out of hours or-?  
[Researcher] During normal working hours. 
[Interviewee] Erm… 
[Researcher] Because what you’ve told me is that out of hours- 
[Interviewee] Yeah, for example mainly the junior doctors they want information cos 
they’re not familiar - for example how to set up an aminophylline infusion [Hmm] how 
much to give so again, erm you have to look this one up [Hmm]. Mainly drug-related. 
 
It was also acknowledged by the researcher that the phrasing of on-call pharmacist 
interview questions could have been improved. Two examples from the interviews 
showing poorly phrased questions are provided below: 
 
[Researcher] OK. That’s really good. Erm we’re nearly there. Erm again we’re… 
[Interviewer laugh] we’re obviously touching on questions that keep coming…but what 
affects what you document? 
 
[Researcher] So it sounds like during normal working hours it’s acceptable just to talk 
to the nurse or the doctor because it’s quicker, you said easier, but out of hours they 
may be…doctors – 
 
The researcher reflected that these poorly phrased questions were likely to have 
occurred because he was nervous during these on-call pharmacist pilot interviews. 
 
In relation to the pilot interview conducted with a doctor, there was unfortunately no 
office available. Instead, the pilot interview was undertaken at the back of a hospital 
staff restaurant. This was not an ideal environment for ensuring good quality sound 
recording.  The researcher noted that he was also nervous during this interview and 
104 
 
reflected that he had been nodding encouragingly when the interviewee was speaking 
in response to questions.  
 
In addition to the reflective diaries kept at the time of all three interviews, the 
researcher reviewed each interview transcript once completed. A number of 
observations were made: all interview transcripts were typed verbatim using different 
text colours to indicate when the researcher or interviewee was speaking, pausing, or 
making an audible sound, e.g. laughing, sighing. It was noted that during the first 
interview with the on-call pharmacist, question seven was asked earlier than planned in 
the schedule. This was because the interviewee made reference to the documentation 
of medicines advice earlier on and therefore it was appropriate to ask this question at 
this point. During the second on-call pharmacist interview the researcher did not ask 
some questions within the interview schedule. This was because the interviewee 
provided this information when previous questions were asked. At the time, the 
researcher believed that the interviewee would feel they were repeating information if 
the interview schedule questions were followed. However, on reflection asking the 
questions may have yielded additional information that was not volunteered by the 
interviewee in response to previous questions. The researcher also used the pilot on-
call pharmacist interviews to ask some additional (not probing) questions to determine 
what further information may have been provided by the interviewee. However, it was 
acknowledged by the researcher that these provided no additional value and future 
questioning should focus on the interview schedule questions with subsequent and 
appropriate probing. 
 
Based on these reflections, and feedback from his supervisor on the interview 
transcripts/audio in response to these, the researcher decided to make some minor 
amendments to the interview questions (Table 9). However, although these were not 
significant enough to delay undertaking further interviews with on-call pharmacists it 
was decided by the researcher not to include these two pilot interviews in the final data 
set. 
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Table 9. Interview schedule changes required following pilot 
Pilot interview schedule Amended interview schedule 
1.What do you think are the medicines 
information needs of doctors and nurses’ 
when working out of hours? How does 
this differ to normal working hours? 
1.What do you think are the medicines 
information needs of doctors and nurses’ 
when working out of hours?  
 
2.How do you go about answering 
questions for medicines advice when 
working out of hours?  How does this 
compare to the same question being 
asked during normal working hours? 
What barriers (if any) do you face? 
2.How does this differ to normal working 
hours? 
3.What do you think about the way in 
which calls for medicines advice are 
handled out of hours by the pharmacy 
service? How does this compare to 
normal working hours?  
3.How do you go about answering 
questions for medicines advice when 
working out of hours?   
4.Is there anything that you would 
change about the way pharmacy 
department provides medicines advice 
out of hours? What impact do you think 7 
day working will have on the on-call 
pharmacy service? 
4.How does this compare to the same 
question being asked during normal 
working hours?  
5.What do you document when you 
handle calls for medicines advice out of 
hours? How would this compare to 
normal working hours (may be a 
difference if MI or clinical pharmacist 
during normal working hours) 
 
5.What barriers (if any) do you face? 
6.What affects what you document? 
Does this differ to normal working hours? 
6.What do you think about the way in 
which calls for medicines advice are 
handled out of hours by the pharmacy 
service? 
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Pilot interview schedule Amended interview schedule 
7.If you did document medicines advice, 
what would affect what you use to 
document, e.g. paper- or electronic-
based form. 
7.How does this compare to normal 
working hours? 
 8.Is there anything that you would 
change about the way pharmacy 
departments provide medicines advice 
out of hours? 
 9.What impact do you think 7 day 
working will have on on-call pharmacy 
services? 
 10.What do you document when you 
handle calls for medicines advice out of 
hours?  
 11.What affects what you document? 
 12.What affects what you use to 
document medicines advice calls? i.e. 
paper, electronic 
 13.How would this compare to normal 
working hours? 
 14.What are your views on the training 
that on-call pharmacists receive 
specifically to help them handle 
medicines advice calls? 
 15.Do you have anything else you would 
like to tell me? 
 
Although the researcher had noted that he had made encouraging nods in response to 
the interviewee comments during the interview, there were no significant issues or 
concerns observed following the interview conducted with a doctor. Based on these 
reflections on the interview transcript/audio, the researcher decided that these was not 
significant enough to delay undertaking further interviews with doctors and nurses. 
Furthermore, no changes were required to the interview schedule. It was for this 
reason that the data from the pilot doctor interview was included in the final data set. 
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Following the pilot with on-call pharmacists, a letter was posted on 5th June to all Chief 
Pharmacists (or individual nominated by the Chief Pharmacist) of the 12 East of 
England Trusts who had consented previously to participate in further study (Section 
3.2). In parallel, this letter was emailed to the same Chief Pharmacists on 9th June in 
order to increase the response rate (Appendix 20). The Chief Pharmacist who was 
contacted for the pilot interviews of on-call pharmacists was included. A reminder letter 
was posted on 22nd June and the same letter emailed on 23rd June, to those Chief 
Pharmacists who had not responded.  
 
The letter/email detailed the next phase of the study and asked them to provide the 
names and email addresses to the researcher of pharmacists who participated on the 
on-call rota. An information sheet about the study was also included (Appendix 16). 
Chief Pharmacists at this time were also informed that the researcher would be 
contacting the MI pharmacist within their department in due course to help support the 
next phase of research. 
 
The researcher then contacted each individual on-call pharmacist by email providing 
them with information about the study (Appendix 21). Positive, negative and no 
responses were documented onto a ‘tracker’ including agreed interview dates where 
applicable. Interviews were conducted with on-call pharmacists (Appendix 22) at a 
mutually convenient time for both the interviewee and researcher. Interviews took place 
at the individuals’ place of work, usually in an office within their department. The same 
method used for the pilot on-call pharmacist interviews as described earlier was 
followed.  
 
In the case of interviews conducted with doctors and nurses, it was decided to 
approach the same Trusts in the East of England where on-call pharmacist interviews 
took place. This was because the researcher wanted to ensure that the doctors and 
nurses interviewed had the same Trust experiences and therefore would be able to 
more easily triangulate any findings. A letter was posted to the MD, DoN and R&D 
departments of each Trust (Appendix 23) on 9th January 2015. This also included a 
request to display and/or circulate a poster within their organisation (Appendix 24) to 
help with the recruitment of doctors and nurses.  
 
Although as previously described, this research was deemed to be a service evaluation 
according to the NHS Health Research Authority decision tool, half of the Trusts that 
responded (n=2/4) took a different view. These Trusts requested a submission via the 
Integrated Research Application System (IRAS) because they deemed this study to be 
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research. For both of these Trusts, the researcher completed and made an IRAS 
submission together with a Site Specific Information form and associated 
documentation, e.g. information sheet, consent forms, curriculum vitae. 
 
In addition to contacting the MD, DoN and R&D departments, the researcher contacted 
these Trusts’ pharmacy MI services via email, where one existed (87.5.8%, n=7/8) 
(Appendix 25). The MI services were asked if they would be willing to help recruit 
doctors and nurses from within their Trust when they contacted them with an enquiry 
during normal working hours. MI services were advised that recruitment would be over 
a 4 to 8 week period depending on the number of doctors and nurses recruited.  
 
A ‘script’ containing information to be read out to the nurse/doctor was provided for MI 
services to use. In addition, a template for MI services to document the contact details 
of doctors and nurses willing to be contacted was provided (Appendix 26). Contact 
details included the individual’s full name, job role, contact email and telephone 
number. This proforma was then submitted via secure email (nhs.net to nhs.net) to the 
researcher on a weekly basis. Doctors and nurses who contacted the researcher 
directly or via the pharmacy department’s MI service expressing an interest to 
participate in the study, were then contacted by email by the researcher (Appendix 27). 
Further details of the study were provided, including an information sheet for doctors 
and nurses (Appendix 18 and 28). Positive, negative and no responses were 
documented onto a ‘tracker’ including agreed interview dates where applicable. It was 
made clear to the participant at that stage that they may not be contacted for an 
interview (due to data saturation). Those interviews that were conducted with doctors 
and nurses were done so at a mutually convenient time for both the interviewee and 
researcher (Appendix 29).  
 
Each interview was transcribed into Microsoft Word by the researcher as soon as 
possible. Any identifying information provided by participants during the interview was 
removed to maintain anonymity.   A copy of the transcript was returned to the 
participant by email for verification of accuracy. In addition, each doctor/nurse was 
asked if they would like a summary of the results after the study was completed. 
 
All interview transcripts were imported from Microsoft Word into NVivo Version 11. 
Each interview transcript was then descriptively coded following the process previously 
described (Chapter 2, Section 2.2.2).  
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CHAPTER 4 RESULTS (ONLINE SURVEY)  
4.1 Introduction 
This chapter outlines the results from the online survey and is reproduced in the 
section orders as per the survey, namely: demographics; on-call pharmacy service 
provision; documentation and training, with sub-classification where appropriate.  
 
4.2 Response rate 
Initially, a response rate of 55.0% (n=120/218) was achieved after two reminders. 
However, two Chief Pharmacists each completed the survey twice. Each Chief 
Pharmacist was contacted and once it was determined which response they wished to 
submit the other response was excluded. Two other Chief Pharmacists consented to 
the study but did not enter any responses.  
 
A total of 116 completed responses were included for the analysis (53.2%). NHS acute 
hospitals represented 76.7% (n=89/116) of the responses with mental health Trusts 
accounting for the remainder (23.3%, n=27/116). No significant differences were seen 
in response rates between acute and mental health Trusts (54.3% v 50.0%). 
 
4.3 Organisational demographics 
The number of responses according to Trust size, by bed number, is shown in Table 
10.   
Table 10. Size and type of organisation 
Number of beds 
Acute Hospital 
Trust 
Mental Health 
Trust 
Total 
(n) 
< 300 10 (8.6%) 13 (11.2%) 
116 
300 – 500 15 (12.9%) 8 (6.9%) 
501 – 700 19 (16.4%) 3 (2.6%) 
701 – 900 14 (12.1%) 3 (2.6%) 
901 – 1200 18 (15.5%) 0 (0%) 
> 1200 13 (11.2%) 0 (0%) 
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4.4 Provision of on-call pharmacy service 
Most hospitals provided an on-call pharmacy service (87.1%, n=101/116); of these, 
acute hospitals were the main providers (86.1%, n=87/101).  There was a statistically 
significant correlation between the type of NHS organisation, i.e. acute hospital or 
mental health Trust, and whether an on-call pharmacy service was provided (Pearson’s 
Chi-Square, X2 = 38.765, df = 1, p = <0.005). Nearly half of mental health Trusts 
(48.1%, n=13/27) did not provide an on-call pharmacy service. A theme generated by 
an analysis of the reasons provided by respondents was that mental health Trusts that 
did not provide an on-call pharmacy service had a service level agreement (SLA) with 
another provider, e.g. a neighbouring acute hospital handled the calls for medication 
supply or advice. 
 
The most common model of on-call services was for pharmacists to be at home 
(94.1%, n=95/101), with just 10% (n=10/101) of Trusts operating a residency 
programme (note total values exceed 100% as four Trusts provided both models). Of 
those Trusts that operated a residency programme, 80% (n=8/10) had more than 900 
beds. 
 
The majority of Trusts (80%, n=76/95) did not routinely have an on-call MI pharmacist 
available; seven Trusts (7.4%) had a dedicated on-call MI pharmacist that answered all 
calls for medicines advice. A further 12.6% (n=12/95) of Trusts had a MI pharmacist 
available out of hours but only to support the on-call pharmacist with questions for 
medicines advice if necessary. There was no correlation between the availability of an 
on-call MI pharmacist or the type of NHS organisation (X2 = 0.110, df = 1, p = 0.740). 
 
4.4.1 Staffing 
The job banding of those pharmacists involved in the provision of on-call services is 
shown in Table 11. Pharmacists were more likely to be Band 6, 7 or 8a, with 
approximately equal numbers of those bands involved. The higher the grade beyond 
8a saw fewer pharmacists participating. 
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Table 11. Job Banding of pharmacists providing on-call services 
Agenda for Change banding a 
Number (%) b 
(n=101) 
Band 6 89 (21.9%) 
Band 7 93 (22.9%) 
Band 8a 87 (21.4%) 
Band 8b 69 (17.0%) 
Band 8c 35 (8.6%) 
Band 8d 23 (5.7%) 
Band 9 10 (2.5%) 
a. Agenda for Change is the pay system used within the NHS for all staff (except doctors and dentists). 
Staff are placed in pay bands (Band 1 to Band 9) on the basis of their knowledge, responsibility, skills 
and effort needed for the job. Newly qualified pharmacists usually start at Band 6, and typically Chief 
Pharmacists are Band 8d or 9. 
b. Respondents (n=101) were asked to indicate the Agenda for Change banding of those pharmacists 
providing the on-call pharmacy service and so could select more than option. 
 
4.4.2 Workload  
The majority of acute hospital Trusts provided both medication and medicines advice 
out of hours (79.2%, n=80/101) compared to only 11.9% (n=12/101) of mental health 
Trusts. Medicines advice only (no medication supply) was provided by a small number 
of acute hospital (5.9%, n=6/101) and mental health Trusts (2.0%, n=2/101). Only one 
acute hospital Trust provided medication supply out of hours (no medicines advice).  
 
The number of calls in a typical week for the supply of medication compared to those 
for medicines advice is shown in Table 12. Nearly two-thirds of Trusts (65.9%, 
n=56/85) received less than 20 calls per week for the supply of medication compared 
to 83.1% (n=74/89) for medicines advice. A fifth of Trusts (17.6%, n=15/85) handled 
more than 50 calls per week for the supply of medication compared to only a small 
number of Trusts (4.5%, n=4/89) handling the same number of calls per week for 
medicines advice.  
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Table 12.  Comparison of the number of calls for supply of medicines and 
medicines advice received during a typical week by the on-call pharmacy 
service  
Number of calls per 
week 
Calls for supply of 
medication 
(n=85) 
Calls for medicines 
advice 
(n=89) 
< 10 30 (35.3%) 45 (50.6%) 
11-20 26 (30.5%) 29 (32.6%) 
21-30 10 (11.8%) 4 (4.5%) 
31-40 2 (2.4%) 5 (5.6%) 
41-50 2 (2.4%) 2 (2.2%) 
> 50 15 (17.6%) 4 (4.5%) 
 
Identification of any relationships within the data were explored and these are outlined 
in the remainder of this section. Firstly, the number of medicines advice calls received 
during a typical week by the on-call pharmacy service was compared to the size of the 
organisation (Table 13).  
 
Table 13. Comparison of the number of medicines advice calls received 
during a typical week by the on-call pharmacy service according to Trust 
size 
Size of Trust 
(by bed 
number) 
Number of medicines advice calls per week 
Total (n) 
≤ 20 > 20 
< 300 11 (12.4%) 0 (0.0%) 
89 
300 – 500 15 (16.9%) 2 (2.2%) 
501 – 700 19 (21.3%) 1 (1.1%) 
701 – 900 13 (14.6%) 3 (3.4%) 
901 – 1200 11 (12.4%) 3 (3.4%) 
> 1200 5 (5.6%) 6 (6.7%) 
 
 A statistically significant correlation between the volume of calls for medicines advice 
and the increasing size of the organisation was identified (Pearson’s Chi-Square, X2 = 
16.238, df = 1, p = 0.000).  
 
The number of medicines supply calls received during a typical week by the on-call 
pharmacy service was then compared to the size of the organisation (Table 14). 
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 Table 14. Comparison of the number of medicines supply calls received 
during a typical week by the on-call pharmacy service according to Trust 
size 
Size of NHS 
hospital Trust 
Number of medicines supply calls per week 
Total (n) 
≤ 20 > 20 
< 300 12 (13.2%) 0 (0.0%) 
91 
300 – 500 11 (12.1%) 4 (4.4%) 
501 – 700 17 (18.7%) 2 (2.2%) 
701 – 900 11 (12.1%) 4 (4.4%) 
901 – 1200 6 (6.6%) 11 (12.1%) 
> 1200 3 (3.3%) 10 (11.0%) 
 
Similarly, a statistically significant correlation was identified between the volume of calls 
for medicines supply and the increasing size of the organisation (Pearson’s Chi-
Square, X2 = 8.646, df = 1, p = 0.005).  
 
The relationship between medicines advice calls handled and the location of the on-call 
pharmacist was also investigated (Table 15).  
 
Table 15. Location of the on-call pharmacist when MI advice calls 
received and the number per week 
Location  
Number of calls per week a 
(n=92) 
≤ 20 > 20 
Residency 3 (3.3%) 5 (5.4%) 
Home 72 (78.3%) 12 (13.0%) 
a. Respondents (n=92) could select more than option 
 
Resident pharmacists handled a significantly higher number of calls compared to those 
located at home (Fishers exact test, X2 = 11.272, df = 1, p = 0.005). 
 
The relationship between the number of medication supply calls handled in a typical 
week and the location of the on-call pharmacist was examined. A greater number of 
Trusts, where the on-call pharmacist was located at home, handled less than 20 calls 
per week (63.8%, n= 60/94) compared to more than 20 calls per week (26.6%, 
n=25/94). Trusts with resident pharmacists were more likely to receive a higher number 
of calls per week: 8.5% (n=8/94) managed more than 20 calls per week compared with 
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1.1% (n=1/94) which handled less than 20 calls per week. A statistically significant 
correlation between the number of medicines supply calls received and the location of 
the on-call pharmacist was identified (Fishers exact test, X2 = 13.334, df = 1, p = 
0.001). This suggests that resident pharmacists were more likely to handle a higher 
number of calls compared to those located at home. 
 
According to Chief Pharmacists’ opinion, the type of healthcare professional that 
contacted the on-call pharmacy service was recorded (91.8%, n=89/97).  Chief 
Pharmacists were asked to rank them according to how often they thought they used 
the on-call pharmacy service (Table 16). Nurses/midwives were ranked as the most 
frequent users; junior doctors were ranked second, followed by senior doctors and then 
allied healthcare professionals. 
 
Table 16. Frequency that healthcare professionals use the on-call 
pharmacy service  
(ranked 1 - 4, with 1 the most frequent users and 4 the lowest users) 
Healthcare Professional 
Ranking  
1 2 3 4 
Nurses/midwifes (n=87) 
69 
(79.3%) 
12 
(13.8%) 
2  
(2.3%) 
4  
(4.6%) 
Junior doctors, e.g. FY1, FY2 
(n=87) 
12 
(13.8%) 
63 
(72.4%) 
11 
(12.6%) 
1  
(1.1%) 
Senior doctors, e.g. consultant, 
registrar (n=82) 
0 
(0.0%) 
9  
(11.0%) 
72 
(87.8%) 
1  
(1.2%) 
Allied healthcare professionals, 
e.g. dieticians (n=83) 
6  
(7.2%) 
0 
(0.0%) 
0 
(0.0%) 
77 
(92.8%) 
 
4.4.3 Service accessibility and promotion 
Various methods were available to contact on-call pharmacists with mobile phones 
(73.3%, n=74/101), bleep/radiopager (68.3%, n=69/101) and landline phone (41.6%, 
n=42/101), being the three most used routes. Text (5.9%, n=6/101) and email (3.0%, 
n=3/101) were infrequently employed. A few respondents (10.9%, n=11/101) selected 
‘other’ and a thematic analysis of these responses found that on-call pharmacists were 
also contacted via the hospital switchboard.  
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The relationship between the different types of communication routes used according 
to the location of the on-call pharmacist was explored. All routes of communication 
were more likely to be used to contact on-call pharmacists located at home rather than 
those in a residency programme. There was no statistically significant correlation found 
between the location of the on-call pharmacist and being contacted by mobile or 
landline phone (X2 = 1.377, df = 1, p = 0.241). 
 
Most Trusts advertised their on-call pharmacy service (82.2%, n=83/101). This was 
either by advertising the services provided by the on-call pharmacy service, e.g. 
medicines advice, medication supply (74.4%, n=61/82), or by advertising the contact 
telephone number(s) for the on-call pharmacist (42.7%, n=35/82). Only a very small 
number of Trusts advertised the contact name(s) of the on-call pharmacists (4.9%, 
n=4/82). Nearly a fifth of Chief Pharmacists (29.3%, n=24/82) did not choose one of the 
options provided and instead gave a written response. Thematic analysis of these 
responses found that Trusts advertised how to contact the on-call pharmacist, e.g. via 
switchboard, and when the on-call pharmacy service should be contacted by 
healthcare professionals.  
 
If a Trust advertised their on-call pharmacy service, Chief Pharmacists were asked to 
select the methods used for promotion. Table 17 shows the methods used by 
pharmacy departments to promote their on-call service. 
 
Table 17. Routes used by pharmacy departments to promote their on-call 
service  
Method 
Number of Trusts (%) 
(n=83) a 
Internet 4 (4.8%) 
Intranet 69 (83.1%) 
Sticker on hard copies of the BNF circulated 
throughout the organisation 
11 (13.3%) 
Notices on the wards/clinical areas 30 (36.1%) 
Other (please specify) b 39 (47.0%) 
a. Respondents (n=83) could select more than option. 
b. This included the on-call pharmacy service promoted in Trust policies, via training for doctors and 
nurses and via signposting, e.g. in junior doctor handbooks/training packs, bulletins, MI service, on the 
wards, pharmacy staff. 
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4.5 Documentation of calls   
The documentation of the number of calls received by on-call pharmacists was high for 
both supply of medication (94.6%, n=88/93) and for medicines advice (91.8%, 
n=89/97). The medicines advice provided by on-call pharmacists was documented all, 
or some of the time by nearly half of respondents (49.5%, n= 47/95). One Chief 
Pharmacist stated that medicines advice was never documented. 
 
Just under half of Trusts (41.1%, n=39/95) had a standard policy for the documentation 
of medicines advice, with more policies in place at acute hospitals (79.5%, n=31/39). 
Chief Pharmacists were asked what information the policy stated should be 
documented. Based on a thematic analysis of responses, Panel nine lists the 
information that is expected to be documented out of hours, as per Chief Pharmacists’ 
Trust policies.  
 
Panel 10. Information expected to be documented by on-call pharmacists 
according to their Trust policies  
• Time the enquiry was received. 
• Urgency of the answer required. 
• Date and time of the enquiry received. 
• Enquirer's contact details (including name and role) and location. 
• Patient's details (where appropriate). 
• Enquirer's question. 
• Resources used to answer the enquiry. 
• Answer provided to the enquirer. 
• Name of the pharmacist handling the call. 
• Time taken to answer the enquiry and respond to the enquirer. 
• Follow-up needed during normal working hours further to the enquiry. 
 
For those Trusts that did not have a policy, Chief Pharmacists were presented with a 
list of information options that might be included, and responses shown for each is 
shown in Table 18.   
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Table 18. Chief Pharmacists’ opinions (where no policy existed) on what 
should be documented by on-call pharmacists when providing medicines 
advice  
 
Number (%) 
(n=56) a 
Time of call 54 (96.4%)  
Enquirer's name 56 (100.0%) 
Enquirer's job role 52 (92.9%) 
Enquirer's contact details 50 (89.3%) 
Enquirer's question 55 (98.2%) 
Resources searched 41 (73.2%) 
Information found from resources accessed 35 (62.5%) 
Medicines information advice provided 54 (96.4%) 
Other b 15 (26.8%) 
a. Respondents (n=56) could select more than one type of information that should be documented by 
on-call pharmacists. 
b. This included date/day that the enquiry was received, the amount of time it took the on-call pharmacist 
to answer the enquiry and the reason for the urgency of the enquiry. 
 
Two thirds (66.7%, n=62/93) of Chief Pharmacists stated that advice was documented 
using paper-based forms, although 29.0% (n=27/93) used an electronic-based form or 
database system, e.g. Microsoft Access. More than half (57.9%, n=55/95) of Trusts’ 
on-call pharmacists had access to a bespoke database (MiDatabank) within the 
organisation out of hours. Just over half of these (52.7%, 29/55) were able to access 
the database remotely when outside the organisation. However, only a small number 
(4.3%, n=4/93) used the bespoke database (MiDatabank) irrespective of location to 
record medicines advice provided out of hours directly onto this database.  
 
All on-call pharmacists had access to information resources to enable them to answer 
requests for medicines advice. Chief Pharmacists were asked if their information 
resources had been reviewed against a recommended list for out of hours provided by 
UKMi. 4 In almost two thirds of Trusts (63.8%, n=60/94) this had been done, although in 
14.9% (n=14/94) of Trusts it had not. One in five Chief Pharmacists did not know if their 
information resources had been reviewed against this list (21.3%, n=20/94).  
 
118 
 
4.6 Training provided to pharmacists to help them answer medicine 
questions out of hours  
Specific training for on-call pharmacists to help them provide medicines advice out of 
hours was provided by 81.1% (n=77/95) of Trusts. Although small numbers, all Trusts 
with a residency programme provided training (100.0%, n=9/9) compared to 79.8% 
(n=71/89) of Trusts which operated a home-based on-call service (note that one Trust 
that provided a residency did not answer this question); both MI (79.2%, n=61/77) and 
other pharmacist staff (70.1%, n=54/77) delivered this training. Of those Trusts that did 
not provide training, two thirds were NHS acute hospitals (66.7%, n=12/18) compared 
to 33.3% (n=6/18) from mental health Trusts. 
  
Training was primarily delivered as one-to-one sessions (n=98.7%, 76/77), with group 
sessions (28.6%, n=22/77) the next most common method employed. A small number 
delivered training using e-learning (6.5%, n=5/77). Two Chief Pharmacists selected 
‘other’: the first referred to use of a portfolio assessment; the second that training is a 
“progression of learning based on past or current examples with answers to queries 
that are challenging shared with all on-call pharmacy staff”. An explanation for how this 
is undertaken in practice was not provided by the respondent.  
 
Chief Pharmacists were asked what training was provided (Table 19).  In addition, the 
table includes Chief Pharmacists’ opinions on what training should be provided where 
they did not provide specific training.  
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Table 19. Provision of training to pharmacists before they begin on-call  
Training 
Training provided by 
Trusts 
Training that should 
be provided  
Number (%) 
(n=77) a 
Number (%) 
(n=18) a 
No additional training should 
be provided to that received 
as part of the pharmacist's 
'normal working hours' role 
N/A as question not 
asked  
8 (44.4%) 
Communication skills 25 (32.5%) 6 (33.3%) 
Use of MI 
Resources/Databases 
71 (92.2%) 11 (61.1%) 
Critical 
evaluation/interpretation of 
information/data 
25 (32.5%) 6 (33.3%) 
Use of I.T. 54 (70.1%) 6 (33.3%) 
Documentation of enquiries 53 (68.9%) 7 (38.9%) 
Use of MiDatabank (MI 
electronic enquiry answering 
database) 
50 (64.9%) 5 (27.8%) 
Questioning skills 33 (42.9%) 5 (27.8%) 
Mock 'on-call' scenarios 33 (42.9%) 3 (16.7%) 
Other (please specify)  16 (20.8%) 3 (16.7%) 
a. Respondents could select more than option. 
 
An analysis of responses, when ‘Other’ was selected for Trusts that provided training, 
generated two themes. These were: completion by the pharmacist of training in the MI 
service before they begin on-call specifically to aid handling of medicines advice calls 
out of hours; and, shadowing/buddying of a senior colleague by the on-call pharmacist 
initially to help them provide MI advice out of hours.  
 
A summary of the three responses, when ‘Other’ was selected for those Trusts that did 
not provide training, outlined that all pharmacists are expected to answer MI enquiries 
whether they are undertaking an on-call role or not. 
 
Looking beyond initial training, Chief Pharmacists were asked to specify any on-going 
training provided: nearly half (48.1%, n=37/77) of Trusts never gave any refresher 
training. A small number provided refresher training every three (n=1), six (n=2) or 
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twelve months (n=7). Thirty Chief Pharmacists selected the option ‘Other’ and these 
responses were analysed. Themes generated were: refresher training was provided as 
required; on-going training needs were identified by reflective discussion of on-call 
events with peers; training was provided as part of the on-call pharmacist’s rotation into 
the MI service or identified through staff appraisal.  
 
On-call pharmacists trained by MI staff (57.4%, n=35/61) were more likely to have their 
training refreshed compared to training provided by other pharmacy staff but this did 
not reach statistical significance. 
 
4.7 Participation in the next phase of the study  
Most Chief Pharmacists (75.3%, n=73/97) agreed to be contacted about the next 
phase of research involving interviews with on-call pharmacists and secondary care 
healthcare professionals. Of these, over half of the Trusts in the East of England had 
agreed to be contacted (54.5%, n=12/22). 
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Chapter 5 RESULTS (SEMI-STRUCTURED INTERVIEWS) 
5.1 Introduction 
This chapter first outlines the respective recruitment of the three professional groups 
before discussing the themes generated from the semi-structured interviews. 
 
5.2 Recruitment 
5.2.1 On-call Pharmacists 
Eight of the twelve Trusts provided the names and email address of pharmacists who 
participated on the on-call rota. All on-call pharmacists (n=107) were contacted and 
invited to participate in semi-structured interviews: just under a third responded (29.9%, 
n=32/107). Responses received from on-call pharmacists and the number contacted to 
arrange a suitable date, time and location at their base organisation for the semi-
structured interview to be conducted are shown in Appendix 30. A total of eight 
interviews were conducted with on-call pharmacists working in Acute Hospital Trusts 
between 10th July 2014 and 5th September 2014; no interviews were conducted with 
those working in a mental health Trust. It was expected that data saturation would be 
reached at this point, i.e. no new codes, themes or ideas were generated.  
 
5.2.2 Doctors and Nurses 
The MD, DoN and R&D departments of the eight Trusts who had agreed to provide 
names and emails of on-call pharmacists were contacted. Four Trusts agreed to 
participate. Most of the pharmacy MI services of those Trusts that agreed to participate 
helped recruit doctors and nurses (75%, n=3/4). One pharmacy MI service declined to 
participate which meant that for this Trust, the only method for recruiting doctors and 
nurses was via the poster. From the expressions of interest generated (n=19), seven 
semi-structured interviews were conducted (Appendix 31) with doctors and nurses 
working in acute hospital trusts between 15th May and 3rd December 2015. Again, none 
of the interviews were conducted with those working in a mental health Trust. A total of 
three interviews were conducted with doctors and four with nurses.   
5.3 Themes 
A total of 19 themes were generated from the interviews conducted with on-call 
pharmacists, doctors and nurses which were grouped into 5 meta themes. These are 
shown below in Table 20 and discussed in the following sections.  
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Table 20. Themes generated from semi-structured interviews 
Meta Themes Themes 
1. An individual’s knowledge 
and experience 
 
a. Affected an individual doctor’s or nurse’s MI 
needs. 
b. Affected on-call pharmacist’s perception of 
the enquiry.  
c. Affected how on-call pharmacists 
approached and documented enquiries.  
d. Affected by training or lack of structured 
training, and/or learning on the job for on-call 
pharmacists. 
2. Information accessibility a. Access to information sources by 
pharmacists. 
b. Accessing or utilising colleagues as sources 
of information out of hours by pharmacists, 
doctors and nurses.  
c. Doctors and nurses access information 
sources electronically. 
d. IT impact on the ability of on-call pharmacists 
and doctors to access information.  
e. Access to information known by the enquirer 
but not necessarily shared with on-call 
pharmacist. 
3. Use of Service a. Hospital Pharmacy Service and MI Service 
use in ‘normal hours’. 
b. Drug administration.  
c. Medication safety check. 
d. On-call pharmacist unapproachability by 
nurses. 
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Table 20. Themes generated from semi-structured interviews 
Meta Themes Themes 
4. Awareness of service   
 
a. Knowledge of on-call pharmacy service, 
access, provision and workload by doctors 
and nurses. 
b. Lack of promotion according to on-call 
pharmacists. 
5. Documentation by the on-
call pharmacist 
a. Affected by time enquiry received. 
b. Affected by remuneration. 
c. Affected by IT issues. 
d. Affected by their concerns.  
 
5.3.1 An individual’s knowledge and experience 
An individual’s knowledge and experience was something that primarily on-call 
pharmacists spoke about, with subsequently three out of the four associated themes 
being specific to this professional group. Only one theme was attributed to doctors and 
nurses and involved their personal needs of MI, and was exemplified by the following 
quotes:  
 
“…the doctors wanted a patient on a syringe driver with Buscopan in it [Hmm]. And I’ve 
never seen anything like this so I contacted the pharmacy….” NR3 
    
“…but sometimes you kind of think, can you give that via a PEG? Can you give that via 
a NG? That would be the sort of things I would anticipate.” DR3 
 
During interviews with on-call pharmacists, specific examples were provided from their 
interactions with doctors and nurses that reinforced the theme about these healthcare 
professionals’ MI needs:   
 
“I had a doctor who bleeped me and [Microbiology] had… recommended co-
trimoxazole 120mg per kg in 3 – 4, 2 – 4 divided doses. And the doctor was just like 
how am I supposed to calculate? How am I supposed to know how many doses to 
give?” OPh7 
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“…they [nurses] had erm levetiracetam on critical care and wanted to know if the 
ampoules could go down the NG tube but actually you know, there’s a syrup so we’d 
use that.”  OPh6 
  
Specific to pharmacist interviews was an individual’s perception regarding their own 
knowledge and experience of handling enquiries. Some examples in particular 
highlighted when on-call pharmacists handled questions outside their area of 
competence:  
 
“You know there could be calls coming from a specialty that you’ve never worked in 
before so you’ve kind of got no basis on what to go with some of the advice and things 
they ask.” OPh8 
 
“…out of hours you’re their only port of call so you suddenly have to answer questions 
about something you have no idea what it is. And I think that’s probably what makes it 
harder, it’s the fact it’s a specialist question not just because it’s a unique question. It’s 
the fact it’s a specialist question and you don’t know much about that specialty.” OPh4 
 
Pharmacists’ knowledge and experience also affected how they approached and 
documented enquiries. In the context of approaching an enquiry, this included the on-
call pharmacist asking additional questions to obtain sufficient background information 
from the enquirer (which interviewees perceived of value) and using resources and 
locating relevant information within these: 
    
“I think that whether you ask those supplementary questions that gets the actual 
question erm does a little bit depend on, on experience.” OPh5  
 
 “…you just try and get a bit more information because usually there’s not that much 
information they give but unless you know you get the idea. So you, you’d ask a few 
more patient details, erm you know the urgency of…you try and get more information 
out of them that you know that the nature of the enquiry.” OPh2 
 
“For example erm I’ve been asked to supply… [a drug] …. and has two different uses 
for prevention of osteoporosis [Hmm] and oncology use. So for this one I had to 
investigate further again as I say, the, what is it used for? How often do you want to 
give it? Erm…what are they prescribing it for? How often? Patient weight? Patient 
eGFR? Liver function and everything in order for me to make a decision…” OPh1 
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“I think it’s relevant to how much you know. I think if something I know off the top of my 
head and I don’t really need to utilise more than one source for it and even that I’m 
confused about it, then I think I would regard that as quite simple.” OPh4 
 
The next set of quotes illustrate the documentation of an enquiry (the second part of 
this theme) by the on-call pharmacist:   
 
“There are some pharmacists here who have been working 30 years and probably 
know everything like that [interviewee chuckle] and can give their answers whereas 
some people wanna you know, cover themselves more and say I said this and this is 
where I got it from [Hmm] and things like that. I guess with out of hours you could get a 
Band 6 pharmacist whose been, you know qualified 6 months, or you could get a you 
know 8b pharmacist, whose you know clinical expertise, is quite experienced and 
things like that.” OPh3 
 
“I think I tend to write quite a lot of detail but I think that’s because I’m new and I just 
want to make sure that I’ve covered everything. Looking back at some of the records 
when I’m searching things some of the pharmacists don’t put as much but that’s 
probably more that they are more confident in what they’ve done. They’ll put the 
answer is this whereas I will put I’ve looked here this has said this, so therefore I’ve 
said [Right, yeah] that.” OPh7 
 
The final theme identified from on-call pharmacists centred on training or lack of; any 
training currently provided appeared to be limited to the operational aspects of the role 
and is supported by findings from the first part of this research (Chapter 4, Section 4.6). 
Examples articulated by interviewees included being shown how to use the laptop and 
which information resources are available and their associated passwords: 
 
“…when I moved here the erm the training was really focused on this is the form you 
have to fill in, erm this is the on-call laptop, this is how you access the laptop, this is the 
password. Not, not anything. It was very operational rather than advice for actually 
answering enquiries.” OPh5 
 
“I think that the thing is for the actual on-call training we just got trained on how to use 
the on-call laptop. We didn’t really get any training on how to answer enquiries ‘cos the 
assumption would be that we’d have MI training but some of the pharmacists- I was 
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lucky because I had gone through MI before I’d done any on-calls [Hmm] but I don’t 
think that’s the case for all the pharmacists. So, yeah we don’t get much training about 
being on-call other than the logistics of using the laptop and how to claim payments 
[Hmm] and that sort of things but yeah, not that much training on how to deal with an 
enquiry.” OPh7 
 
Rather than any structured training, there was a high degree of learning on the job by 
individual on-call pharmacists: 
 
“Erm we have a residents’ password to log on to MiDatabank so that those who haven’t 
rotated through MI are able to access things in a read only format. But case of being 
shown that that you’ll be shown that by one of the residents how to access it.” OPh8 
 
“…from my own experience erm and I’ve done on-calls in 3 different trusts I’ve never 
had any formal training on how to you know, answer calls, what to ask… if you’re newly 
qualified and you’re just starting out it…it is  good to have you know a set of questions 
there or things you need to ask or just you know, unless you then have to learn by 
default you know, erm you, you take a few you, ask a few questions, you get a few 
answers and then you say oh you ring back I should have asked this, I should have 
asked this…” OPh2 
 
In addition, in some cases experiential learning involved access to a colleague or 
‘buddy’ to support their training: 
 
“Well there wasn’t any training [interviewee chuckle] is the honest answer. Our erm, our 
first, my first on-call shift was having another pharmacist on as a second person to go 
to if I needed any help. And a few minutes of here’s the laptop, here’s how you turn it 
on, the password, you know here’s some resources.” OPh3 
 
“…I did my junior pharmacist job in a large DGH teaching Trust and their training…was 
that for your first on-call you had a backup pharmacist…and that pharmacist was just 
as on-call as you were… you were kind of expected to ring them for all but the most 
ridiculous enquiries so that they could check that what you were doing was OK 
[Yeah]…but other than the informal advice given by that pharmacist who was your 
mentor, whatever you want to call it for that one week period, didn’t have any particular 
training.” OPh5 
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Some on-call pharmacists suggested there is a role for MI services in their training so 
they can handle medicines advice questions out of hours: 
 
“I mean it would be great if somebody UKMi or came up with some kind of, which they 
have I suppose, the MI training, training book. But erm I suppose what we need is 
some kind of standardised manual. I’m all for standardised [interviewee/interviewer 
chuckle] making sure everyone’s got the same information they can’t argue… I think 
everybody probably on a regular basis probably should inclu- definitely including myself 
should have refreshers on MI answering [Hmm]…” OPh6 
 
5.3.2 Information accessibility 
Information accessibility was a meta theme generated from interviews: two of the five 
themes were specific to on-call pharmacists, one related to on-call pharmacists and 
doctors, one generated from doctors and nurses, and one that was attributable to all 
three professional groups.     
 
On-call pharmacists highlighted access to information sources as a potential barrier by 
them when working out of hours. Pharmacists contrasted the access that they had to 
drug and clinical information during normal working hours with the lack of, or limited 
access to this same information when working out of hours: 
 
“… ‘cos we don’t have access to MiDatabank when we’re on-call unless we come in 
and obviously a lot of the enquiries and probably a lot of the information is on there. A 
lot of the time when I’ve got problems on the ward most of the time they’ve already 
looked into and found an answer for a different patient and you can just apply the 
information to [Hmm], to your patient. Obviously you haven’t got that… you can’t go 
and look at the drug chart, you can’t go and look at the notes to have a look to see 
what’s going on yourself…but obviously if you’re on the ward you’d been able to go and 
look at the notes and be like oh so they’ve got this condition that this would mean that 
would be inappropriate [Hmm]” OPh7 
 
During normal working hours, pharmacists also outlined the benefits of being able to 
access the patient as a source of information in addition to drug and clinical 
information, which they believed they could not do in an out of hours situation:  
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“If it’s on my ward you might, very likely you know the patient so you’ve got a bit of 
background information anyway and I might just go to the patient notes [Hmm] rather 
than sort of you know, at least you’ve got it there because if someone reads it out 
during the night erm it’s always a little bit more difficult than actually when you can 
have it in front of you and you look at it in writing [Hmm].” OPh2 
 
…that electronic stuff you can do if you get the IT to work [at home] but sort of looking 
at paper notes and you know, looking at the patient against the nursing note. How sick 
are they? You know, it’s very easy to read about how sick someone is but until you’ve 
actually seen them it’s, you can tell just by looking at someone if they’re properly, you 
know, properly in danger, properly sick.” OPh5 
 
Pharmacists also highlighted that during normal working hours, colleagues or the MI 
service are readily available as information resources:   
 
“Erm so a lot of the erm medicines information requests will go through the ward 
pharmacists erm we’ve got quite a lot of access to resources on the ward. Erm and 
then it tends to be pharmacists that refer to the medicines information team for the 
ward’s benefit.” OPh8 
 
“Well normally if I get asked a question obviously I, I’d look into it if I have any further 
questions I’d go find the doctor or nurse to find out I’d go look at the notes if I needed to 
look at the drug chart erm and then either answer it myself if I feel I can answer it with 
the resources we’ve got on the ward or again either come down to MI or discuss with 
MI [Hmm] or discuss with another pharmacist if I, if it was like antibiotics, I’d speak to 
the antimicrobial pharmacist or such ‘cos obviously everyone’s here so you know in 
your head you’re thinking if I’m not sure of the answer I know I can go and ask such a 
such a person because they know more than I do in that specialist area.” OPh7 
 
The second theme specific to on-call pharmacists related to ‘access’ which centred on 
their experiences that information known by the enquirer was not always shared with 
them; this created problems when providing medicines advice. On-call pharmacists felt 
this was due to a lack of understanding by the healthcare professional about the 
reasons why they might need this information: 
 
“…out of hours you’re relying on someone else and sometimes they don’t understand 
that you might need extra information for pharmacy input. They don’t understand what 
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you’re talking about [interviewee chuckle], so they don’t understand why a pharmacy 
might need to know renal function - that’s nothing to do with us apparently – or, why we 
might need kidney erm liver impairment or anything like that they don’t understand.” 
OPh4 
 
“And you haven’t got access- You’re relying on what the person’s telling you, you can’t 
go and look at the drug chart, you can’t go and look at the notes to have a look to see 
what’s going on yourself because quite often there’s information that they don’t thinks 
relevant that they haven’t told you and you haven’t necessarily thought to ask.” OPh7 
 
The third theme, which all professional groups highlighted, was access or utilisation of 
colleagues from their own professional group as sources of information when working 
out of hours. Examples from pharmacist interview transcripts show how either senior 
colleagues or specialist pharmacists could be contacted out of hours: 
 
“…it was reassuring to know that you could ring anyone and they [senior pharmacists] 
make a point of it and tell everyone that you can ring us which I think is very reassuring 
to be perfectly fair….” OPh4 
 
“…if one of us on-call pharmacists run into problems you ring someone. If it’s an 
oncology patient you’d ring the oncology pharmacist and they wouldn’t mind depending 
on what time it is. You know obviously [interviewee laugh] I think up until 11 I think 
we’re all quite happy to be contacted by the on-call pharmacist…”  OPh2 
 
Similarly, doctors and nurses also contacted their respective colleagues out of hours: 
 
“You might talk to colleagues. Erm so you might bounce some ideas off erm the other 
consultants.” DR2 
 
“…I haven’t personally done it but erm some of the nurses phone IDA or ITU ‘cos those 
nurses are mostly, not mostly, more experienced in giving [short pause] like, different 
IV medication than us so we ask them for an opinion erm but I haven’t personally done 
it.” NR3 
 
This was supported by a perception by on-call pharmacists that nurses and doctors 
used their colleagues as a source of information out of hours: 
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“When the nurses are confused regarding an administration part, they can ask other 
colleagues because there’s quite a few around but I think out of hours there’s just a 
couple of them so I think they just, don’t know and that‘s kind of understandable if you 
don’t have anyone to ask then that’s fine. And I think this is the same for the doctors, 
especially if they’re junior doctors and they have no-one to ask…” OPh4  
 
Doctors and nurses (but not pharmacists) spoke about accessing information 
electronically out of hours when searching for MI, primarily restricted to hospital-based 
sources, before or instead of contacting the on-call pharmacy service. There was a lack 
of knowledge about the on-call pharmacy service by doctors and nurses.  It is unknown 
whether these electronic resources were searched before, or instead of contacting the 
on-call pharmacist: 
 
“Erm so I’ve got BNF app on my phone [OK], erm [short pause] sometimes I will 
consult the iv administration guide on the hospital’s administration guide. Erm [short 
pause] there’s also erm like a best practice website called UpToDate [Oh yes] …that 
has quite [short pause] good erm sometimes dosing information, frequency of dosing, 
sort of indications for particular medicines to use in particular conditions depending on 
what you’re treating.” DR1 
 
“Erm the monographs online, pharmacy documents on [Trust Intranet] if I happen to be 
lucky enough to be working near a computer… occasionally I have been known to stick 
things into Google and hope it comes up with an answer of some description but again, 
it’s taking is that a reliable source.” NR4 
 
For the final theme, doctors and pharmacists identified IT, mainly related to hardware 
or connectivity, as a barrier to accessing information. For on-call pharmacists, 
hardware issues mainly related to laptop use and particularly in relation to handling 
calls when off-site: 
 
“…you have got the laptop, you’ve got to make sure that the person handing it over to 
you charged, charged it ‘cos we’ve had that issue where somebody’s gone into [town] 
and needed to use the resource but it’s been flat [Hmm]… so I think as long as you’ve 
got access to some IT I think you’re pretty much OK. ” OPh6 
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“Internet access erm out and about. So obviously you can, you can plug the Internet 
over your phone and stick in a computer. First of all you have to have a relative modern 
phone, you have your phone up, you have to set the laptop up erm and it’s fine if 
you’ve done all that in advance but if you’ve got someone on the other end of the 
phone and wants something quickly and you have to configure your phone and the 
computer, erm it’s a bit of a nightmare. So that, that really doesn’t help. So that’s 
difficult having good IT access because so many resources now are online…” OPh5 
 
Whereas for doctors’ hardware and hospital intranet search functionality were the main 
IT issues, which affected their ability to find MI: 
 
“The problem with [hospital intranet] is it’s a bloody nightmare to try and navigate 
through it and you can’t find anything [Hmm]. You know you put in antidote or 
something and it’ll all come up with rubbish and it’s not a great search engine with that 
respect [Hmm]. So unless you can navigate through it and you know exactly where 
something is [hospital intranet], is a big black hole.” DR2 
 
“…it takes a long to log in [Hmm] and if you’re not logged in you can’t print things out. 
‘Cos to do a printout you have to be logged in under you so if I’m trying to print out an 
information sheet for a patient I need to be logged in as me. So you have to log in wait 
for it to load and I do have a laptop with BYOD access from home but the Wi-Fi signal 
in the hospital is so variable so I could take my laptop but it’s going to take me just as 
long [Hmm].” DR3 
 
5.3.3 Use of Service 
The third meta theme generated from interviews was the use of service. Two of the 
four themes were generated from interviews with all three professional groups; one 
from nurses and pharmacists; and, one theme from nurses only.   
 
The first theme noted was that all groups interviewed spoke about using the hospital 
pharmacy and MI service during normal working hours. Pharmacists gave examples of 
utilising MI in situations where a response was needed to a complex question and/or 
the pharmacist did not feel able to handle the enquiry due to time pressures: 
 
“And obviously the questions that go through MI do tend to be more complicated. I 
mean not always necessarily you do get some simple ones but if the pharmacist is on, 
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on the ward then they would answer the simple enquiries. It tends to be the more 
complicated ones or ones from clinics that go through medicines information.” OPh7 
 
“So things that I would refer…would probably be if a nurse says to me how do we give 
this and I’m in the middle of doing something in the middle of the ward, and I’d say I 
dunno just ring the MI centre. If I had a complex urgent question which I didn’t have 
time to deal with now, I’d definitely refer that.” OPh5 
 
 “Erm sometimes it can be due to the time that you’ve got available on the ward erm 
and to look into things erm just if you’re not sure and what a second opinion. 
Sometimes medicines information or the specialist pharmacist erm…yeah, somethings 
that’s just- I can’t think of an example- but a little a bit more obscure [Hmm]. Some sort 
of unlicensed thing crops up sometimes.” OPh8 
 
Doctors and nurses made reference to hospital pharmacy and MI services as 
information sources for medicines advice. This included the pharmacist’s role as a 
member of the multidisciplinary team: 
 
“…I just think it’s nice to get to know who your pharmacists are erm and they’re part of 
the team. You know in some of the hospital the pharmacists are on the ward round 
[Hmm]. You know they’re part and parcel of the ward round [Hmm] not just floating 
around on the ward, they’re actually with your, with you and rest of the team doing the 
ward round [Hmm] very much a joint thing.” DR2 
 
The MI service was cited as an option if the pharmacist working as part of the 
multidisciplinary team was unable to provide a response: 
 
“Erm there’s a pharmacist specific to our clinic who I can phone and ask about and 
they can lead you to phone medicines information if they can’t answer your query. Erm 
I don’t contact them enormously but I know exactly who I would contact and they would 
very quickly respond and they come up to the office or clinic and I’ve always really 
good support from a specific pharmacist for my area erm and they are the first port of 
call if it’s not specific Medicines Information I think you’re wanting to phone [Hmm].” 
NR2 
 
Doctors and nurses identified drug administration as one of the main types of 
medicines advice questions sought during out of hours:  
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“Err if you’re going to put things in a syringe driver or anything like that and you felt that 
something unusually has been prescribed erm and you’re concerned about the 
compatibility of the drugs because it’s something you then, you definitely need to seek 
advice and make sure get the most appropriate person and that’ll be the pharmacist 
really who is on-call before you administer the drugs.” NR1 
 
“Very occasionally we’ll get a, “Can you give this i/v? Can you give this via a PEG? 
[Hmm] Can you give this sub-cut? What’s it mixable with sub-cut?... but sometimes 
you kind of think, can you give that via a PEG? Can you give that via a NG?” DR3 
 
On-call pharmacists also gave examples of drug administration enquiries they had 
handled:  
 
“We have patients with stroke or patients with erm [Hmm] unable to swallow so then 
again we have to look for them for this conversion from liquid to-sorry from tablets to 
liquid.”  OPh1 
 
“Nurses would be like how do I administer? What do I use? How do I make the dose 
up? Erm, how do I get the minimum volume in if it’s too small or large?” OPh4 
 
Nurses spoke of ‘medication safety checks’ as another one of the main types of 
medicines advice questions out of hours. This involved nurses clarifying or confirming 
that a treatment intention was ‘safe’ with on-call pharmacists. For example, this could 
include the choice, dose, route, frequency, or whether it interacts with other medicines:  
 
“So for example Ferinject I’m trying to prescribe in preparation for them coming in a 
couple days’ time [Yes] sometimes I would like someone else to check my maths.” 
NR4 
 
“Erm because it could be a new drug that’s been prescribed and you’re not familiar with 
it and you’d like the reassurance of somebody from pharmacy erm that a) the drug is 
safe to use. It’s OK to use for that specific patient.” NR1 
 
Specific examples supporting this theme were provided by on-call pharmacists: 
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“One of the calls was just to confirm that the dose was OK. [OK] Erm you know, 
they’ve not seen this before and they just wanted to double-check that, that was alright 
to happen.” OPh6 
  
“And a few of the, the IV administrations that tends to be the nurses double-checking 
that what the doctor’s put actually what they’re supposed to do.” OPh7 
 
“…the nurses ones seem to be a little less, a little more simpler, more simple is not the 
best term really but just things like I’ve got this type of insulin, is this correct?” OPh3 
 
 
Although nurses did ask for advice from on-call pharmacists they also detailed their 
anxiety in contacting them as they felt they were unapproachable. Nurses described 
their thoughts when they considered contacting the on-call pharmacy service:  
 
“…I dread calling them [Right]. I know it has to be done and I know it’s a long 
monologue from my side [Yeah] to convince them that we’ve done everything we 
should…” NR3 
 
5.3.4 Awareness of service  
The fourth meta theme centred on the awareness of the service. The first of the two 
associated themes were generated from interviews with doctors and nurses, and the 
second from on-call pharmacists. The first theme was that there was a lack of 
knowledge about on-call pharmacy services by doctors and nurses. This included 
provision and accessibility of the on-call pharmacy service, and the workload handled:  
 
“…I know they’re there. If I, if I did think oh goodness, I don’t know what to do here, I 
could phone them [medium pause]. I suppose I don’t know how their on-call service 
works or who’s going to be at the end of the phone and what their service provision is. 
Kind of on-call – and I think there’s a difference between on-call during reasonable 
hours’ kind of 9 in the morn- or 8 in the morning til 9 o’clock at night and a difference to 
2 o’clock in the morning.” DR3 
 
“So my understanding of on-call pharmacist is that’ve you got one pharmacist on-call 
for the hospital [Hmm] and again going back to that whole workload and if they’re 
covering all these other beds and- Then I’d want to be pretty certain that I needed an 
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answer there and then rather than just phoning up to say I’m a bit uncertain about the 
iron dose for 3 days’ time [Hmm]. That would be the only reason why. It’s not because 
I don’t think of them, value or respect them, it’s just considering everyone’s workload 
really.” NR4 
 
The second theme was that pharmacists felt that the on-call pharmacy service needed 
to be better promoted, particularly as they believed healthcare professionals were 
unaware of what could be provided: 
 
“…maybe we should erm promote it a little bit more look that out of hours we’re not just 
there to supply stuff erm we’re also there and available to give advice rather than 
having the patient sit and wait there until the next morning.” OPh2 
 
“…I don’t think they’re aware that there’s an on-call pharmacist because I’ve heard 
[doctor’s name] say I didn’t know pharmacists were on-call. So that’s clearly saying 
something they’re not like junior doctors they’re consultants even registrars, it’s quite 
shocking really. I think the only ones that know are the ones that come across us. 
Actually, it’s most nurses that refer doctors to us.” OPh4 
   
5.3.5 Documentation 
The fifth and final meta theme was documentation generated from interviews with on-
call pharmacists. There is crossover between the previously reported theme ‘an 
individual’s knowledge and experience affected how on-call pharmacists approached 
and documented enquiries’ in Section 5.3.1, and this meta theme of documentation.  
 
Documentation was affected by the time a call was received and the following are 
examples provided by on-call pharmacists that support this theme:  
  
“Depends what time of the day the call is. If it’s up to midnight then yeah, I generally 
tend to leave the laptop on [interviewee chuckle] but if it’s after that and I’m asleep then 
it’ll [documentation of enquiry] be the next day.” OPh4 
 
“Possibly not [document enquiry] in that kind of time in the morning because I might 
want to do when I’m a bit more awake make sure – obviously when you’re a bit asleep 
and you’re documenting it straight onto the database once its submitted you can’t, can’t 
change it so I probably would tend to write it up on a piece of paper what I’ve said and 
then when I’m more awake in the morning and probably put it on the database because 
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obviously you don’t want to risk making a mistake and putting incorrect information on 
there…So yeah, I guess if it was, if it was early in the morning and I’d already gone to 
bed and had to get up then I’d probably more likely just to scrawl it down on a piece of 
paper and document it fully later.” OPh7 
 
Documentation was also affected by remuneration, either as a financial payment for the 
time taken to handle the enquiry or time off in lieu: 
 
“…you would document every call you get even if it’s just you know for stock, [out of 
hours] we need you know we’ve run out of aspirin or whatever you know… you would 
put that down because here it’s like erm if you take a phone call and it takes you 5 
minutes or it take you an hour erm this is the time you then can claim back as TOIL. So 
hence you would put literally every call down no matter what nature it was.” OPh2 
 
“Yeah, we have to put on there [on-call log database]. It’s all linked in with all the hours 
we claim so if we don’t put it on the database, it didn’t happen and we can’t claim for it 
[interviewee laugh].” OPh7 
 
IT issues also had a bearing on documentation, particularly the use of a laptop or being 
able to document enquiries electronically at the time: 
 
“Erm I’m mean the on-call laptop has got the database too so in theory you could do it 
there and then but at you know 11 o’clock or 1 o’clock in the morning I would not make 
that, er , er I wouldn’t because it takes 15 minutes for the laptop to, to fire up I wouldn’t 
do it then you’d rather do at work when you’ve got it on your screen and you can do it 
then and it’s quicker.” OPh2 
 
“At the moment we only have access to [MI enquiry answering database] on one 
computer in the dispensary. We don’t have access to it once we go- We have access 
to all of the erm Trust’s intranet from the flats on site but don’t have access to [MI 
enquiry answering database] when we’re there. So, if they’re calls that you take after 
midnight then that wouldn’t be feasible to record at the time. Potentially put it in the 
next morning back on site.” OPh8 
 
The fourth theme was that documentation by the on-call pharmacist was affected by 
their concerns. These concerns included the enquirer’s understanding about the 
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medicines advice provided and so there was a strong desire by the on-call pharmacist 
to record and justify their advice:  
 
“I think occasionally if it’s something complicated and I’m not entirely sure the doctors 
understood it or there’s other people who will need to understand why we’ve done what 
we’ve done then I would write in the patient’s notes and document in there have the 
discussion with junior doctor or consultant or whoever I’ve spoken …out of hours you 
can’t physically see what they’ve done so you’ve got to rely more on the doctors 
listening properly and doing what you tell them [interviewee chuckle].” OPh7 
 
“So what sometimes happens is that you give an answer repeatedly and the person 
doesn’t seem to get it and then decide that they’re bored and wants to go and then, 
they want to document in some sort of record – nursing record or medical record – 
what you’ve said. I think it’s important that I have my own documentation of what I’ve 
said so that if action is taken based on what they thought was my advice but wasn’t my 
advice and something bad happens it’s very clear from my point of view the advice I did 
give.” OPh5 
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CHAPTER 6 DISCUSSION  
This chapter discusses the results from both phases of the research (online survey and 
semi-structured interviews) focused on the provision and use of the on-call pharmacy 
service; information accessibility; documentation; and, training. Limitations associated 
with this research are then discussed, followed by implications for practice. 
 
The first section discusses the provision and use of the on-call pharmacy service. This 
research has determined that on-call pharmacy services are almost universally 
provided by English hospital Trusts through non-residency (home-based) pharmacists. 
The most common model of on-call services was for pharmacists to be at home, with 
just 10% of Trusts operating a residency programme. This finding is similar to those 
reported previously by Cotter et al in 1994 and McCleod et al in 2014. 86, 87 This 
suggests that on-call pharmacy services have remained unchanged over a long period 
time and unless 7-day hospital clinical pharmacy services are implemented as 
recommended by NHS England with sufficient staffing, this picture is unlikely to 
change. 34 Most Trusts that operated a residency programme had more than 900 beds, 
representing larger hospitals. This is in line with previously reported results in which 
there was a trend towards hospitals with a resident pharmacist being found in larger 
hospitals compared to those without a non-resident on-call pharmacist. 87 The 
implications are that on-call pharmacists working in larger hospitals as part of a 
residency programme will have better access to the patient and clinical information 
because they are on-site and could result in the medicines advice provided being better 
tailored to the individual patient involved in the enquiry.  
 
Nearly all provided medicines advice, although acute hospital Trusts did so more than 
mental health Trusts. This maybe in part due to the decreasing number of ‘inpatient’ 
beds seen in mental health Trusts as patients are now managed more in the 
community. 88,89 It is also likely that for this reason nearly half of mental health Trusts 
did not provide an on-call pharmacy service and instead held a SLA with another 
provider. In the researcher’s opinion, this may represent a more cost-effective option 
for mental health Trusts, particularly as the volume of calls decreased with the size of 
the organisation. However, this means that acute hospital Trust on-call pharmacists 
may have to handle medicines advice enquiries involving mental health conditions and 
associated medicines. Due to a lack of evidence, it is not known whether the 
knowledge of psychotropic medicines and associated mental health conditions by 
acute hospital Trust pharmacists is comparable to those working in a mental health 
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Trust and whether this would have any impact on the quality of medicines advice 
provision.  
On-call pharmacy services were provided predominantly by staff on lower Agenda for 
Change banding, typically these will be junior staff with limited years’ experience 
working as a pharmacist.  Those pharmacists on higher banding (beyond Band 8a) 
were less likely to undertake on-call. This means that on-call pharmacy services lack 
senior pharmacists and is similar to that reported by Dunn in NHS Tayside (Scotland) 
where only Bands 6 – 8a pharmacists were involved in on-call pharmacy provision.18 
The provision of pharmacy on-call services does seem at odds with other hospital 
clinical services. For example, those provided by medicine and physiotherapy, where 
all grades of staff, except the most senior, i.e. consultant and superintendent 
physiotherapist III, are expected to participate. 90,91   Whilst there is no restriction on the 
length of time a hospital pharmacist can work at each of these Bands, typically 
individuals will have worked 3 – 4 years before working as a Band 8a pharmacist. It is 
this researcher’s opinion that this could imply that the knowledge, skills and experience 
of pharmacists providing on-call services are comparably less than the pharmacy 
workforce during normal working hours. This could mean that medicines advice 
enquiries handled by on-call pharmacists are not of the same quality as those 
managed by dedicated MI staff. Research evidence from the medical literature has 
shown that greater clinical experience is associated with better diagnostic ability and 
less risk-averse decisions.92,93   It therefore seems reasonable to suggest that 
pharmacists with greater clinical experience will provide higher-quality answers.    
 
In general, on-call pharmacy services handled a higher number of enquiries about 
medicines supply compared to medicines advice and is consistent with other reported 
data from UK studies.1,61,62 This reflects the traditional model of on-call pharmacy 
services, which have centred on medicines supply rather than advice. 94 Data did show 
that on-call pharmacists located at home handled more calls for medicines advice 
compared to those part of a residency programme. It is not entirely clear why there was 
a difference in the type of calls handled and due to the small numbers, no relationships 
within the data were found by the researcher. However, as on-call pharmacy services 
with residency programmes are located in larger hospitals and typically provide 
specialised services within the NHS, 95 one might have expected these to handle a 
higher number of medicines advice calls because of the associated complex medicines 
used.  
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Although the majority of hospital pharmacy departments advertised their on-call 
pharmacy services, pharmacists interviewed believed that healthcare professionals 
were unaware of what could be provided, and greater promotion was needed. This was 
corroborated by interviews with doctors and nurses who were unaware of the on-call 
pharmacy service, its provision, accessibility and workload handled. The accessibility of 
on-call pharmacy services is supported by a previous study which reported that junior 
doctors had suggested that greater access to pharmacists out of hours would be 
helpful, especially as they felt they could be difficult to find. 96 This suggests that the 
current methods used by hospital pharmacy departments, as identified by the online 
survey, to promote their on-call service are not working. In practice doctors and nurses, 
the most frequent users of the service consistent with other works, 1,18,58-60 may not 
know how to access the on-call pharmacy service or understand what services it 
provides. This may lead to these healthcare professionals seeking MI from alternative 
sources. Although doctors and nurses accessed information sources electronically or 
used colleagues, a limitation of the interviews was that they did not identify if these 
were instead of or before contacting the on-call pharmacist. However, when the MI 
service is unavailable, previous studies have reported that enquirers confirmed that 
they would seek advice themselves which included the Internet, calling the 
manufacturer, contacting a colleague, looking in books, using other MI resources or 
contacting specialists, e.g. consultants. 12,13 It therefore seems reasonable to conclude 
that doctors and nurses are seeking MI from alternative sources out of hours if they are 
not contacting the on-call pharmacy service. Based on the interviews, each 
professional group did not appear to describe using each other as a source of 
information out hours, i.e. nurse contacting a doctor, which has been reported during 
normal working hours. 97 There is a potential risk that doctors and nurses use their own 
colleagues as a source of medicines advice during or outside normal working hours 
which could potentially lead to incorrect information which may then be used in the 
management of specific patients. This is supported by evidence that showed doctors’ 
and nurses’ information seeking and evaluation skills could be improved. 98-100  
 
When on-call pharmacists were contacted, this was most often by phone and 
bleep/radiopager, although this is likely to change over the next few years as recent 
announcements by the Department of Health and Social Care have said 
bleeps/radiopagers will no longer be used in the NHS. 101-103 Mobile phones, and in 
particular secure instant messaging, are increasingly being used by healthcare 
professionals to communicate with colleagues and a recent study conducted at a single 
UK hospital, explored the experiences of pharmacy staff using WhatsApp when 
working out of hours. 104 This method of communication could change the way on-call 
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pharmacists are accessed in the future although without improvement to mobile phone 
networks, connectivity issues may remain an issue. 105  
 
Of concern was the perceived unapproachability of on-call pharmacists by nurses. 
Words and phrases such as “dread” and “don’t like to bother” came up during 
interviews. This may result in nurses deciding not to contact the on-call pharmacist 
because of their anxiety, and so potentially lead them to make decisions based on 
alternative information sources, as previously discussed. In contrast, doctors did not 
reveal perceived unapproachability as an issue and positive working relationships have 
been reported in the literature between pharmacists and nurses, and with doctors. 106-
109 In addition, both doctors and nurses highlighted the role of the pharmacist as a 
source of medicines advice, as part of the multidisciplinary team, and the MI service 
during normal working hours. These findings are supported by previous studies that 
reported doctors and nurses are users of MI services during normal working hours. 37-39, 
42, 43 Therefore the anxiety of nurses to contact the on-call pharmacist may be linked to 
other factors specific to out of hours. This could include a lack of understanding about 
the on-call pharmacy service, as previously discussed. Alternatively, pharmacists 
perceived that information known by the enquirer (nurse) was not always shared with 
them. On-call pharmacists felt that this was due to a lack of understanding by the nurse 
about the reasons why this information may be needed. Therefore the on-call 
pharmacist believed if they asked additional questions in order to help inform their 
response to a question, the enquirer did not understand why this information was being 
asked. This miscommunication and misunderstanding between nurses and 
pharmacists may explain why these professional groups had differing viewpoints. It 
therefore seems that better communication about the service and when people should 
utilise it needs to be addressed.  
 
This finding appears to link to the individual’s knowledge and experience which 
affected their MI needs. The first, which was sought by doctors and nurses, was drug 
administration. This was reinforced by pharmacists based on the calls handled out of 
hours. Although prescribing is the most common patient-level intervention within the 
NHS, 110 a vast number of drug administration occurs and so it is not unexpected that 
this may be an area for MI. This is supported by recent UK publications, found in the 
grey literature, which have also reported drug administration as a frequent enquiry type 
for on-call pharmacy services. 23,24,64 It has also been cited in previous studies as one 
of the most common enquiry type handled by MI services. 12, 37,39,41-43 Therefore drug 
administration is an information need for doctors and nurses irrespective of the time of 
day. It is not known from this research what generates drug administration enquiries: it 
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could be related to an absence of information or a lack of awareness about the 
resources available to support healthcare professionals, as reported by Lilley et al, in 
which nearly 80% of paediatric nurses were unaware of the national injectable 
medicines guide. 111 However, enquiries could also be generated by nurses seeking 
clarification about information they have accessed. This was the second type of 
medicines advice sought out of hours by nurses, i.e. ‘medication safety check’. On-call 
pharmacists described enquiries which supported this theme and involved nurses 
clarifying or confirming that a treatment intention was ‘safe’. Examples included the 
choice, dose, route, frequency, or whether it interacts with other medicines.  Seeking 
information to confirm the safety aspects of a medicine has previously been identified 
as an action by doctors and nurses when contacting MI and clinical pharmacy services 
during normal working hours.10, 11, 97, 112 Therefore this is an information need 
irrespective of the time of day. 
 
The ability of on-call pharmacists to handle ‘medication safety check’ questions links to 
the second part of this discussion which focuses on information accessibility. It was 
clear from interviews that pharmacists working during normal working hours had 
greater access to drug and clinical information and particularly, better access to the 
patient and patient information compared to out of hours. A recent study published by 
Lewis et al which explored the experiences and opinions of hospital pharmacists 
working 24/7 shifts reported that by being present on-site, pharmacists had access to 
greater resources and patients themselves, enabling them to respond to queries from 
the wider team in a more timely manner when compared to the on-call pharmacy 
service. 113 Therefore on-call pharmacists may find it difficult to provide a tailored and 
timely response to such questions without access to clinical information about the 
patient. Since these interviews were conducted, digital transformation has become a 
high priority for the NHS, not only including the rollout of electronic prescribing and 
medicines administration (EPMA) systems but also improved connectivity between 
different parts of the health system to enable better access to information, 32, 37  Based 
on the researcher’s own experience, EPMA systems can be accessed remotely and 
this may help to improve access to clinical information about the patient by on-call 
pharmacists.  
 
In general, Chief Pharmacists perceived that on-call pharmacists had good access to 
information resources although a third of respondents either had not reviewed these 
against a recommended list for out of hours use provided by UKMi or did not know. 4 It 
is not known how this recommended resource list has been promoted by individual MI 
centres within their pharmacy departments. However, national standards not only state 
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that staff working in MI services during normal working hours should be able to access 
recommended resources but also that that appropriate resources are accessible out of 
hours. 4 Despite the perceptions of Chief Pharmacists and recommendations within 
national standards, access to information sources was cited by on-call pharmacists 
during interviews as a potential barrier. In particular, on-call pharmacists described IT 
issues impacting on their ability to access information which mainly centred around use 
of laptops. These issues included the setup time required before the laptop could be 
used to access information; the laptop not being fully charged when handed over by 
another on-call pharmacist; and, Internet access. All of these may affect the ability of 
the on-call pharmacist to access information in a timely manner which could result in a 
delayed response to the enquirer. This could lead to dissatisfaction by doctors and 
nurses about the on-call pharmacy service although there are no studies which have 
assessed user satisfaction. Alternatively, it is the researcher’s opinion that these issues 
could result in the on-call pharmacist feeling pressurised to provide a response without 
first accessing information. This could lead to incomplete or incorrect information being 
provided although there is no information to support this theory. Alternative hardware, 
in particular mobile phone technology as discussed earlier, could be harnessed which 
would avoid the setup time needed for laptops and therefore improve the timeliness of 
accessing information, but not necessarily improve Internet access.   
 
Data derived from interviews with pharmacists revealed they routinely used MI services 
in office hours, particularly when a response to a complex question was needed, or 
when they felt unable to handle the enquiry due to time pressures. However, outside of 
normal working hours, this study has shown that only 20% of on-call pharmacy 
services had access to a MI pharmacist. This means that the majority of on-call 
pharmacists handle all enquiries, irrespective of complexity, with no access to a MI 
pharmacist. Although interviews with on-call pharmacists showed that questions 
outside their area of competence were handled, it was also reported that pharmacy 
colleagues were contacted as a source of information when dealing with questions. 
These colleagues included specialist pharmacists or senior colleagues, depending on 
the nature of the question. This has been similarly reported by other healthcare 
professionals providing hospital on-call services, who are also able to access senior 
colleagues for support. 114,115 Communication with a healthcare professional’s own 
colleagues has been observed in other studies within the hospital environment 
(communities of practice) 116,117, and specifically using colleagues as a source of 
information out of hours has been reported previously. 64 When handling medicines 
advice questions, a senior colleague may not necessarily be best placed to advise the 
on-call pharmacist although this is dependent on the enquiry and the senior 
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pharmacist’s own knowledge and experience. However, a specialist pharmacist may be 
a more appropriate choice if the question relates to their clinical specialty, e.g. 
specialist oncology pharmacist if a question involved a cancer medicine.  
 
The third section of this discussion focuses on issues around documentation of on-call 
activities as articulated by pharmacists during interviews. Documentation of activities is 
an important aspect of clinical care. 118,119 and regularly highlighted as a contributing 
factor to near misses and errors associated with the handling of MI enquiries during 
normal working hours. 120-123 Outside of MI, a systematic review of 54 studies about 
medication administration errors found inadequate documentation as one of the 
causative factors. 124 Chief Pharmacists reported that the recording of the number of 
calls was high and on-call pharmacists explained that remuneration (financial payment 
or as time) they received was based on the documentation of calls handled out of 
hours. In other words, for every medicines advice call handled out of hours, the on-call 
pharmacist received an ‘on-call payment’ or time off in lieu if it was documented. 
However, the details of the enquiry, e.g. enquirer, question, resources used, advice 
provided, were not completed all the time according to Chief Pharmacists. One reason 
for this may be attributable to a lack of organisational procedure particularly as less 
than half of Trusts had a standard policy for the documentation of medicines advice. 
Pharmacy departments lacking policy on documentation was unexpected given there 
are national,4 and professional standards for data capture to demonstrate the impact of 
hospital pharmacy services on patient outcomes. 125   Regardless of whether a policy 
existed, there was broad agreement by Chief Pharmacists on what should be 
documented. Where policy was lacking Chief Pharmacists placed little value on 
documenting which resources had been used and the information found within these, 
both of which are included within national standards. 4 Although it was not a theme 
generated from interviews, some on-call pharmacists commented that they 
documented the resources used but did not record the information found. On-call 
pharmacists admitted that they did not know the reason for this although some 
suggested it was because of the structure of the document they were expected to use 
to record enquiries. This is concerning, as the basis of an answer stems from the 
resources used and can act as an audit trail if there is a need to return to the advice 
provided. For example, a very small number of on-call pharmacists were able to access 
past enquiries recorded by colleagues out of hours. Without this information, individuals 
may be less confident about using previously answered enquiries which may lead to 
duplication of work. Although not explicitly stated during interviews with on-call 
pharmacists, some responses inferred that Chief Pharmacists’ expectations may have 
influenced individual’s actions within departments and these senior leaders have 
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previously been reported to influence colleagues within a department. 126 Additionally, 
individual pharmacists during interviews gave other reasons, which generated themes, 
as to why documentation may not be as expected. These included the time an enquiry 
was received, IT issues and concerns by the on-call pharmacist about the enquirer’s 
understanding. These three themes will now be discussed in more detail. 
 
Firstly, the time an enquiry was received: if a call was received late in the night or early 
in the morning, then the pharmacist was more likely to delay the recording of the 
enquiry. National guidelines for handling medicines advice enquiries during normal 
working hours recommend that the documentation of the question, research and 
answer to be given should take place before the response is communicated. 4 Some 
on-call pharmacists did make reference to receiving the call, finding the relevant 
information and then calling the enquirer back. However, in practice the time of the call 
may mean that documentation is not completed or is done so retrospectively. Not 
documenting information at the time of the call may mean that recall of the enquiry may 
be inaccurate. Secondly, with respect to IT issues, pharmacists often described using a 
laptop when working out of hours and depending on the time of the call received, 
frequently commented that it may not be switched on in order to document the enquiry. 
Not having the ability to electronically document the call at the time it is received 
increases the likelihood that it will be recorded on paper. During interviews on-call 
pharmacists referred to their ‘scribbles’ on paper and reported that their writing was 
illegible. This makes it difficult, if not impossible, to use this information as a repository 
for on-call pharmacists to access in the future when searching for previous similar 
enquiries. A national report has previously recommended that computer technology 
should enable on-call pharmacy services to be provided off-site and out of hours.127 A 
bespoke enquiry answering database (MiDatabank) is used by MI pharmacists to 
document medicines advice during normal working hours,48 but its uptake out of hours 
is very low according to Chief Pharmacists. Although no themes were generated from 
interviews conducted with on-call pharmacists, comments were made which suggested 
that MiDatabank was perceived to be only for use by the MI service and not more 
widely. This may be dependent on how the MI pharmacist has promoted this within 
their department and could be influenced by whether they also participate in the on-call 
pharmacy service and perceive this to be beneficial. However, there may also be 
something about the platform used for MiDatabank, i.e. computer desktop programme, 
which when combined with the IT issues raised by on-call pharmacists, particularly 
those related to laptops, and the time calls are received, does not make it conducive for 
use out of hours. Despite these issues, another computer desktop programme (On Call 
Manager) has been specifically designed for the handling of on-call pharmacist calls 
146 
 
and is now used in at least five acute hospital Trusts. 128 An evaluation of On Call 
Manager or comparison with MiDatabank does not appear to have been completed to 
determine which is better for documenting on-call pharmacist enquiries. However, 
some limited evidence from 2018, found in the grey literature, reported that on-call 
pharmacists did not use MiDatabank to document enquiries, instead preferring to 
choose this alternative software. 129 A formal comparison of the two databases would 
be helpful to determine the ideal IT solution for documenting medicines advice calls out 
of hours. Alternative software, as described by Dunn, is available and consists of an 
app for installation on mobile devices. This enables the on-call pharmacist to document 
enquiries at the time of the call using the app which also includes functionality to 
search previously recorded questions. 18 In theory, this would overcome some of the IT 
issues raised by on-call pharmacists in this research such as not needing to wait for a 
laptop to setup. However, it does not appear to have been widely promoted outside 
NHS Tayside and it is known if the use of this mobile app would introduce new 
challenges for on-call pharmacists such as data entry, for example.   
 
The third and final theme which affected documentation was concerns by on-call 
pharmacists about the enquirer’s understanding, particularly that of nurses. During 
interviews, on-call pharmacists described situations in which if they perceived a nurse 
not to understand the advice or appeared to intentionally not follow the advice 
provided, then this would increase the likelihood of the enquiry being documented. 
Misunderstanding, or intentionally not following the medicines advice received from on-
call pharmacists were not themes generated during interviews with nurses or doctors. It 
has been reported that healthcare professionals do not always follow the medicines 
advice provided by MI services for clinical reasons, 10,11, 44 and whilst there is no data 
available for on-call pharmacy services, it would seem reasonable to conclude that this 
may occur out of hours. Furthermore, a systematic review by Keers et al, about the 
causes of medication administration errors concluded that the causes of ‘violations’ 
may lie in staff relationships, amongst others, 124 and so the rapport created between 
the nurse and pharmacist could be a factor affecting whether medicines advice is 
followed out of hours. Therefore concerns by on-call pharmacists manifested as self-
protectionism from potential litigation.  
 
Training provided to pharmacists to help them answer medicines advice questions out 
of hours was also investigated in this research. According to the majority of Chief 
Pharmacists, on-call pharmacists received specific training to help them provide 
medicines advice out of hours and was more likely to be provided by those Trusts with 
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a residency programme, all of whom were University Teaching Hospitals and have 
significant involvement in education. 130 Where training was offered, this was provided 
by both MI and other pharmacy staff, and mainly delivered using one to one face-to-
face sessions. These methods reflect those already used to deliver training to trainees 
undertaking rotations in a MI service, and there is some literature, of limited quality, 
which has attempted to evaluate these in that context. 7,131-133 However, although these 
training methods have been adopted for teaching MI skills to on-call pharmacists, who 
may not be rotating into the service, these have not been evaluated in that context. 
Therefore it is not known whether these methods are the most appropriate for 
delivering training to on-call pharmacists for handing medicines advice calls. 
 
The skillset required for on-call pharmacists to work efficiently and safely has not been 
established. However, according to Chief Pharmacists the training content provided by 
hospital pharmacy departments to on-call pharmacists primarily consisted of 
operational issues whereas non-operational training to support the handling of MI 
enquiries out of hours such as questioning skills, mock on-call scenarios, critical 
evaluation/interpretation of information/data and communication skills were less likely 
to be included. On-call pharmacists confirmed during interviews that training was 
limited to operational issues and examples given included how to use the laptop, the 
information sources available and their associated passwords. This research did not 
seek to understand why training related to operational issues was more likely to be 
delivered but it is possible that operational issues are perceived by senior pharmacy 
managers as being essential for providing an on-call pharmacy service, whereas non-
operational training may be viewed as something that is acquired during a rotation in 
the MI centre and/or developed through experiential learning. This training may indeed 
be developed whilst newly qualified (Band 6) pharmacists undertake rotations into MI 
however, not all Trusts may be able to operate a rotational pharmacist programme 
because of the size of the organisation, recruitment difficulties or may not perceive this 
as a priority. 134 Furthermore, junior pharmacists (Band 7) or more senior pharmacists 
(Band 8a and above) may have either rotated some time ago, not at all or they may 
have joined from a different organisation. Therefore there are likely to be differences in 
knowledge between pharmacists providing the on-call pharmacy service, and this was 
supported by interviews conducted with pharmacists which confirmed that an 
individual’s knowledge and experience is affected by the training or lack of structured 
training and/or learning on the job that is received. In turn, the knowledge and 
experience of the on-call pharmacist affected how medicines advice enquiries were 
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approached according to interviews, and so this may lead to variation between 
individual on-call pharmacists, and on-call pharmacy services.  
 
Although Chief Pharmacists stated that both non-MI pharmacy and MI staff were 
involved in the training of on-call pharmacists, the interviews suggested that there 
could be a greater role for the latter, although no specific themes were generated. 
However, within the literature and in practice, there have been developments to 
improve the structure and content of training specifically for on-call pharmacists to 
handle medicines advice enquiries. These have included simulation-based training as a 
way of enhancing the preparedness of pharmacists undertaking on-call, 135 and an e-
learning platform (Medicines Learning Portal) developed during the past few years to 
develop clinical problem-solving skills for pharmacists. 136 In September 2016, a 
specific module for on-call pharmacists was developed and launched for the Medicines 
Learning Portal. This included a checklist for pharmacists which describes the duties 
and role of the on-call pharmacist, seven clinical problem scenarios to complete, and a 
list of websites that can used. This was written by MI pharmacists with input from a 
regional group of Chief Pharmacists, the Royal Pharmaceutical Society’s Hospital 
Expert Advisory Group, an on-call pharmacist and this researcher. Although an 
evaluation of the Medicines Learning Portal has shown it to be popular resource and 
has had a positive effect on junior pharmacists’ learning, 109 its impact on handling of 
medicines advice enquiries by on-call pharmacists is not known. 
 
It appears that whilst some Trusts did give initial training there was little in the way of 
refresher courses for handling medicines advice calls. This was an unexpected finding 
given that new information sources become available on a regular basis, or the way in 
which they can be accessed can change, e.g. book, website, app. This could mean that 
if on-call pharmacists are not made aware of these changes and/or trained on how to 
use them they will either be unaware of the resource, unable to use it with confidence 
or use it inefficiently/incorrectly which may affect the handling of enquiries out of hours. 
137 It could be argued that pharmacists may become familiar with such changes as a 
result of their role during normal working hours. However, it is this researcher’s opinion 
that whilst this may be true for rotational pharmacists (Band 6 and 7), this is less likely 
for more senior pharmacists as they may spend minimal time in the MI centre. One 
example of change is the enquiry answering database (MiDatabank) used by MI 
services to document questions. Over half of Chief Pharmacists in the survey stated 
their on-call pharmacists were able to access MiDatabank out of hours within the 
organisation to search for previous enquiries. This access would provide the on-call 
pharmacist with information about the question previously asked, the sources 
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searched, information found, and the answer provided by the MI service. This could 
help reduce duplication of effort or the time needed to respond to a question received 
out of hours by the on-call pharmacist. In September 2014, UKMi services were given 
the opportunity to upload and share anonymised enquiries with other participating 
centres via MiDatabank. 48 Although this is being used in practice by UKMi services, it 
is not known whether this functionality is being accessed by on-call pharmacists. 
However, if refresher training is not provided this may mean that on-call pharmacists 
are unaware of this resource which could further increase the likelihood of finding 
relevant information. Despite this, issues related to the suitability of MiDatabank for use 
out of hours as discussed earlier, may still affect its uptake. 
 
6.1 Limitations 
This section discusses the limitations of this research and consists of two parts: those 
associated with the online survey, and then with the semi-structured interviews.  
 
6.1.1 Online Survey  
Firstly, the response rate to the online survey was just over 50% and although this was 
comparable to other published studies involving Chief Pharmacists, 70-74 the data 
cannot be said to be truly representative; therefore, these findings need to be 
interpreted with caution.  However, the proportion of acute hospital (76.7%) and mental 
health Trusts (23.3%) that responded were aligned with the national organisational 
demographic across the NHS in England (75.2% and 24.7%, respectively). Therefore, 
the data is representative of the Trust types across NHS England.   
 
Secondly, two Trusts had completed the online survey twice and the decision for which 
response was to be included within the dataset was made by the Chief Pharmacist 
after they had been contacted by the researcher for clarification. The rationale for their 
decision was not requested by the researcher although the survey which had been 
more fully completed was always offered as the preferred response by the Chief 
Pharmacist. On reflection it would have been preferable for a more robust decision-
making process to have been used to determine which response to include within the 
results. The reasons for which response was included could then be clearly justified. 
However, it is unlikely that the data from just two Trusts would significantly affect the 
reliability or validity of the results. 
Finally, there were some limitations associated with the survey design. These included 
the appropriateness of the Chief Pharmacist as a point of contact for each Trust, not 
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knowing what information they had based their responses on and use of the term 
‘typical week’. Each of these will now be discussed in more detail. Whilst Chief 
Pharmacists were contacted as a consistent point of contact across all NHS hospital 
pharmacy departments in England, they may not have always been the best person to 
answer all of the questions posed within the online survey. This is because some 
questions related to the everyday operational, rather than managerial aspects of the 
service. It should also be noted that Chief Pharmacists may have delegated the 
completion of the survey to more appropriate staff without the researcher’s knowledge. 
However, it is the researcher’s opinion that there was no suitable alternative to the 
Chief Pharmacist as a single point of contact to be used in each of the Trusts. 
Attempting to ask different individuals within the pharmacy teams to complete various 
sections of the online survey would not have been practical and could have potentially 
led to inconsistency within responses or lower response rates. It is not known what 
information the Chief Pharmacist used when responding to workload questions about 
the number of calls or types of healthcare professionals that contacted the on-call 
pharmacy service, They may have referred to documented data within their department 
before responding or based it instead on their opinion, although they were provided 
with this option within the online survey if that was the case. However, because there 
was very little published information about on-call pharmacy services it was not known 
what information was documented by hospital pharmacies across England. Therefore 
the researcher did not specify on what information the Chief Pharmacist should base 
their response. 
 
Throughout the online survey questions related to workload about medicines supply 
and advice calls used the term ‘typical week’ but this was not defined by the 
researcher. The term ‘typical week’ was used to define seven days (Monday to Friday) 
and the word ‘typical’ referred to the volume and type of work handled. This may have 
potentially been misinterpreted; a ‘typical week’ in an organisation as perceived by one 
Chief Pharmacist may have been different to another hospital.  
 
6.1.2 Semi-structured interviews 
The limitations associated with the semi-structured interviews, as part of this research, 
are now discussed.  
 
Although a reasonable number of interviews were conducted with pharmacists, a 
relatively smaller number were undertaken with doctors (n=3) and nurses (n=4). 
151 
 
Although none of the interviewees were recruited from mental health Trusts, the vast 
majority of Trusts that provided on-call pharmacy services were acute hospitals. 
Therefore, these are more likely to represent the views of pharmacists, doctors and 
nurses. The first phase of this research concluded that nurses were the most frequent 
users of on-call pharmacy services, followed by junior doctors. As two of the doctors 
interviewed were consultants and one a junior doctor, it might be argued that the 
interviewees were not entirely representative of on-call pharmacy service users. 
Furthermore, none of the doctors and nurses were recruited via the poster; all 
expressed an interest to participate via the hospital pharmacy MI service. There is 
therefore a potential risk of bias from only including doctors and nurses recruited in this 
manner because they were already aware of the hospital pharmacy MI service and this 
may have affected some of their responses to the interview questions.  
 
The researcher believes that interviews conducted with on-call pharmacists had 
reached data saturation as no new ideas or themes were generated. However, 
because of the recruitment difficulties described above, and challenges arranging 
interviews at times that were convenient for doctors and nurses within their busy 
schedules, data saturation may not have been reached for these two groups. However, 
some of the themes generated from interviews with doctors and nurses also occurred 
with pharmacists or supported by the existing literature thereby triangulating these 
findings. 
 
During interviews with on-call pharmacists and some doctors and nurses, the 
researcher was aware that individuals knew he was also a practising pharmacist. 
Although doctors and nurses working within the same organisation as the researcher 
were complimentary about the pharmacy service, the effect of this awareness on their 
responses to questions in general is unknown.  
 
In response to the first interview question, “What do you think are the medicines 
information needs of doctors and nurses’ when working out of hours?” the researcher is 
aware that some pharmacists answered this question in the context of MI services. In 
some of the interviews this had to be clarified by the researcher and was not something 
that had arisen as an issue during the pilot interviews. However, when reviewing 
responses across all pharmacist interview transcripts, similarities were identified and 
themes generated.  
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6.2 Implications for Practice 
Whilst hospital pharmacy departments continue to develop seven day services, this 
research has identified a number of considerations about the use and provision of on-
call pharmacy services, including medicines advice. These include an awareness and 
understanding of the on-call pharmacy service by doctors and nurses; access to 
information and support out of hours for doctors, nurses and on-call pharmacists; 
documentation of enquiries handled by on-call pharmacists including benchmarking; 
and, training for on-call pharmacists to handle medicines advice questions. These are 
now each discussed in more detail. 
 
Firstly, UKMi together with Chief Pharmacist networks could develop material which 
can be used and adapted locally by all hospital pharmacy departments to improve the 
awareness and understanding by doctors and nurses of what services hospital 
pharmacies provide out of hours. This might include how the on-call pharmacy service 
is accessed, types of services provided, its staffing and workload. The current way that 
on-call pharmacy services are promoted varies between Trusts, but the perception of 
doctors and nurses is that it is a source of supply rather than also as a source of 
medicines advice. In particular, nurses perceive the service to be unapproachable. 
Therefore, Chief Pharmacists with their MI services should consider how best locally to 
use this material to promote the service as the current ways used, e.g. Intranet most 
commonly, do not appear to be conveying this message effectively. Together, they 
should ensure that the awareness and understanding of the on-call pharmacy service 
by doctors and nurses locally is improved.  
 
Secondly, there are a number of implications for doctors, nurses and pharmacists 
working out of hours with regards to information and support. National policy makers 
could develop clear guidelines on what information on-call pharmacists should be able 
to access remotely within an EPMA system, in order to provide medicines advice for 
patient care. In addition, UKMi working with Chief Pharmacist networks could review 
the existing recommended list of information resources that should be available and 
accessible to on-call pharmacists to ensure that it reflects the types of enquiries likely 
to be handled. This should extend to doctors and nurses, so that Chief Pharmacists 
working with their MI services can consider how it can support local access to 
electronic MI resources when working out of hours. In particular, this should include a 
review of the resources available to doctors, nurses and on-call pharmacists about 
drug administration, and their promotion. Finally, national policy makers should ensure 
that on-call pharmacists have access to specialist pharmacy colleagues as 
standardised practice. 
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Thirdly, there is variation in the way that enquiries handled by on-call pharmacists are 
documented. UKMi could work with Chief Pharmacist networks to develop guidelines 
for what information should be documented by all on-call pharmacists when handling 
medicines advice calls. There is a need for an IT product which can support the 
documentation of enquiries handled by on-call pharmacists in real time. The 
expectation of what is documented needs to be realistic and achievable – considering 
the factors that affect documentation out of hours - but also sufficient to enable 
benchmarking of workload data. As hospital pharmacy services develop seven day 
clinical pharmacy services as part of their HPTPs, data about the provision of, and the 
workload managed by on-call pharmacy services could be monitored and 
benchmarked nationally. This could be used to monitor the development of extended 
pharmacy services.   
 
Finally, there are implications for the training of on-call pharmacists to handle 
medicines advice enquiries. National pharmacy policy makers could consider 
structured training for all pharmacists before they begin on-call. This training should be 
repeated on a regular basis to ensure knowledge is kept current. UKMi could develop 
or build on existing training material to develop MI skills for on-call pharmacists; not all 
pharmacists maybe able to complete a MI rotation before participating in the on-call 
rota. However, further research is required to determine the most effective method for 
delivering this training. 
 
In summary, national standards should be developed which include the following 
aspects of on-call pharmacy services: provision, information accessibility, 
documentation and training.   
 
6.3 Considerations for future research 
Based on the implications for practice described in the previous section, there are 
some considerations for future research. 
  
Firstly, this research did not seek to understand why nearly half of mental health Trusts 
did not provide an on-call pharmacy service. Further research could explore this area, 
particularly as no interviews were conducted with pharmacists, doctors or nurses from 
mental health Trusts. This would align with the recent focus on unwarranted variations 
across mental health (and community health) services. 139  
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Differences in the proportion of medicines supply and medicines advice calls were 
observed between Trusts that operated a resident pharmacy programme and those 
that did not. Further research could explore the reasons for these differences, which 
may help inform other recommendations, such as the best way for hospital pharmacies 
to promote their on-call pharmacy services to ensure that doctors and nurses are 
aware of what is provided.  
 
There is some very limited published information about the quality of enquiries 
documented by on-call pharmacists as previously discussed. However, the quality of 
on-call pharmacy services is an area that could be further explored particularly in 
relation to medicines advice enquiries in comparison with that provided by clinical 
pharmacy and MI services during normal working hours, but also between the different 
Agenda for Change banding of pharmacists. The role of IT to help support 
documentation of enquiries handled out of hours is also an area for research.  
 
Determining what knowledge and experience is required for on-call pharmacists, and 
the optimal methods that should be used to deliver this training so they can handle 
medicines advice questions could be explored further. Whilst there is a role for MI 
services, it is unclear what this should be. 
 
Further in-depth research is needed to better understand the types of enquiries 
handled by on-call pharmacy services, triangulated with the information being sought 
by nurses and doctors out of hours. This links to suggestions for further exploring 
documentation and IT. 
 
Finally, research which assesses the impact of on-call pharmacy services on patient 
care/patient outcome should be considered. 
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CHAPTER 7 CONCLUSION  
This research is the first to provide an insight into the national landscape of on-call 
pharmacy services, particularly exploring the opinions of those involved in providing 
and those who use the service.  
 
The documentation of medicines advice calls by on-call pharmacists varied within and 
between Trusts, compounded by a lack of policy standardisation nationally, according 
to a survey of Chief Pharmacists. The factors which affected the documentation of 
medicines advice questions by on-call pharmacists were identified from interviews with 
on-call pharmacists and included, amongst others, IT issues. Despite an IT-based 
recording system used by hospital MI services during normal working hours, questions 
handled by on-call pharmacists were still documented on paper. This IT system is 
desktop-based and the use of a laptop, provided by many departments for on-call 
pharmacists to use, was frequently cited during interviews as an issue for 
documentation. These issues included the laptop not being charged when handed over 
by another on-call pharmacist and the setup time it took before it could be used. 
Therefore an IT product which supports documentation of queries by on-call 
pharmacists in real time is needed.  Variation in the documentation of medicines advice 
questions handled out of hours makes it difficult to benchmark on-call pharmacy 
services and identify trends or medicines-related issues experienced by doctors and 
nurses working out of hours. The latter makes it difficult to identify what support might 
be provided for these healthcare professionals working out of hours although interviews 
with doctors and nurses found that drug administration and ‘medication safety check’ 
were two question types frequently sought.  
 
On-call pharmacy services across England were provided predominantly by less senior 
staff with limited years’ experience working as a pharmacist. Although MI services were 
involved in the training of on-call pharmacists, interviews conducted with the latter 
identified there was a greater role for MI staff in their training to handle medicines 
advice calls out of hours. The training provided to on-call pharmacists mainly consisted 
of operational issues whereas non-operational training to support the handling of MI 
enquiries out of hours was less likely to be included. Additionally, refresher courses 
were rarely provided. This may lead to differences in the knowledge between 
pharmacists and therefore the way in which enquiries are handled, a finding supported 
by this research. National pharmacy policy makers could consider structured training, 
repeated on a regular basis, for all pharmacists before they begin on-call although 
further research is needed to determine the most effective method for delivering this 
training. 
156 
 
 
Although Chief Pharmacists stated that their on-call pharmacy services are generally 
well advertised, doctors and nurses interviewed in this research continued to be 
unaware of its provision, workload handled and how to access. This maybe 
compounded by the variation between individual on-call pharmacists and between 
different hospital pharmacy departments, affected by the lack of national 
standardisation for documentation and training. Nurses also raised concerns during 
interviews about the unapproachability of the on-call pharmacist. All of these factors, in 
the researcher’s opinion, may have also led to on-call pharmacy services handling less 
medicines advice calls compared to medicines supply.  
  
This research has also determined that there is a difference in access to information for 
pharmacists out of hours compared to during normal working hours. Chief Pharmacists 
surveyed perceived that on-call pharmacists had good access to information resources. 
However, when interviewed, on-call pharmacists cited access to information resources 
as a potential barrier and this was linked to IT issues including Internet access. In 
addition, pharmacists perceived that access to drug and clinical information out of 
hours, particularly the patient and patient information, was not as good as during 
normal working hours. One implication of this was that there was a reliance by the on-
call pharmacist on the nurse or doctor to provide information. This sometimes led to 
concerns by the pharmacist about whether they were being provided with all relevant 
information related to the question being asked by the doctor or nurse.  
 
In summary, this research has significantly contributed to the limited published 
information about on-call pharmacy services. This is the first time a mixed methods 
approach has been used to explore the views of pharmacists involved in the provision 
of on-call pharmacy services, and of doctors and nurses who most frequently use the 
service. The combination of quantitative and qualitative methods has enabled a 
richness of data not seen before in this area.  There is a clear role here for MI services 
to show leadership and greater involvement supporting medicines advice provision by 
on-call pharmacy services. In particular, the need for national standards for on-call 
pharmacy services.  
 
 
157 
 
CHAPTER 8 REFERENCES 
1. McRobbie D, West T. Open all hours—running a resident pharmacy service. Hosp 
Pharm 2002; 9: 127 – 129.  
2. Slee A. Should pharmacy departments provide an extended service? Hospital 
Pharmacist 2000; 7: 34. 
3. UK Medicines Information. Effective information for managing medicines. A strategy 
for the UK Medicines Information network in the NHS; 2007. Available from 
http://www.ukmi.nhs.uk/filestore/misc/Strategy2007[2].pdf  
4. UKMi. UKMi audit standards and toolkit for measuring quality in NHS medicines 
information services; 2018. Available from https://www.sps.nhs.uk/articles/ukmi-
standards-and-audit/   
5. UKMi. Training resources on MI skills [Internet]. 2017 [cited 2019 Apr 7]. Available 
from https://www.sps.nhs.uk/articles/training-resources-on-mi-skills/  
6. Aujla T, Brown D, Emerson A. UKMi training tools: are they fit for purpose? 33rd 
UKMi Practice Development Seminar; 2007 Oct 31; London. 
7. Garrett S. Introducing a new method of medicines information training. British 
Journal of Clinical Pharmacy 2010; 2 (7): 218 – 220. 
8. Spinewine A, Dean B. Measuring the impact of medicines information services on 
patient care: methodological considerations. Pharmacy World and Science 2002; 
24: 177 – 181. 
9. Hands D, Stephens M, Brown D. A systematic review of the clinical and economic 
impact of drug information services on patient outcome. Pharmacy World and 
Science 2002; 24: 132 – 138. 
10. Bramley D, Innes AJ, Duggan C, Oborne A. The impact of Medicines Information 
enquiry answering on patient care and outcomes. International Journal of 
Pharmacy Practice 2013; 21 (6): 393 – 404. 
11. Innes AJ, Bramley DM, Wills S. The impact of UK Medicines Information services 
on patient care, clinical outcomes and medicines safety: an evaluation of 
healthcare professionals’ opinions. European Journal of Hospital Pharmacy 2014; 
21: 222 – 228. 
12. Bramley D, Mohandas C, Soor S, Erskine D, Oborne CA. Does a medicines 
information service have a positive impact on patient care? Pharmaceutical Journal 
2009; 282: 139 – 140. 
13. Alkhaldi N, Desborough J, Wright D, House T. What would you do without 
medicines information: a feasibility study to determine whether clinical outcomes 
resulting from the absence of an MI service can be elicited? International Journal of 
Pharmacy Practice 2013; 21 (Suppl 1): 34. 
158 
 
14. Rimmer S, Davies JG, Harkness L, Soor S. The use of advice provided by a 
medicines information enquiry answering service and its impact on patient 
outcome. 33rd UKMi Practice Development Seminar; 2007 Oct 31; London. 
15. Rutter J, Fitzpatrick R, Rutter P. What effect does medicine advice provided by UK 
Medicines Information pharmacists have on prescriber practice and patient care: a 
qualitative primary care study. Journal of Evaluation in Clinical Practice 2015; 1 – 6. 
16. Williams N. Pharmacy after dark – life as a resident pharmacist at Wirral University 
Teaching Hospital NHS Foundation Trust. Tomorrow’s Pharmacist; 2010 (no 
pagination). Accessed via https://www.pharmaceutical-
journal.com/opinion/comment/pharmacy-after-dark-life-as-a-resident-pharmacist-at-
wirral-university-teaching-hospital-nhs-foundation-trust/11016268.fullarticle  
17. Foster JJ, Rudall NL. Re-engineering out-of-hours pharmacy services for a new 
decade. Clinical Pharmacist 2010; Suppl 3: S23. 
18. Dunn J. On-call hospital pharmacy services: a perspective from NHS Tayside, 
Scotland. European Journal of Hospital Pharmacy 2018; 25: 72 – 78. 
19. Rutter J, Brown D, Rutter P. Primary care practitioners update of a secondary care-
based medicines information service in the United Kingdom. Drug Information 
Journal 2004; 38 (4): 407 – 416. 
20. Rutter J, Rutter P. User satisfaction with the enquiry answering service at Wessex 
Regional Medicines Information Service [poster]. 30th UKMi Practice Development 
Seminar; 2004 Sept; Warwick. 
21. Anon. Wessex Regional MI Service Audit Report [unpublished]; 2014. 
22. Anon. East Anglia MI Service Audit Report [unpublished]; 2013. 
23. Cheeseman M. Improving information governance for pharmacists working out of 
hours: involvement of a MI service. 34th UKMi Practice Development Seminar; 2008 
Sept 18 – 19; Warwick. 
24. Cheeseman M. The East Anglia Medicines Information out of hours project – 
results from a pilot study. 35th UKMi Practice Development Seminar; 2009 Sept 17 
– 18; Edinburgh.  
25. Cheeseman M. The on-call pharmacist’s bag – is there a different way? Clinical 
Pharmacist 2010; 2: 98 – 100.  
26. Hands D. What is the future for drug information units in the NHS? The Hospital 
Pharmacist 1994; 1: 103 – 106. 
27. Kerr S. Using medicines wisely. The medicines information pharmacist’s role. 
Hospital Pharmacist 2002; 9: 164 – 166. 
28. NHS England. The Review of Specialist Pharmacy Services in England; 2014. 
Available from https://www.england.nhs.uk/wp-content/uploads/2014/05/sps-final-
rep-28-05-14.pdf  
159 
 
29. Oxford University Press. English Oxford Living Dictionaries [Internet]. 2019 [cited 
2019 Apr 7]. Available from https://en.oxforddictionaries.com/?utm_source=od-
panel&utm_campaign=en  
30. UKMi. UKMi Directory [Internet]. 2019 [cited 2019 Apr 7]. Available from 
http://www.ukmi.nhs.uk/ukmi/directory/results/results.asp?selkeyword=southampto
n   
31. Department of Health. Health and Social Care Act 2012; 2012. Available from  
http://www.legislation.gov.uk/ukpga/2012/7/pdfs/ukpga_20120007_en.pdf 
32. NHS England. NHS Five Year Forward View; 2014. Available from  
https://www.england.nhs.uk/wp-content/uploads/2014/10/5yfv-web.pdf   
33. Department of Health & Social Care. 7-day NHS services: a factsheet [Internet]. 
2015 [cited 2019 Apr 7]. Available from  
https://www.gov.uk/government/publications/7-day-nhs-services-a-factsheet/7-day-
nhs-services-a-factsheet  
34. NHS England. Transformation of seven day clinical pharmacy services in acute 
hospitals; 2016. Available from https://www.england.nhs.uk/wp-
content/uploads/2016/09/7ds-clinical-pharmacy-acute-hosp.pdf  
35. Lord Carter of Coles. Operational productivity and performance in English NHS 
acute hospitals:  Unwarranted variations; 2016. Available from 
https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/4992
29/Operational_productivity_A.pdf  
36. Woods F. Extended Hours MI Service (paper for Welsh Chief Pharmacists meeting) 
[unpublished]; 2008. 
37. NHS England. The NHS Long Term Plan; 2019. Available from 
https://www.longtermplan.nhs.uk/wp-content/uploads/2019/01/nhs-long-term-
plan.pdf 
38. Maguire ME, D’Arcy PFD, Smith AMJ. From the drug information centres. A decade 
of drug information experience in Northern Ireland. Journal of Clinical and Hospital 
Pharmacy 1985; 10: 297 – 302.  
39. Maguire ME, D’Arcy PFD. Drug information services in four capital cities in the 
United Kingdom. ’A tale of four cities’ – London (North East Thames), Cardiff, 
Belfast, Edinburgh. Journal of Clinical Pharmacy and Therapeutics 1988; 13: 207 – 
212.  
40. Rosenberg JM, Koumis T, Nathan JP, Cicero LA, McGuire H. Current status of 
pharmacist-operated drug information centers in the United States. American 
Journal of Health System Pharmacy 2004; 61: 2023 – 2032.  
160 
 
41. Timpe M, Motl SE. Increased availability of information resources and the effects on 
the complexity of drug information requests asked to an academic center. 
Pharmacotherapy 2004; 24 (10): 1429. 
42. Bertsche T, Hammerlein A, Schulz M. German national drug information service: 
user satisfaction and potential positive patient outcomes. Pharmacy World and 
Science 2007; 29: 167 – 172. 
43. Fathelrahman AI, Awang R, Bashir AA, Taha IA, Ibrahim HM. User satisfaction with 
services provided by a drug information center in Sudan. Pharmacy World and 
Science 2008; 30 (6): 759 – 763. 
44. McEntee JE, Henderson SL, Rutter PM, Rutter J, Davis HJ, Randall CJ. A survey of 
UK dental health professionals using a medicines information service: what 
questions do they ask and do they get useful answers? British Dental Journal 2011; 
211 (1): 17 – 21.  
45. Alkhaldi N, Desborough J, Wright D, Wood J, House T. A five year review of patient 
focused medicine information queries at a large UK teaching Trust: assessing the 
trends, predicting the future. Journal of Pharmaceutical Care and Health Systems 
2014; 1: (3): 116.  
46. Entezari-Maleki T, Taraz M, Javadi MR, Hajimiri MR, Eslami K, Karimzadeh I, et al. 
A two-year utilization of the pharmacist-operated drug information center in Iran. 
Journal of Research in Pharmacy Practice 2014; 3 (4): 117 – 122. 
47. About UKMi. [Internet]. 2006 [cited 2019 Apr 7]. Available from 
http://www.ukmi.nhs.uk/ukmi/about/default.asp?pageRef=1 
48. CoAcS. MiDatabank. [Internet]. 2019 [cited 2019 Apr 7]. Available from 
http://www.midatabank.com  
49. Schjott J, Pomp E, Gedda-Dahl A. Quality and impact of problem-orientated drug 
information: a method to change clinical practice among physicians? European 
Journal of Hospital Pharmacy 2002; 57 (12): 897 – 902. 
50. Basselin C, Ferreira E, Martin B, Touzin J, Morin C, Bussieres JF, et al. A survey 
on sources consulted by health care providers and on the satisfaction of the IMAGe 
service. Birth Defects Research Part A - Clinical and Molecular Teratology 2009; 85 
(5): 494. 
51. Frost Widnes SF, Schjott J. Drug use in pregnancy-physicians’ evaluations of 
quality and clinical impact of drug information centres. European Journal of Hospital 
Pharmacy 2009; 65 (3): 303 – 308. 
52. Hedegaard U, Damkier P. Problem-orientated drug information: physicians’ 
expectations and impact on clinical practice. European Journal of Hospital 
Pharmacy 2009; 65 (5): 515 – 522. 
161 
 
53. McEntee JE, Henderson SL, Rutter PM, Rutter J, Davis HJ. Utility and value of a 
medicines information service provided by pharmacists: a survey of health 
professionals. International Journal of Pharmacy Practice 2010; 18: 353 – 361. 
54. Fischer MI, Tavares LA, Dal Pizzol TS. User’s satisfaction in a Brazilian Drug 
Information Center: evaluation under a new approach. Latin American Journal of 
Pharmacy 2012; 31 (8): 1138 – 1142. 
55. Kinky DE, Erush SC, Laskin MS, Gibson GA. Economic impact of a drug 
information service. Annals of Pharmacology 1999; 33: 11 – 16.  
56. Strobach D, Gruber AC, Mohler NC, Vetter-Kerkhoff C. Clinical impact of the 
hospital pharmacy drug information service: how does information on drug-drug 
interaction enquiries translate into clinical decisions? European Journal of Hospital 
Pharmacy 2015; 22: 83 – 88. 
57. Lewis P, Forster A, Magowan M, Butler G. Exploring the experiences and opinions 
of Pharmacists working in a 24/7 hospital pharmacy service. International Journal 
of Pharmacy Practice 2015 (Suppl 2): 16. 
58. Peak VJ, Greene SA, Hansen LA, et al. Twenty-four-hour clinical services provided 
by an on-call pharmacist. American Journal of Hospital Pharmacy 1986; 43: 1753 – 
1754. 
59. Pitner JK. Clinical pharmacy on-call service in a tertiary care hospital. 
Pharmacotherapy 1999; 19 (4): 530. 
60. Heath EK, Welch SA, Costello N. On-call pharmacist enquiries and outcomes: an 
on-call database review, 2003–2012. Journal of Pharmacy Practice and Research 
2014; 44: 201 – 204. 
61. Kapadia T, Kelly D, Singal R. Evaluating the out-of-hours residency pharmacy 
service at a large NHS Trust. International Journal of Pharmacy and Practice 2016; 
24 (Suppl 3): 85. 
62. Kilcullen N, O'Brady C. Do you need the on-call pharmacist? European Journal of 
Hospital Pharmacy 2016; 23: A159 – A160. 
63. Auckland H, Belton R. UKMi 24/7: Audit of the quality of medicines information 
enquiries answered out-of-hours. 33rd UKMi Practice Development Seminar; 2007 
Oct 31st; London.  
64. Emerson A. UKMi 24/7: What are the information needs of health professionals out-
of-hours? 33rd UKMi Practice Development Seminar; 2007 Oct 31; London. 
65. NHS Research Authority. UK policy framework for health and social care research; 
2017. Available from via https://www.hra.nhs.uk/documents/1068/uk-policy-
framework-health-social-care-research.pdf 
66. Crotty M. (1998) The foundations of social research: meaning and perspective in 
the research process, Sydney, NSW: Allen & Unwin. 
162 
 
67. Creswell JW, Creswell JD. Research design: qualitative, quantitative, and mixed 
methods approaches. 4th ed.  London: Sage; 2014. 
68. Gray DE. Doing research in the real world [Internet]. London: Sage; 2013 [cited 
2019 Apr 7]. Available from: https://www.sagepub.com/sites/default/files/upm-
binaries/58626_Gray__Doing_Research_in_the_Real_World.pdf#page=6 
69. Fan W, Yan Z. Factors affecting response rates of the web survey: a systematic 
review. Computers in Human Behaviour 2010; 26: 132 – 139. 
70. Cox AR, Marriott JF, Wilson KA, Ferner RE. Message from the top: chief 
pharmacists’ views of adverse drug reporting. International Journal of Pharmacy 
Practice 2004; 12 (Suppl): R68. 
71. Hassell K, Jacobs S, Potter H, Prescott J, Schafheutle E, Seston L. Managing 
performance concerns about pharmacists. A report for the National Clinical 
Assessment Service. London: NCAS, 2010.  
72. Norton C, Sinclair A, Marriott JF. Supporting MCRN research through improving 
clinical trial delivery by hospital pharmacies. Arch Dis Child 2011; 96: e1. 
73. Howard P. A survey of national, regional and hospital chief pharmacists on 
consultant pharmacist appointment strategy and performance in the United 
Kingdom. European Journal of Hospital Pharmacy: Science and Practice 2012; 19: 
253. 
74. Williams M, Jordan A, Scott J, Jones MD. Operating a patient medicines helpline: a 
survey study exploring current practice in England using the RE-AIM evaluation 
framework. BMC Health Services Research 2018; 18: 868.  
75. Braithwaite D, Emery J, de Lusignan S and Sutton S. Using the Internet to conduct 
surveys of health professionals: a valid alternative? Family Practice 2003; 20: 545 – 
551. 
76. Heale R, Twycross A. Validity and reliability in quantitative studies. Evidence Based 
Nursing 2015; 18 (3): 66 – 67. 
77. Smith F. Survey research: (2) Survey instruments, reliability and validity. 
International Journal of Pharmacy Practice 1997; 5: 216 – 226. 
78. Altman DG. Practical statistics for medical research. London: Chapman & Hall; 
1993.  
79. Pope C, van Royen P, Baker R. Qualitative methods in research on healthcare 
quality. Quality and Safety in Health Care 2002; 11: 148 – 152. 
80. Fox, N. Using Interviews in a Research Project. The NIHR RDS for the East 
Midlands / Yorkshire & the Humber; 2006.  
81. Gale NK, Heath G, Cameron E, Rashid S, Redwood S. Using the framework 
method for the analysis of qualitative data in a multi-disciplinary health research. 
BMC Medical Research Methodology 2013; 13: 117. 
163 
 
82. Saldana J. The coding manual for qualitative researchers. 2nd ed. London: Sage; 
2013 
83. Silverman D. Doing qualitative research. 4th ed. London: Sage; 2013. 
84. Mays N, Pope C. Assessing quality in qualitative research. BMJ 2000; 320: 50 – 52 
85. NHS Health Research Authority. Decision tool [Internet]. 2017 [cited 2019 Apr 7]. 
Available from http://www.hra-decisiontools.org.uk/research/ 
86. Cotter S, Barber N, McKee M: Survey of clinical pharmacy services in United 
Kingdom National Health Service hospitals. Am J Hosp Pharm. 1994, 51: 2676-
2684. 
87. McLeod M, Ahmed Z, Barber N, Franklin BD. A national survey of inpatient 
medication systems in English NHS hospitals. BMC Health Services Research 
2014; 14: 93. 
88. The King’s Fund. NHS hospital bed numbers: past, present and future; [Internet]. 
2017 [cited 2019 Apr 7]. Available from 
https://www.kingsfund.org.uk/publications/nhs-hospital-bed-numbers  
89. The King’s Fund. Funding and staffing of NHS mental health providers: still waiting 
for parity. [Internet]. 2018 [cited 2019 Apr 7]. Available from 
https://www.kingsfund.org.uk/publications/funding-staffing-mental-health-providers 
90. Brown M, Shaw D, Sharples S, Le Jeune I, Blakey J. A survey-based cross 
sectional study of doctors’ expectations and experience of non-technical skills for 
out of hours work. BMJ Open [Internet. 2015 [cited 2019 Apr 7]; 5 (2): e006102. 
Available from: doi: 10.1136/bmjopen-2014-006102. 
91. Harden B, Cross J, Thomas S. An exploration of emergency respiratory on-call 
service provision within the United Kingdom. Journal of the Association of 
Chartered Physiotherapists in Respiratory Care 2005; 37: 17 – 24. 
92. Groves M, O’Rourke P, Alexander H. The clinical reasoning characteristics of 
diagnostic experts. Medical Teacher 2003; 25: 308 – 13. 
93. Lawton R, Robinson O, Harrison R, Mason S, Conner M, Wilson B. Are more 
experienced clinicians better able to tolerate uncertainty and manage risks? A 
vignette study of doctors in three NHS emergency departments in England. BMJ 
Quality & Safety [cited 2019 Apr 7]. ePub ahead of print 2019 Feb 6. Available 
from doi: 10.1136/bmjqs-2018-008390). 
94. NHS Improving Quality/NHS England. NHS services—open seven days a week: 
every day counts; 2013. Available from https://www.england.nhs.uk/improvement-
hub/wp-content/uploads/sites/44/2017/11/Seven-Day-Services-Every-Day-
Counts.pdf 
95. National Audit Office. The Commissioning of specialised services in the NHS. 
London: National Audit Office; 2016. Available from https://www.nao.org.uk/wp-
164 
 
content/uploads/2016/04/The-commissioning-of-specialised-services-in-the-
NHS.pdf 
96. Axon DR, Lim R, Lewis P et al. Junior doctors’ communication with hospital 
pharmacists about prescribing: findings from a qualitative interview study. 
European Journal of Hospital Pharmacy 2018; 25: 257 – 261. 
97. Creswick N, Westbrook JI. Who do hospital physician and nurses go to for advice 
about medications? A social network analysis and examination of prescribing error 
rates. Journal of Patient Safety 2015; 11 (3): 152 – 159. 
98. Cullen R, Clark M, Esson R. Evidence-based information-seeking skills of junior 
doctors entering the workforce: an evaluation of the impact of health literacy 
training during pre-clinical years. Health Information & Libraries Journal 2011; 28 
(20: 119 – 129. 
99. Coumou HCH, Meijman FJ. How do primary care clinicians seek answers to clinical 
questions? A literature review. Journal of the Medical Library Association 2006; 94 
(1): 55 – 60. 
100. Younger P. Internet-based information seeking behaviours amongst doctors 
and nurses: a short review of the literature. Health Information & Libraries Journal 
2010; 27 (1): 2 – 10. 
101. Martin G, Janardhana P, Withers T, Gupta S. Mobile revolution: a requiem for 
bleeps? Postgraduate Medical Journal 2016; 92: 493 – 496. 
102. O’Reilly MK, Nason GJ, Liddy S, Fitzgerald CW, Kelly ME, Shields C. DOCSS: 
doctors on-call smartphone study. Irish Journal of Medical Science 2013; 183 (4): 
573 – 577. 
103. Department of Health & Social Care. Health and social care secretary bans 
pagers from the NHS. [Internet]. 2019 [cited 2019 Apr 7]. Available from 
https://www.gov.uk/government/news/health-and-social-care-secretary-bans-
pagers-from-the-nhs 
104. Robinson A, Rathbone A, et al. Pharmacy 2.0: experience of using WhatsApp 
as a real time communication tool to deliver out-of-hours pharmacy services. 
Research in Social and Administrative Pharmacy 2018; 14 (8): e28 – e29. 
105. Ofcom. Further options for improving mobile coverage. Advice to Government. 
London: Ofcom; September 2018. Available from 
https://www.ofcom.org.uk/__data/assets/pdf_file/0017/120455/advice-government-
improving-mobile-coverage.pdf 
106. Anon. Survey: nurses speak up about hospital pharmacists. RN 2006; 69 (1): 
20. 
165 
 
107. Ryan K, Patel N, Lau WM, Abu-Elmagd H, Stretch G, Pinney H. Pharmacists in 
general practice: a qualitative interview case study of stakeholders' experiences in 
a West London GP federation. BMC Health Services Research 2018; 18 (1): 234. 
108. Celio J, Ninane F, Bugnon O, Schneider MP. Pharmacist-nurse collaborations 
in medication adherence-enhancing interventions: A review. Patient Education and 
Counselling 2018; 101 (7): 1175 – 1192. 
109. Chan B, Reeve E, Matthews S, Carroll PR, Long JC, Held F, et al. Medicine 
information exchange networks among healthcare professionals and prescribing in 
geriatric medicine wards. British Journal of Clinical Pharmacology 2017; 83 (6): 
1185 – 1196. 
110. NHS Digital. Prescribing and medicines team. [Internet].  2018 [cited 2019 
Apr 7]. Available from https://digital.nhs.uk/data-and-information/data-insights-and-
statistics/prescribing-and-medicines-team 
111. Lilley R, Collins S, North-Lewis P. The development of a paediatric specific 
online injectable medicines guide. Stage one: an assessment of paediatric nurses' 
current practice. Archives of Disease in Childhood 2010; 95: e1. 
112. Smeulers M, Onderwater AT, van Zwieten MCB, Vermeulen H. Nurses’ 
experiences and perspectives on medication safety practise: an explorative 
qualitative study. Journal of Nursing Management 2014; 22 (3): 276 – 285. 
113. Lewis PJ, Forster A, Magowan M, Armstrong D. Exploring the experiences and 
opinions of hospital pharmacists working 24/7 shifts. Eur J Hosp Pharm [cited 2019 
Apr 7]. ePub ahead of print 2018 Mar. Available from: doi:10.1136/ejhpharm-2017-
001401.  
114. Callaghan R, Hanna G, Brown N, Vassilas C. On call: a valuable training 
experience for senior house officers? Psychiatric bulletin 2005; 29: 59 – 61.  
115. Dixon T, Reeve JC. Emergency on-call duties: audit of support, education and 
training provision in one NHSE region. Physiotherapy 2002; 89 (2): 104 – 113.  
116. Cott C. “We decide, you carry it out”: a social network analysis of 
multidisciplinary long-term care teams. Soc Sci Med 1997; 45: 1411 – 1421.  
117. Creswick N, Westbrook JI. Social network analysis of medication advice-
seeking interactions among staff in an Australian hospital. Int J Med Inform 
[Internet]. 2010 Jun [cited 2019 Apr 7]; 79 (6): e116–e125. Available from: 
https://www.sciencedirect.com/science/article/pii/S1386505608001512 
118. Nursing & Midwifery Council. The Code: Professional standards of practice and 
behaviour for nurses, midwives and nursing associates. London: Nursing & 
Midwifery Council; 2018. Available from 
https://www.nmc.org.uk/globalassets/sitedocuments/nmc-publications/nmc-
code.pdf  
166 
 
119. General Medical Council. Good medical practice. London: General Medical 
Council; 2014. Available from https://www.gmc-uk.org/-/media/documents/good-
medical-practice---english-1215_pdf-51527435.pdf 
120. UKMi. The Incident Reporting in Medicines Information Scheme Database 
Report: Q4 2017 (October - December). Accessed 07.04.19 via 
https://www.sps.nhs.uk/articles/incident-reporting-in-medicines-information-
scheme-irmis/ 
121. UKMi. The Incident Reporting in Medicines Information Scheme Database 
Report: Q1 2018 (January - March). Available from 
https://www.sps.nhs.uk/articles/incident-reporting-in-medicines-information-
scheme-irmis/ 
122. UKMi. The Incident Reporting in Medicines Information Scheme Database 
Report: Q2 2018 (April - June). Available from 
https://www.sps.nhs.uk/articles/incident-reporting-in-medicines-information-
scheme-irmis/ 
123. UKMi. The Incident Reporting in Medicines Information Scheme Database 
Report: Q3 2018 (July - Sept). Available from 
https://www.sps.nhs.uk/articles/incident-reporting-in-medicines-information-
scheme-irmis/ 
124. Keers RN, Williams SD, Cooke J, Ashcroft DM. Causes of Medication 
Administration Errors in Hospitals: A Systematic Review of Quantitative and 
Qualitative Evidence. Drug Safety 2013; 36: 1045 – 1067. 
125. Royal Pharmaceutical Society. Professional standards for hospital pharmacy 
services. London: Royal Pharmaceutical Society; 2017. Available from  
https://www.rpharms.com/Portals/0/RPS%20document%20library/Open%20access
/Professional%20standards/Professional%20standards%20for%20Hospital%20pha
rmacy/Hospital%20Standards-2017.pdf?ver=2017-12-21-132808-697 
126. Auta A, Maz J, Strickland-Hodge B. Perceived facilitators to change in hospital 
practice in England. Int J Clin Pharm 2015; 37: 1068 – 1075. 
127. Department of Health Audit Commission. Spoonful of Sugar—medicines 
management in NHS hospitals. London: HMSO, 2007. Available from 
http://www.eprescribingtoolkit.com/wp-
content/uploads/2013/11/nrspoonfulsugar1.pdf  
128. On Call Manager. [Internet]. 2019 [cited 2019 Apr 7]. Available from 
http://www.ocmonline.co.uk/ 
129. Angowska J, Yu K. The use of MiDatabank by shift workers out of hours. 44th 
UKMi Practice Development Seminar; 2018 Sept 12; Birmingham. 
167 
 
130. University Hospital Association. University Hospital Association. [Internet]. 2019 
[cited 2019 Apr 7]. Available from https://www.universityhospitals.org.uk/who-we-
are/membership/  
131. Brennan K. Is training remotely beneficial? Comparing face-to-face and ‘remote’ 
delivery of MI training. 35th UKMi Practice Development Seminar; 2009 Sept 2009; 
Edinburgh.  
132. Wills S, Badiani A. Impact of the Medicines Learning Portal. 43rd UKMi Practice 
Development Seminar; 2017 Sept 26; Birmingham. 
133. Beswick T, Wills S. Medicines information training in the UK. Hospital Pharmacy 
Europe [Internet].2016 May [cited 2019 Apr 7]; Issue 81. Available from 
http://www.hospitalpharmacyeurope.com/pharmacy-practice/medicines-information-
training-uk 
134. Fitzpatrick RW, Sanders S. Hospital pharmacy staffing levels in England: has 
anything changed in the last 5 years? European Journal of Hospital Pharmacy 
2016; 23:327 – 330. 
135. Lloyd M, Watmough S, Bennett N. Simulation-based training: applications in 
clinical pharmacy. Clinical Pharmacist [Internet]. 2018 Sept [cited 2019 Apr 7]; 10 
(9): (no pagination). Available from https://www.pharmaceutical-
journal.com/research/review-article/simulation-based-training-applications-in-
clinical-pharmacy/20205302.fullarticle?firstPass=false  
136. On-call training. Medicines Learning Portal. [Internet]. 2017 [cited 2019 Apr 7]. 
Available from https://www.medicineslearningportal.org/2016/07/on-call-
training.html 
137. Rankin B, Zogopoulou T, Auyeung V, El-Daya T. Availability and utility of 
medicines information resources used by pharmacy staff working out-of-hours to 
support decision making and patient safety. 41st UKMi Practice Development 
Seminar; 2015 Sept 11; Nottingham. 
138. NHS Improvement. NHS Operational Productivity: unwarranted variations. 
Mental health services, community health services; May 2018. Available from 
https://improvement.nhs.uk/documents/2818/20180524_NHS_operational_producti
vity_-_Unwarranted_variations_-_Mental_....pdf  
 
  
168 
 
APPENDIX 1 Search strategy for MI provision  
(last updated December 2018) 
Th
em
e 
B
ib
lio
gr
ap
hi
c 
da
ta
ba
se
 
Se
ar
ch
 te
rm
s 
H
its
 
Su
bj
ec
t t
o 
ab
st
ra
ct
 re
vi
ew
 
R
ej
ec
te
d 
R
el
ev
an
t 
D
up
lic
at
es
 
In
cl
ud
ed
  
MI 
services 
Scopus "drug information 
service" AND hospital [Limited to 
English Language, articles, 
reviews, conference papers, 
short surveys and erratums]  
1947 31 18 13 
27 23 
Scopus ("drug 
information" OR” medicines 
information”) AND “service” AND 
NOT “patient” [Limited to English 
Language, 2000 – date]  
1035 5 2 3 
Embase (exp *DRUG INFORMATION/ 
OR exp *MEDICAL 
INFORMATION/) AND exp 
*HOSPITAL PHARMACY/ 
150 21 6 15 
Embase exp *HEALTH CARE 
PERSONNEL/ AND exp 
HOSPITAL/ AND exp 
*MEDICAL INFORMATION 
50 4 4 0 
Embase (exp * INFORMATION 
SERVICE/ OR exp 
INFORMATION CENTER/) AND 
exp *DRUG INFORMATION/ 
AND [Limited to English 
Language, Human] 
105 21 12 9 
Medline exp *DRUG INFORMATION 
SERVICES/ AND exp 
*PHARMACY SERVICE, 
HOSPITAL 
335 2 1 1 
Medline exp *DRUG INFORMATION 
SERVICES/ NOT exp 
ADVERSE DRUG REACTION 
REPORTING SYSTEMS/ 
[Limited to English, Human] 
1864 9 5 3 
Medline (Drug information.af OR 
medicines information.af) AND 
exp *DRUG INFORMATION 
SERVICES/ Limited to English 
Language, Human and 2000 to 
current] 
620 16 6 10 
af = all fields 
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APPENDIX 2 Search strategy for on-call pharmacy services  
(last updated December 2018) 
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On-call 
pharmacy 
services 
Scopus (((ALL (medicines 
information)) OR (ALL (drug 
information)) OR (ALL 
(advice))) AND ((ALL (on 
call)) OR (ALL (on-call)) OR 
(ALL (emergency)))) AND 
(ALL (pharmacist)) 
113 103 102 1 0 
14 
Scopus (ALL (healthcare)) AND 
(((ALL (medicines 
information)) OR (ALL (drug 
information)) OR (ALL 
(advice))) AND ((ALL (on 
call)) OR (ALL (on-call)) OR 
(ALL (emergency)))) 
883 11 10 1 1 
Embase PHARMACIST/ AND 
EMERGENCY HEALTH 
SERVICE/ AND exp DRUG 
INFORMATION/ 
9 11 3 0 0 
Embase PHARMACIST/ AND (out 
AND of AND hours).af 
55 15 11 3 0 
Embase PHARMACIST/ AND (on 
AND call).af 
85 18 4 14 8 
Embase (PHARMACIST/ AND 
EMERGENCY HEALTH 
SERVICE/) AND exp DRUG 
INFORMATION/ 
9 9 9 0 0 
Medline (exp *”PHARMACISTS”/ 
AND exp AFTER-HOURS 
CARE/) 
1 1 1 1 1 
af = all fields 
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On-call 
pharmacy 
services 
Medline (exp *”PHARMACISTS”/ 
AND exp “NIGHT 
CARE”/) 
1 1 1 0 0 
 
Medline (exp *”PHARMACISTS”/ 
AND (out of hours).af) 
 
 
20 20 20 0 0 
Medline "exp *PHARMACISTS/ AND 
(on call).af" 
 
83 1 0 1 1 
Medline exp PHARMACISTS/ AND 
exp EMERGENCY 
MEDICAL SERVICES/ 
239 1 0 1 1 
Medline exp DRUG INFORMATION 
SERVICES AND (on call).af 
 
48 2 2 0 0 
UKMi 
PDS 
All poster presentations 
listed within conference 
proceedings available 
electronically from 2005 
http://www.ukmi.nhs.uk/activi
ties/manpowerTraining/defau
lt.asp?pageRef=14 
291 8 2 4 0 
NeLM* pharm* emerg* duty hospital 
 
 
 
1 1 0 1 1 
NeLM* pharm* duty hospital 
 
1 1 1 0 0 
NeLM* pharm* call hospital 
 
 
4 3 1 3 3 
NeLM* pharm* out hour* 
 
 
2 2 2 0 0 
NeLM* pharm* on call 
 
2 2 1 1 1 
* Website no longer exists and was last searched in 2010; af = all fields.  
 
One additional source of evidence was identified via personal communication, in 
addition to the 14 hits for ‘on-call pharmacy services’.  
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APPENDIX 3 Online survey question development  
No. Question Answer Options Linked  objective Justification Notes 
A 
Please enter your 
unique code 
Contained in the email I 
send to the Chief 
Pharmacist 
N/A Each respondent 
will be assigned a 
unique code that 
the respondent 
enters at the 
beginning. This 
key would be kept 
by researcher 
securely and 
separate to the 
study.  
  
1 
What type of Trust 
do you work for? 
Acute hospital trust, 
mental health trust (only 
one option) 
1 Enable separation 
of data for acute 
hospital and 
mental health 
trusts.  
GO to 2 
2 
How many beds are 
in your Trust? 
Free text box 1 Provides data 
about size of 
hospital. If local 
population data 
needed, this can 
be obtained from 
Trust websites. 
Delivery of service 
may be linked with 
size of Trust/local 
population. 
GO to 3 
3 
Does your 
department provide 
an on-call pharmacy 
service to 
secondary care 
healthcare 
professionals? 
Yes, No 1 Pivotal to the 
survey 
Yes 
GO to 
5, No 
GO to 4 
4 
If response to 
Question 3 is NO: 
Please explain why 
your department 
does not provide an 
on-call pharmacy 
service to 
secondary care 
healthcare 
professionals. 
Free text 
1 
Pivotal to the 
survey 
GO TO 
44 
5 
Please indicate the 
number of 
pharmacists in each 
of the Agenda for 
Change banding 
that provide your 
on-call pharmacy 
service (you can tick 
more than one 
option) 
List of bands: 6, 7, 8A, 
8B, 8C, 8D, 9 with a tick 
box next to each 
banding 
1 
Identify the 
different 
experiences of 
staff providing this 
service 
GO to 6 
6 
What route(s) are 
available to 
secondary care 
healthcare 
professionals for 
them to contact your 
on-call 
pharmacists? (You 
can select more 
than one option) 
Landline, mobile phone 
(calls), mobile phone 
(text), email, 
bleep/radio-pager, other 
(please specify) 1, 2, 5 
Contributes to 
understanding of 
accessibility by 
HCPs who may 
use or not use the 
service and their 
perceptions 
Go to 7 
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No. Question Answer Options Linked  objective Justification Notes 
7 
Do you advertise 
your on-call 
pharmacy service to 
secondary care 
healthcare 
professionals? 
Yes, No (only one 
option) 
1 
Contributes to 
awareness of 
HCPs who may 
use or not use the 
service and their 
perceptions 
Yes 
GO to 
8, No 
GO to 
10 
8 
If response is YES 
to Question 7: How 
is your on-call 
pharmacy service 
advertised/promoted 
to secondary care 
healthcare 
professionals? (You 
can select more 
than one option) 
Via the: Internet, 
intranet, sticker on 
BNF, notices on 
wards/clinical areas, 
other (please specify) 
(can choose more than 
one option) 
1, 6 
Feeds into 
objective Identify 
the perceptions of 
secondary care 
healthcare 
professionals 
about the current 
provision of 
medicines advice 
by pharmacy out of 
hours services. 
GO to 9 
9 
What aspects of the 
on-call pharmacy 
service do you 
advertise to 
secondary care 
healthcare 
professionals? (You 
can select more 
than one option) 
Contact name(s) of on-
call pharmacists, 
contact telephone 
number(s) for on-call 
pharmacists, services 
provided by on-call 
pharmacy service, other 
(please specify) 
1, 6 
Feeds into 
objective Identify 
the perceptions of 
secondary care 
healthcare 
professionals 
about the current 
provision of 
medicines advice 
by pharmacy out of 
hours services. 
GO to 
10 
10 
When not in the 
pharmacy 
department, where 
are your on-call 
pharmacists 
typically located? 
Home, hospital 
residency (only one 
option) 
1 
The number/type 
of enquiries may 
differ depending 
on whether on-call 
pharmacists are on 
site/offsite (i.e. 
accessibility) and 
also level of 
documentation 
may be dependent 
on this. 
GO TO 
11 
11 
What service(s) are 
provided by your on-
call pharmacists? 
(A) Supply of 
medicines, e.g. in-
patients, discharge; (B) 
Medicines Information 
advice, © Both (only 
one option) 
1 
Pivotal to the 
survey 
A = GO 
TO 12 
B = GO 
TO 13 
C = GO 
TO 13 
12 
As a department, do 
you record the total 
number of calls 
received by on-call 
pharmacists for the 
supply of 
medicines? 
Yes, No (choose one 
option) 
1 
Need to ask this 
before I can then 
ask questions 
about 
recording/numbers 
of calls involving 
advice. This will 
help identify the 
proportion of calls 
which involve 
advice. 
Yes = 
GO to 
14, No 
= GO 
to 16 
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No. Question Answer Options Linked  objective Justification Notes 
13 
As a department, do 
you record the total 
number of calls 
received by on-call 
pharmacists for the 
supply of 
medicines? 
Yes, No (choose one 
option) 
1 
Need to ask this 
before I can then 
ask questions 
about 
recording/numbers 
of calls involving 
advice. This will 
help identify the 
proportion of calls 
which involve 
advice. 
Yes = 
GO to 
15, No 
= GO 
to 17 
14 
How many calls 
about the supply of 
medicines, e.g. in-
patient supply, 
discharge supply, 
are received during 
a typical week by 
the on-call 
pharmacy service? 
< 10, 11 - 20, 21 - 30, 
31 - 40, 41 - 50, > 50 
1 
Need to ask this 
before I can then 
ask questions 
about 
recording/numbers 
of calls involving 
advice. This will 
help identify the 
proportion of calls 
which involve 
advice. 
GO TO 
44 
15 
As a department, 
how many calls 
about the supply of 
medicines, e.g. in-
patient supply, 
discharge supply, 
are received during 
a typical week by 
the on-call 
pharmacy service? 
< 10, 11 - 20, 21 - 30, 
31 - 40, 41 - 50, > 50 
1 
Need to ask this 
before I can then 
ask questions 
about 
recording/numbers 
of calls involving 
advice. This will 
help identify the 
proportion of calls 
which involve 
advice. 
GO to 
18 
16 
As a department, 
how many calls 
about the supply of 
medicines (e.g. in-
patient supply, 
discharge supply), 
in your opinion, are 
received during a 
typical week by the 
on-call pharmacy 
service? 
< 10, 11 - 20, 21 - 30, 
31 - 40, 41 - 50, > 50 
1 
Need to ask this 
before I can then 
ask questions 
about 
recording/numbers 
of calls involving 
advice (although 
subjective). This 
will help identify 
the proportion of 
calls which involve 
advice. 
GO TO 
44 
17 
As a department, 
how many calls 
about the supply of 
medicines (e.g. in-
patient supply, 
discharge supply), 
in your opinion, are 
received during a 
typical week by the 
on-call pharmacy 
service? 
< 10, 11 - 20, 21 - 30, 
31 - 40, 41 - 50, > 50 
1 
Need to ask this 
before I can then 
ask questions 
about 
recording/numbers 
of calls involving 
advice (although 
subjective). This 
will help identify 
the proportion of 
calls which involve 
advice. 
GO to 
18 
18 
As a department, do 
you keep a record 
of the total number 
of calls received by 
the on-call 
pharmacy service 
for medicines 
information advice? 
Yes, No (choose one 
option) 
1, 2 
Need to ask this 
before I can then 
ask questions 
about the numbers 
of calls involving 
advice. 
Yes = 
GO to 
19, NO 
= GO 
to 20 
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No. Question Answer Options Linked  objective Justification Notes 
19 
How many calls for 
medicines 
information advice 
are received during 
a typical week by 
the on-call 
pharmacy service? 
< 10, 11 - 20, 21 - 30, 
31 - 40, 41 - 50, > 50 
1, 2 
Will help find out 
the proportion of 
calls involving 
advice from the 
total number of 
calls. Will also help 
inform objective 7 
and 8 of study later 
on. 
GO to 
21 
20 
In your opinion, how 
many calls for 
medicines 
information advice 
are received during 
a typical week by 
the on-call 
pharmacy service? 
< 10, 11 - 20, 21 - 30, 
31 - 40, 41 - 50, > 50 
1, 2 
Will help find out 
the proportion of 
calls involving 
advice from the 
total number of 
calls (although 
subjective). Will 
also help inform 
objective 7 and 8 
of study later on. 
GO to 
21 
21 
Do you record the 
different types of 
secondary 
healthcare 
professionals that 
contact your on-call 
pharmacy service 
for medicines 
information advice? 
Yes, No (choose one 
option) 
1, 2, 5 
Need to ask this 
before I can then 
ask the next 
question (i.e. 
based on data or 
opinion) 
Yes = 
GO to 
22, No 
= GO 
to 23 
22 
Please rank the 
following secondary 
care healthcare 
professionals in 
order of the 
frequency in which 
they use your on-
call pharmacy 
service 
Senior hospital doctors, 
e.g. consultant, 
registrar; Junior hospital 
doctors, e.g. FY1, FY2; 
Hospital 
nurses/midwifes; Allied 
healthcare 
professionals, e.g. 
dieticians; Other 
(please specify) (can 
choose more than one 
option) 
5 
Based on available 
data, this will 
provide information 
about which 
secondary care 
healthcare 
professionals use 
their service for 
advice. This can 
be validated by 
methods used later 
on in the study 
(objective 7 and 8 
of study). 
GO to 
24 
23 
In your opinion, 
please rank the 
following secondary 
care healthcare 
professionals in 
order of the 
frequency in which 
they use your on-
call pharmacy 
service 
Senior hospital doctors, 
e.g. consultant, 
registrar; Junior hospital 
doctors, e.g. FY1, FY2; 
Hospital 
nurses/midwifes; Allied 
healthcare 
professionals, e.g. 
dieticians; Other 
(please specify) (can 
choose more than one 
option) 
5 
Subjective but 
gives an idea of 
who the chief 
pharmacists think 
use their service 
for advice. This 
can be validated 
by methods used 
later on in the 
study (objective 7 
and 8 of study).  
GO to 
24 
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No. Question Answer Options Linked  objective Justification Notes 
24 
Which of the 
following statements 
apply to your on-call 
pharmacy service: 
(A) A medicines 
information pharmacist 
is available for 
SUPPORT to on-call 
pharmacists when 
dealing with questions 
from secondary 
healthcare 
professionals for 
medicines information 
advice, (B) A on-call 
medicines information 
pharmacist ANSWERS 
ALL calls for medicines 
information advice from 
secondary care 
healthcare 
professionals; 
information advice, (C) 
A on-call medicines 
information pharmacist 
ANSWERS CERTAIN 
calls for medicines 
information advice from 
secondary care 
healthcare 
professionals; (D) A 
medicines information 
pharmacist is NOT 
available outside of 
normal working hours. 
1,2 
Would like to find 
out if a MI 
pharmacist is 
available for 
support to on-call 
pharmacists OR 
whether some 
hospitals use the 
MI pharmacist to 
answer ALL or 
CERTAIN 
medicines 
information advice 
questions 
A, B or 
D = GO 
TO 26, 
C = GO 
TO 25 
25 
Please can you 
describe the types 
of calls for 
medicines 
information advice 
that your on-call 
medicines 
information 
pharmacist 
answers. 
Free text 
1, 2 
If a MI pharmacist 
answers CERTAIN 
medicines 
information advice 
questions out of 
hours, it would be 
useful to find out 
what "certain" 
means. 
GO TO 
26 
26 
Do you have a 
standard Trust 
policy for the 
documentation of 
advice provided out 
of hours? 
Yes, No (only one 
option) 
2 
Will provide some 
idea at this stage 
of the way in which 
enquiries for 
advice OOH are 
handled and 
therefore help to 
inform objective 8 
of the project. 
YES = 
GO to 
27, NO 
= GO 
to 28 
27 
Please list the 
information that the 
hospital policy 
states should be 
documented by on-
call pharmacists 
when they handle 
calls for medicines 
information: 
Free text 
2 
  GO TO 
29 
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No. Question Answer Options Linked  objective Justification Notes 
28 
In your opinion, 
what information do 
you think should be 
documented by on-
call pharmacists 
when they provide 
advice out of hours 
to secondary care 
healthcare 
professionals? 
Time of call, Enquirer's 
name, Enquirer's job 
role, Enquirer's contact 
details, Enquirer's 
question, Resources 
searched by the on-call 
pharmacist, Information 
found in the resources 
by the on-call 
pharmacist, Medicines 
information advice 
provided by the on-call 
pharmacist, Other 
(please specify)  (can 
choose more than one 
option) 
2 
Will provide some 
idea of what chief 
pharmacists think 
should be 
documented by 
on-call 
pharmacists when 
they provide MI 
advice out of 
hours. This will 
help later stages of 
the study.  
GO to 
29 
29 
Which of the 
following statements 
apply to your on-call 
pharmacy service: 
(A) Medicines 
information advice is 
documented by on-call 
pharmacists ALL the 
time; (B) Medicines 
information advice is 
documented by on-call 
pharmacists SOME of 
the time; (C) Medicines 
information advice is 
NEVER documented by 
on-call pharmacists.  
2 
Documentation of 
advice important to 
find out as this will 
also help inform 
other objectives of 
the study later on. 
A = GO 
to 30, B 
= GO 
to 30, C 
= GO 
to 31 
30 
How is the 
medicines 
information advice 
provided by your on-
call pharmacists to 
secondary 
healthcare 
professionals 
currently 
documented? 
(A) A paper-based 
form, (B) MI department 
electronic enquiry 
answering database, 
(C) Non-MI department 
electronic-based 
form/database 
2 
Documentation of 
advice important to 
find out as this will 
also help inform 
other objectives of 
the study later on. 
GO TO 
32 
31 
Do your on-call 
pharmacists receive 
training specifically 
to handle questions 
for medicines 
information advice? 
Yes, No, Don't know 
(choose one option) 
1 
  YES = 
GO to 
32, NO 
= 33 
32 
What type(s) of 
training is provided 
to on-call 
pharmacists 
specifically to help 
them provide 
medicines 
information advice 
out of hours? 
No specific training 
should be provided to 
that received as part of 
the pharmacist's normal 
role, Communication 
skills, Use of MI 
Resources/Databases, 
Critical 
evaluation/interpretation 
of information/data, Use 
of I.T., Documentation 
of enquiries, Use of 
MiDatabank, 
questioning skills 
training, Mock 'on-call' 
scenarios, Other 
(please specify) (can 
choose more than one 
option) 
1 
If different 
grades/experience 
of staff are 
involved in the 
provision of advice 
OOH, this will help 
provide information 
about the training 
they receive 
GO to 
34 
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No. Question Answer Options Linked  objective Justification Notes 
33 
In your opinion, 
what type(s) of 
training should be 
provided to on-call 
pharmacists 
specifically to help 
them provide 
medicines 
information advice 
out of hours? 
No specific training 
should be provided to 
that received as part of 
the pharmacist's normal 
role, Communication 
skills, Use of MI 
Resources/Databases, 
Critical 
evaluation/interpretation 
of information/data, Use 
of I.T., Documentation 
of enquiries, Use of 
MiDatabank, 
questioning skills 
training, Mock 'on-call' 
scenarios, Other 
(please specify) (can 
choose more than one 
option) 
1 
If different 
grades/experience 
of staff are 
involved in the 
provision of advice 
OOH, this will help 
provide information 
about the training 
they receive 
GO to 
38 
34 
Who delivers this 
training to on-call 
pharmacists? 
MI department, Other 
pharmacy staff, Non-
Pharmacy staff, Non-
Trust staff 1 
Useful to find out if 
MI are directly 
involved in the 
training of 
pharmacists 
providing advice 
OOH 
GO to 
35 
35 
How is this training 
delivered to on-call 
pharmacists? 
1:1 training session, 
group training session, 
e-training 1 
Useful to compare 
how different 
pharmacies deliver 
this training 
GO to 
36 
36 
At what stage is this 
training delivered to 
on-call 
pharmacists? 
On induction of normal 
working hours role, on 
induction of joining the 
on-call rota, don't know 1 
Some hospitals 
may give just one-
off training and 
then no further 
training, MI is 
changing all the 
time. Should be 
updated regularly. 
GO to 
37 
37 
How often is this 
training for on-call 
pharmacists 
repeated? 
Every 12 months, every 
6 months, every 3 
months, Not at all 
1 
Some hospitals 
may give just one-
off training and 
then no further 
training, MI is 
changing all the 
time. Should be 
updated regularly. 
GO to 
38 
38 
Do your on-call 
pharmacists have 
access to 
information 
resources when 
dealing with 
questions for 
medicines 
information advice? 
Yes, No (only one 
option) 
1, 2 
A standard list of 
resources that on-
call pharmacists 
should have 
access to has 
been published by 
UKMi. This is to try 
and standardise 
access to 
information 
sources. 
Yes = 
GO to 
39, No 
= 40 
39 
Have these 
information 
resources been 
reviewed against 
the recommended 
list for out of hours 
access provided on 
the UKMi website? 
Yes, No, Don't know 
(choose one option) 
1, 2 
  GO to 
40 
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No. Question Answer Options Linked  objective Justification Notes 
40 
Can your on-call 
pharmacists access 
MiDatabank (or MI 
enquiry answering 
database) remotely, 
i.e. outside of the 
pharmacy 
department? 
Yes, No (only one 
option) 
1, 2 
MiDatabank is a 
useful resource 
during normal 
working hours. I 
believe it can also 
be useful OOH. 
YES = 
41, NO 
= GO 
TO 42 
41 
If response is YES: 
Can your on-call 
pharmacists access 
MiDatabank (or MI 
enquiry answering 
database) remotely, 
i.e. outside of the 
pharmacy 
department? 
Yes, No (only one 
option) 
1, 2 
MiDatabank is a 
useful resource 
during normal 
working hours. 
Some centres can 
access remotely. 
GO TO 
42 
42 
Would you like me 
to send you the 
results of this 
service evaluation? 
Yes, No 
N/A 
My hospital R&D 
Office suggested 
that I should offer 
this as an incentive 
for them answering 
the questionnaire. 
From the KEY I 
can work out which 
email address to 
send this to. 
GO TO 
42 
43 
In the future, I would 
like to interview on-
call pharmacists and 
secondary care 
healthcare 
professionals from 
various different 
hospitals. Would be 
happy for me to 
contact you about 
this in due course? 
Yes, No 
N/A 
From the KEY I 
can work out which 
chief pharmacist I 
can contact 
GO TO 
END 
END END END END END END 
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APPENDIX 4 On-call pharmacist interview schedule 
development 
 
On-call Pharmacist Interview question Research  
objective 
What do you think are the medicines information needs of doctors 
and nurses’ when working out of hours? How does this differ to 
normal working hours? 
2,3,4 
How do you go about answering questions for medicines advice 
when working out of hours?  How does this compare to the same 
question being asked during normal working hours? What barriers 
(if any) do you face? 
2,3,7 
What do you think about the way in which calls for medicines 
advice are handled out of hours by the pharmacy service? How 
does this compare to normal working hours?  
2,3,6 
Is there anything that you would change about the way pharmacy 
department provides medicines advice out of hours? What impact 
do you think 7 day working will have on the on-call pharmacy 
service? 
6 
What do you document when you handle calls for medicines advice 
out of hours? How would this compare to normal working hours  
7 
What affects what you document? Does this differ to normal 
working hours? 
7 
If you did document medicines advice, what would affect what you 
use to document, e.g. paper- or electronic-based form. 
7 
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APPENDIX 5 Doctor and nurse interview schedule development 
 
Doctor/Nurse Interview question Research 
objective 
1. What are the types of information or advice about medicines 
that you need to find when working out of hours?  
 
(If the interviewee replies ‘don’t know’ or struggles to answer this 
question, I would prompt with, 
 
Doctor: For example, have you ever needed some 
information/advice when you’ve been asked to prescribe a 
medicine for a patient? 
Nurse: For example, have you ever needed some 
information/advice when you have had to administer a medicine 
that a doctor has prescribed for a patient? 
2,4 
2. How does this compare to normal working hours? 2,4 
3. How do you access information on medicines when working out 
of hours?  
5 
3a. What sources would you typically use to find information on 
medicines out of hours? 
2,5 
3b. What barriers (if any) do you face when trying to access 
information on medicines out of hours? 
2,5 
4. How does this (question 3, 3a and 3b) compare during normal 
working hours? 
2,5 
5. Tell me what support does the pharmacy department provide 
you with during out of hours when you have questions related 
to medicines? 
a. Is there anything that you would change?  
b. How does this compare to normal working hrs? 
6 
6. Do you have anything else you would like to tell me? 
 
None 
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APPENDIX 6 University ethics approval (Online survey)  
 
The extract below has been taken from the University of Wolverhampton Behavioural  
Sciences Ethics Committee meeting minutes at which this research proposal was  
considered:  
 
 
SCHOOL OF APPLIED SCIENCES 
Behavioural Sciences Ethics Committee (BSEC) 
Minutes of the Behavioural Sciences Ethics Committee Meeting 
Wednesday 25th July 2012 at 2pm in MC124 
Present: Dr J Chen-Wilson, Prof K Manktelow (Chair), Dr N Morris, Dr P Rutter & Mrs J 
Williams (BSEC Administrator) 
1. Apologies: Dr C Brown, Dr D Chadwick and Dr W Nicholls 
 
 
 
4.4 Mr M Cheeseman (Dr P Rutter) 
 RES20A, “How can UK Medicines Information (UKM) better support healthcare 
 professionals providing a 24/7 NHS service in England?” 
1. Appendix A, On-Line Survey (1) Q12 – This is rather vague, and could be better 
worded. Does it relate to the out of hours service?  The investigator is advised to use 
“provide name and the services you offer” or a similar description; and (2) Q13 – 
Again, this could be better phrased. Suggest “where are your pharmacists based?” 
or similar. 
 Supervisor to monitor 
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APPENDIX 7 Email invitation to participate in the online survey 
pilot 
 
Dear [insert individual’s name], 
 
I am carrying out a study as part of my PhD research project at the University of 
Wolverhampton. This study is being supervised by Professor Paul Rutter and Professor 
Ray Fitzpatrick. 
 
The objectives of this first phase are to identify the way in which hospital pharmacies in 
NHS England provide out of hours services and how calls for medicines advice are handled 
during this time.  
 
As discussed, I am inviting you to pilot an online survey that Chief Pharmacists will 
be asked to complete. It should take participants no more than 10 minutes to complete.   
 
If you are willing to participate in this pilot, I would be grateful if you could try completing the 
survey more than once, selecting different answers to questions so that I may find out: 
 
• Did you understand the information sheet/consent form attached to this email? 
• Did you understand the consent form at the start of the survey? 
• Did the survey work for you? i.e. technical functionality  
• Did you understand the questions asked within the survey?  
 
If your answer is ‘no’ to any of the above questions, please email me directly with your 
reasons. 
 
The information you provide will only be identifiable by the investigator and my supervisors. 
No data you provide will be identifiable in any reports or publications.  No data that you 
input into the survey will be used as part of the final dataset. 
 
You will be asked at the beginning of the survey to enter your Unique Identifier Number 
(UIN) which is [insert a UIN for the pilot, e.g. P100]. 
 
The survey can be found at https://www.surveymonkey.com/s/QGYVB5X. I would be 
extremely grateful if you did not share or discuss the contents of this survey with anyone 
else at this stage. 
 
Finally, I would be grateful if you could complete this by 29th August 2012. 
 
If you require any further information, please do not hesitate to contact me.  
 
183 
 
APPENDIX 8 Information sheet for online survey  
 
How can UK Medicines Information (UKMI) better support healthcare 
professionals providing a 24/7 NHS service in England?  
 
Dear [insert Chief Pharmacist’s name] 
   
I would like to invite you to take part in a study which I am carrying out as part of my 
PhD research project at the University of Wolverhampton. This study is being 
supervised by Professor Paul Rutter and Professor Ray Fitzpatrick. 
 
The objectives of this first phase are to identify the way in which hospital pharmacies in 
NHS England provide out of hours services and how calls for medicines advice are 
handled during this time.  
 
Participating in this study will involve you completing an online survey which should 
take no more than 10 minutes to complete.  
 
The information you provide will only be identifiable by me, the investigator, and my 
supervisors. No data you provide will be identifiable in any reports or publications.  The 
information sheet provided at the beginning of the online survey gives more details 
about the study.  
 
You will be asked at the beginning of the survey to enter your Unique Identifier Number 
(UIN) which is [insert UIN for the Chief Pharmacist]. 
 
If you would like me to email you a copy of the results, please indicate this when asked 
at the end of this survey. 
 
The survey can be found at [insert hyperlink to survey] or you can copy this link and 
paste into your web browser. You will be asked to read an information sheet and give 
your consent before participating in this study. 
 
If you require any further information, please do not hesitate to contact either myself or 
my supervisors via email or telephone. Contact details are also provided in the 
information sheet.  
 
Many thanks for your time. 
 
Yours sincerely, 
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APPENDIX 9 Online survey pilot 
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APPENDIX 10 Comments received about the pilot online survey 
questions and actions taken  
 
UIN Comment Action taken 
P100 
 
Q9 has a tick box for ‘others’ and a text box for 
comments – if you tick others and do not enter 
comments you are prompted to do so.  
 
No action needed. If other is 
ticked, then yes comments are 
needed. 
Q10, Q21, Q23, Q24 Also have text boxes with 
‘others’ above the box but if no comments are 
entered you are not prompted to do so. Should 
Q10, 21, 23 and 24 have a tick box for others? 
A tick box for ‘others’ added to 
Q10, 21, 23 and 24. 
P400 
Q17 In the question how many calls in an average 
week questions would it be better for the user to 
input a figure into this box. 
No amendment required. 
Q18 Please state which healthcare professionals 
use your on-call pharmacy service (rank 1 - 4, with 
1 the greatest users and 4 the lowest users): I 
wanted to give a value for users who never use 
the service should there be a zero value. (in some 
trusts the OOH service for advice may only 
advertised to doctors therefore only they use it and 
nobody else) 
No further action needed as this 
is not a forced question. 
P700 
2nd page - big box to enter my unique code - 
might make participants think they need to put in 
something else 
Cannot restrict box to 3 
numerical characters. Have 
amended question to "Please 
enter your unique 3-digit code 
(see letter/email containing link 
to this survey) 
Q18 - you ask, 'In your opinion which healthcare 
professional use the service?' Is it possible that 
some places may collect this data and so know 
the answers more accurately? 
User has not understood that 
this option is only for those who 
do not know this data. No action 
needed. 
Question 20 - if they have such a policy - would it 
be helpful for you to see a copy - is it worth asking 
them to send you one? 
No action needed at this stage. 
Maybe something to ask later 
on in study. 
Q22 asks how often MI advice given by on call 
pharmacists is documented - if you say never the 
next question still asks you how it is documented 
Investigated - this routes to the 
next correct question. I do not 
know why the piloter 
experienced this. 
Q23 - is it possible that advice is recorded on 
paper at the time and then transferred to an 
electronic system subsequently? 
Question amended to find out 
where the advice is documented 
at the time of a call 
Q25 - you can pick 'No specific training is 
provided' and other options for what training is 
provided. There's no tick box for other - just the 
box for the detail 
Tick box for other amended. 
Options have to remain. 
P800 
Q7 Asks about how can you contact on call 
pharmacist. Possible that you might get the wrong 
info. For example, you have to go via a landline to 
get the switchboard operator but after that the 
operator has various ways of contacting 
them. what do you want to know?? 
Amended question to include 
'directly or via hospital 
switchboard/bedsite team' 
Q10 Is there any merit in splitting this question to 
reflect if the on-call service provides inpatient 
supply and outpatient supply or in patient only?? 
Beyond the scope of this 
research. No further action 
needed. 
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UIN Comment Action taken 
P800 
Q18 When you rank users on a scale of 1 -4 you 
are able to not rank a group and proceed. by 
default, does this mean the group does not use 
the service?? chance that person completing the 
survey will make an accidental omission. 
No further action needed. 
Q25 You can select "no specific training is 
provided" then proceed to select what training is 
provided. you could collect inaccurate data here? 
Options have to remain like this. 
No further action needed. 
Q32 Please describe type of question the on call 
meds info pharmacist would answer would a Chief 
Pharmacist know this? as it is free text would 
whoever is completing just give a few examples 
and move on. could you miss some data capture 
here?? 
Limitation of survey. No further 
action needed. 
P900 
Q4 How accurate an answer do you need? Could 
you do this as tick boxes with options in ranges 1-
500, 500-1000, 1000+, 3000+ 
Added a similar scale based on 
data found from a search of 
different hospitals via Google 
Q16 I did not realise that I was ranking in order 
until it would not let me rank two categories as 
3.  (i.e. survey will only allow you to rank one 
category with 1 number) Was this intentional? 
Does this need to be explained for bears of small 
brain, like myself. 
No further action needed. 
Q17 Is a compulsory question.  Information 
summary at beginning of survey states that if you 
do not want to answer a question you do not have 
to give one. However, if you try and avoid Q 17 
survey demands an answer in red. You may want 
to make it clear in your information summary that 
some questions are compulsory. 
Information sheet reworded as 
agreed with supervisor. 
Q19, Q22, Q23 give you the option to answer by 
typing in a text box headed other. There is no tick 
box for other. If you type text in the text box and 
do not tick anything. Survey does not think you 
have answered the question and for some of these 
because they are compulsory, it demands an 
answer in red. Again, this may be intentional and 
only a problem when coming up against bears of 
small brain like myself. I think Q7 is formatted 
correctly with both a tick box for other and a text 
box for associated comment. 
Amended. 
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APPENDIX 11 General comments received about the pilot 
online survey and actions taken 
 
UIN Comment Action taken 
P100 
At the end you ask if people will be willing to 
participate in future interviews, but you do not take 
any contact details – is this because you will know 
who replies have come from? Does this mean that 
the survey is not anonymised? Would people be 
put off by this? 
I have contact details in the 
KEY if I need to go back to the 
Trust. Would assume that Chief 
Pharmacist knows if he/she has 
delegated responsibility. 
P100 
I didn’t time myself so I’m not sure how long I took 
to answer the questions. I wonder in a large trust 
how many Chief Pharmacists would be able to 
answer these questions (30 seems quite a lot and 
some are very MI specific) in 10 minutes. For 
example, would [Chief Pharmacist] know in 
[hospital] whether we have all the right MI 
resources as per the UKMI list? Is it possible to 
part complete the survey and go back to it if you 
need to find out information? 
Achieved. 
P100 
I don’t seem to be able to log back into the survey 
and do it again – I’ll try from home tonight 
No action needed - resolved at 
start of pilot after this initial 
feedback to allow multiple log-
on from same PC. 
P500 
I tried out your survey a few times, tried lots of 
combinations! Everything was working fine, the 
only thing I wanted to mention is that the survey 
allowed you to leave some of the questions blank 
and then move onto the next page, I wasn’t sure if 
this was intentional? 
Ethics submission required that 
questions were not forced. No 
further action needed. 
P700 
In your covering e-mail to me you refer to Paul 
Rutter as 'Professor' but in the attached information 
sheet you have him as 'Dr'. 
Amend covering letter.  
P700 
 2nd paragraph on information sheet you have 
'objectives.....is' presumably should be 'objectives 
....are' 
Amend information sheet.  
P700 
4th paragraph on information sheet - you say 
information will only be identifiable 'by the 
investigator and my supervisors' - as you are the 
investigator and it's your name at the bottom of the 
sheet couldn't you say 'by myself and my 
supervisors'? 
Amend information sheet. 
P700 
4th paragraph - you say there's an information 
sheet at the beginning of the online survey but I 
thought what I was reading was the information 
sheet - are there 2 - if so, suggest different 
terminology to avoid confusion 
No further action needed. 
P700 
Couldn't use link in e-mail below - had to copy and 
paste into search on new page 
Amend letter to say if hyperlink 
does not open, copy and paste 
link and insert into web 
browser.  
P700 
Survey - not sure about capitals for headings Cannot change - limitation of 
online form. No further action 
needed. 
P700 
1st page - Reasons for conducting the study - here 
you describe as aims what you had as objectives in 
the information sheet 
"Aims" changed to "objectives" 
for consistency. 
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UIN Comment Action taken 
P700 
1st page - you don't say that the participant can 
have a copy of the results of the survey although 
you offer this in the information sheet 
This is offered at the end of the 
survey. No further action 
needed. 
P800 
The participant covering email/ postal letter refers 
to Dr Paul Rutter whereas email refers to Professor 
Paul Rutter 
Amend letter/online survey.  
P800 The first page of electronic survey has a title 
referring to OOH pharmacy services. As this is the 
start should it be in full i.e. Out Of Hours ?? 
Title changed.  
P800 Does this survey need to go to Chief Pharmacists. 
would clinical pharmacy service managers or 
equivalent be able to provide more accurate 
answers?? Are you expecting Chief Pharmacists to 
delegate this down??  could this be expressed in 
the covering letter?? 
Chief Pharmacists first point of 
contact. No other way of 
identifying leads in each acute 
or mental health trust 
pharmacy.  
P800 Some questions ask if you record number of 
enquiries etc. the next question is the same if you 
answer yes or no to the previous question and asks 
for their "opinion" on numbers. this would be ok if 
you answered no but if they answered yes they 
could provide a more accurate answer. 
Checked. No further action 
needed. 
P800 On the intro page of the survey all the headings are 
in block capitals. is that ok??  purely a style thing!! 
Limitation of survey. No further 
action needed. 
P800 it was an easy survey to complete and the Survey 
Monkey format is straightforward and easy to use. 
N/A 
P900 
Overall: very good. Also see comments on 
information sheet (file P900Informationsheet) 
Agreed. Make change to letter 
as suggested, i.e. move 
sentence "If you would like me 
to email you a copy of the 
results, please indicate this 
when asked at the end of this 
survey" to the end of the letter.  
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APPENDIX 12 Invitation (letter/email) to Chief Pharmacists to 
participate in the online survey  
 
How can UK Medicines Information (UKMI) better support healthcare 
professionals providing a 24/7 NHS service in England?  
Dear Ms/Mr [insert individual’s surname], 
I would like to invite you to take part in a study which I am carrying out as part of my PhD 
research project at the University of Wolverhampton. This study is being supervised by 
Professor Paul Rutter and Professor Ray Fitzpatrick. 
The objectives of this first phase are to identify the way in which hospital pharmacies in 
NHS England provide out of hours services and how calls for medicines advice are 
handled during this time.  
Participating in this study will involve you completing an online survey which should take 
no more than 10 minutes to complete.  
The information you provide will only be identifiable by me, the investigator, and my 
supervisors. No data you provide will be identifiable in any reports or publications.  The 
information sheet provided at the beginning of the online survey gives more details about 
the study.  
You will be asked at the beginning of the survey to enter your Unique Identifier Number 
(UIN) which is XXXX. 
The survey can be found at https://www.surveymonkey.com/s/8R7LQLJ or you can copy 
this link and paste into your web browser. You will be asked to read an information sheet 
and give your consent before participating in this study. 
If you would like me to email you a copy of the results, please indicate this when asked 
at the end of this survey. 
If you require any further information, please do not hesitate to contact either myself or 
my supervisors via email or telephone. Contact details are also provided in the 
information sheet.  
Many thanks for your time. 
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APPENDIX 13 Online survey  
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APPENDIX 14 University ethics approval (semi-structured 
interviews)  
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APPENDIX 15 Email to Chief Pharmacist to pilot on-call 
pharmacist interview schedule  
 
Dear [name], 
 
Thank you for completing the online survey that I sent you last year which was the first 
stage of my PhD research project. At the end of that survey you agreed that I could contact 
you in due course about the next phase. 
 
I am now about to start the next stage of my PhD project with the University of 
Wolverhampton. The objectives of this next stage are to: 
 
• Identify the perceptions of on-call pharmacists about the medicines advice they provide 
out of hours. 
• Identify the medicines information needs of nurses and doctors when working out of 
hours. 
• Identify how on-call pharmacists, nurses and doctors access information when needing 
medicines advice out of hours. 
• Identify the perceptions of on-call pharmacists, nurses and doctors about the current 
provision of medicines advice by pharmacy out of hours services. 
• Identify what would affect when and what on-call pharmacists document when 
providing medicines advice out of hours. 
  
I wondered if you would allow me to conduct pilot face-to-face semi-structured interviews 
with your on-call pharmacists. 
 
The information provided by the on-call pharmacists will only be identifiable by myself and 
my supervisors. No data that they provide including anything about the [hospital] will be 
identifiable in any reports or publications. 
 
If you would be happy for me to conduct pilot face-to-face semi-structured interviews in 
your pharmacy department, I would be very grateful if you could email me the names and 
contact details of your on-call pharmacists. I will then contact each one providing them 
with information about the study. They will be asked if they are interested in participating 
and if they are, be asked to provide the most appropriate days(s) and time(s) for when they 
would be available to take part in an interview. 
 
If you would like me to email you a copy of the results once this phase of the study is 
completed, please let me know. 
 
If you require any further information, please do not hesitate to contact either myself or my 
supervisors via email or telephone. 
 
Many thanks for your time. 
 
Yours sincerely, 
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APPENDIX 16 Information sheet for on-call pharmacists 
Reasons for conducting the study 
I am carrying out this service evaluation as part of my PhD research project at the University of 
Wolverhampton. The aims are to find out the perceptions of hospital on-call pharmacists’, doctors’ 
and nurses’ needs, access and provision of medicines advice out of hours. 
Why have I been chosen? 
I am seeking the opinions of on-call pharmacists.  
Do I have to be involved? 
No – it is your decision whether you want to be involved in the study. Before agreeing to participate 
in an interview you will be asked for written consent. Even after agreeing to take part in an 
interview you can choose to withdraw at any time without giving a reason. 
Benefits of taking part of benefits of the study 
There are no intended personal benefits. The information obtained will however, help to contribute 
to understanding how UK medicines information (UKMi) services usually based in hospital 
pharmacy departments can better support healthcare professionals providing a 24/7 NHS service 
in England. 
If you decide to take part, you will be contacted to participate in an interview which should take 
no more than one hour to complete. Depending on the number of pharmacists agreeing to take 
part, it is possible that you will not need to be interviewed. 
What will happen if I decide not to take part?  
I would like to thank you for taking the time to read this information. No further action is needed 
on your part.  
What will happen to the information I provide and confidentiality? 
All contact information and data from interviews will be confidential. Interviews will be digitally 
recorded and transcripts manually entered onto a qualitative software package (NVivo). This 
software will be used to analyse data but may be additionally analysed using other commercially 
available software. All data transferred onto software packages will be password protected and 
only accessed by the researcher and the supervisory team. Any information that could identify 
you will be coded or not be entered. Any quotes you give that are used in reports will be 
anonymised. Recordings of all interviews will be destroyed at the end of the study.  
Results of the study 
The results will be included in a final thesis submitted as part of the researcher’s PhD to the 
University of Wolverhampton. The results may be made available for a peer reviewed journal or 
conference. No individual results will be made available. 
What should I do now if I want to take part? 
If you would like to take part in the study, please email me with the most appropriate day(s) and 
time(s) of the week that you would be available for an interview within your organisation. You will 
be asked for written consent before the interview. 
Contact for further information 
If you have any questions about this study before deciding to take part, please contact the 
researcher Mark Cheeseman, either by telephone XXXX or email XXXX  
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APPENDIX 17 Consent form for semi-structured interviews 
Title of study:  How can UK Medicines Information (UKMI) better support healthcare 
professionals providing a 24/7 NHS service in England?  
 
Name of 
Researcher: Mark Cheeseman 
 
 
Thank you for reading the information sheet about this research project. If you would like to take 
part, please read and sign this form. 
Please initial the boxes if you agree with each statement 
1.  
 
I have read the information sheet for the above study and have been given 
a copy to keep. I have had the opportunity to consider the information, ask 
questions and have had these answered satisfactorily. 
 
2.  I understand that my participation is voluntary and that I am free to 
withdraw at any time without giving any reason. 
 
 
3.  I agree to my interview being audio recorded and I understand that 
transcripts of my interview will be anonymised. 
 
 
4.  I understand that the recording will be digitally stored until the end of the 
study whereupon it will be destroyed/deleted. 
 
 
5.  I understand that the information will be kept confidential. 
 
 
 
 
6.  I understand that I will not benefit financially from this study. 
 
 
 
 
7.  I know how to contact the researcher if I need to. 
 
 
 
8.  I agree to participate in this study 
 
 
 
 
   
Participant:  
name surname 
Date Signature 
Mark Cheeseman   
Researcher taking consent:  
name surname 
Date Signature 
One copy to participant and one copy to researcher 
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APPENDIX 18 Information sheet for doctors 
Reasons for conducting the study 
I am carrying out this service evaluation as part of my PhD research project at the University of 
Wolverhampton. The aims are to find out the perceptions of hospital on-call pharmacists’, 
doctors’ and nurses’ needs, access and provision of medicines advice out of hours. 
 
Why have I been chosen? 
I am seeking the opinions of doctors.  
 
Do I have to be involved? 
No – it is your decision whether you want to be involved in the study. Before agreeing to 
participate in the study you will be asked to give written consent. Even after agreeing to take 
part in the study you can choose to withdraw at any time without giving a reason. 
 
Benefits of taking part of benefits of the study 
There are no intended personal benefits. The information obtained will however, help to 
contribute to understanding how UK medicines information (UKMi) services usually based in 
hospital pharmacy departments can better support healthcare professionals providing a 24/7 
NHS service in England. 
 
If you decide to take part, you will be contacted to participate in an interview which should take 
no more than one hour to complete (subject to pilot). Depending on the number of doctors 
agreeing to take part, it is possible that you will not need to be interviewed. 
 
What will happen if I decide not to take part?  
I would like to thank you for taking the time to read this information. No further action is needed 
on your part.  
 
What will happen to the information I provide and confidentiality? 
All contact information and data from interviews will be confidential. Interviews will be digitally 
recorded and transcripts manually entered onto a qualitative software package (NVivo). This 
software will be used to analyse data but may be additionally analysed using other commercially 
available software. All data transferred onto software packages will be password protected and 
only accessed by the researcher and the supervisory team. Any information that could identify 
you will be coded or not be entered. Any quotes you give that are used in reports will be 
anonymised. Recordings of all interviews will be destroyed at the end of the study.  
 
Results of the study 
The results will be included in a final thesis submitted as part of the researcher’s PhD to the 
University of Wolverhampton. The results may be made available for a peer reviewed journal or 
conference. No individual results will be made available. 
 
What should I do now if I want to take part? 
If you would like to take part in the study, please email me (XXXX) and provide any dates and 
times which would be suitable for me to conduct the interview with yourself within your 
organisation.  
 
Contact for further information 
If you have any questions about this study before deciding to take part, please contact the 
researcher Mark Cheeseman, either by telephone XXXX or email XXXX 
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APPENDIX 19 Reflective diary for interviews  
I thought I struck up a good rapport with interviewees before the start of the pilot 
interviews. Before the interviews started, I spoke to each interviewee without taking any 
notes about their background, e.g. how long they had worked at the organisation, their 
role at the Trust, and tried to use positive body language, i.e. arms not folded, smiled. 
The reason I did not take notes at this moment was to distinguish this initial discussion 
of putting the interviewees at ease with the actual interview.  
During all interviews I tried hard not to interrupt during the interviewee’s responses to 
questions. This seemed to work well during the first pilot pharmacist interview but less 
so during the second interview. Despite this, the conversation seemed to flow well. 
Interruption was not such an issue with subsequent interviews conducted with 
pharmacists, doctors and nurses and I believe this was because my confidence had 
developed by this point. 
During both pilot pharmacist interviews I used my iPad to view the interview schedule. 
However, because of the length of time between questions asked, the iPad kept turning 
itself off. This then meant I had to keep entering my password to turn the iPad back on 
and this led to some delay between questions. I was aware that this caused me to feel 
a little under pressure (despite trying hard not to show this to the interviewee) and it is 
not clear what impact this may have had on the interviewee. I therefore decided that for 
all future interviews with on-call pharmacists, doctors and nurses, I would take a printed 
copy of the interview schedule to avoid this happening again. This did mean that 
pauses related to technological issues was not a problem for all other interviews 
conducted. 
Both pilot pharmacist interviewees involved use of an office with windows (blinds were 
closed) located within the pharmacy department. I did not change the layout of the 
room and I was sat across a table from the interviewee. I did not notice any unusual 
body language and I attempted to reflect the body language of all interviewees as 
much as possible. Subsequent interviews with on-call pharmacists were conducted in 
an office within their hospital pharmacy department. One of these interviews 
experienced interruptions because it was an office in which other pharmacy staff had 
left personal belongings that they needed to collect. Whilst frustrating, this did not 
appear to be affect the manner in which the interviewee responded to questions. All 
interviews with doctors except one were conducted in their own offices, which I believe 
helped to put them at ease. During one of these interviews, there was a doctor’s 
colleague (another doctor) in the room working at their computer. I was conscious of 
their presence and also that this may have affected the responses given to my 
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questions. During this interview it did feel as though the consultant wanted to finish the 
conversation quickly. However, I made sure that I asked all of the questions and 
maintained the same approach used in other interviews. This required discipline from 
myself to ensure that I did not mirror this apparent notion of the interview finishing 
quickly. Another interview with a doctor had to be completed at the rear of the hospital 
restaurant because no other space had been secured. This was not ideal as it was 
particularly noisy at times, although this subsided as with continuation of the interview 
as the staff lunchtime was coming to an end. The interview was conducted in a corner 
of the restaurant which meant that the interviewee was less likely to be concerned 
about staff colleagues over-hearing the conversation. Interviews with most nurses were 
conducted in an office with the hospital pharmacy department and I am aware that this 
may have influenced their responses. One nurse interview was conducted within an 
office on the ward that they were working.  
I was aware that some interviewees knew me as a pharmacist and may have perceived 
me as such, rather than as a researcher. Although I tried to ensure that before, during 
and after the interviews I approached matters as a researcher, e.g. all correspondence 
included PhD researcher rather than Pharmacist, I am aware that this may have had an 
influence on interviewee’s behaviour. 
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APPENDIX 20 Letter/email to Chief Pharmacists requesting on-
call pharmacist contact details  
Dear [name] 
I am contacting you because you previously agreed for me to contact you about the next phase 
of this study which is part of my PhD research project at the University of Wolverhampton. This 
study is being supervised by Professors Paul Rutter and Ray Fitzpatrick. 
The objectives of this second phase are to: 
Identify the perceptions of on-call pharmacists about the medicines advice they provide out of 
hours. 
• Identify the medicines information needs of nurses and doctors when working out of hours. 
• Identify how on-call pharmacists, nurses and doctors access information when needing 
medicines advice out of hours. 
• Identify the perceptions of on-call pharmacists, nurses and doctors about the current 
provision of medicines advice by pharmacy out of hours services. 
• Identify what would affect when and what on-call pharmacists document when providing 
medicines advice out of hours. 
  
Participating in this study will involve your on-call pharmacists completing a face-to-face semi-
structured interview which should take no more than an hour to complete. Depending on the 
number of pharmacists agreeing to take part, it is possible that not all on-call pharmacists will 
need to be interviewed. 
I will also be contacting your medicines information (MI) pharmacist(s) in due course to recruit 
nurses and doctors that contact the service. These nurses and doctors will then be contacted by 
myself for the purpose of conducting a semi-structured interview. This will not create any 
significant increase in the MI service workload. 
The information provided by on-call pharmacists will only be identifiable by myself and my 
supervisors. No data that they provide including individual hospitals will be identifiable in any 
reports or publications.  
I would be very grateful if you could email me the names and contact details of your on-call 
pharmacists. I will then contact each one providing them with information about the study. 
They will be asked if they are interested in participating and if they are, be asked to provide the 
most appropriate days(s) and time(s) for when they would be available to take part in an 
interview. 
If you would like me to email you a copy of the results from this phase of the study, please let 
me know. 
If you require any further information, please do not hesitate to contact either myself or my 
supervisors via email or telephone. 
Many thanks for your time. 
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APPENDIX 21 Letter/email to on-call pharmacists 
Dear [name],  
 
I am contacting you because your Chief Pharmacist [name] has agreed for me to contact 
you.  
 
I would like to invite you to take part in a study which I am carrying out as part of my PhD 
research project at the University of Wolverhampton. This study is being supervised by 
Professors Paul Rutter and Ray Fitzpatrick. 
 
The objectives of this second phase are to: 
 
• Identify the perceptions of on-call pharmacists about the medicines advice they provide 
out of hours. 
• Identify the medicines information needs of nurses and doctors when working out of 
hours. 
• Identify how on-call pharmacists, nurses and doctors access information when needing 
medicines advice out of hours. 
• Identify the perceptions of on-call pharmacists, nurses and doctors about the current 
provision of medicines advice by pharmacy out of hours services. 
• Identify what would affect when and what on-call pharmacists document when 
providing medicines advice out of hours. 
 
Participating in this study will involve a face-to-face semi-structured interview with myself at 
your place of work. The interview should take no more than one hour to complete. 
Depending on the number of pharmacists agreeing to take part, it is possible that you will 
not need to be interviewed. 
 
The information you provide will only be identifiable by the myself and my supervisors. No 
data that you provide will be identifiable in any reports or publications.   
 
If you would like to participate in this study, please email me the most appropriate day(s) 
and time(s) that you would be available. An information sheet is enclosed and gives more 
details about the study. Before the interview takes place you will be asked to give your 
consent in taking part in the study. 
 
If you require any further information, please do not hesitate to contact either myself or my 
supervisors via email or telephone. Contact details are also provided in the information 
sheet.  
 
Yours sincerely, 
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APPENDIX 22 Interview schedule for on-call pharmacists  
 
1. What do you think are the medicines information needs of doctors and nurses’ 
when working out of hours?  
 
2. How does this differ to normal working hours? 
 
3. How do you go about answering questions for medicines advice when working out 
of hours?   
 
4. How does this compare to the same question being asked during normal working 
hours?  
 
5. What barriers (if any) do you face? 
 
6. What do you think about the way in which calls for medicines advice are handled 
out of hours by the pharmacy service?  
 
7. How does this compare to normal working hours?  
 
8. Is there anything that you would change about the way pharmacy departments 
provide medicines advice out of hours? 
 
9. What impact do you think 7 day working will have on on-call pharmacy services? 
 
10. What do you document when you handle calls for medicines advice out of hours?  
 
11. What affects what you document? 
 
12. What affects what you use to document medicines advice calls? I.e. Paper, 
electronic 
 
13. How would this compare to normal working hours? 
 
14. What are your views on the training that on-call pharmacists receive specifically to 
help them handle medicines advice calls? 
 
15. Do you have anything else you would like to tell me? 
 
END 
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APPENDIX 23 Letter to MD/DoN/R&D 
 
How can UK Medicines Information (UKMI) better support healthcare 
professionals providing a 24/7 NHS service in England?  
Dear [name], 
I would like to inform you of a study which I am carrying out as part of my PhD research 
project at the University of Wolverhampton. This study is being supervised by Professors 
Paul Rutter and Ray Fitzpatrick. 
The objectives of this study are to: 
• Identify the perceptions of on-call pharmacists about the medicines advice they provide 
out of hours. 
• Identify the medicines information needs of nurses and doctors when working out of 
hours. 
• Identify how on-call pharmacists, nurses and doctors access information when needing 
medicines advice out of hours. 
• Identify the perceptions of on-call pharmacists, nurses and doctors about the current 
provision of medicines advice by pharmacy out of hours services. 
• Identify what would affect when and what on-call pharmacists document when 
providing medicines advice out of hours. 
 
The participation of doctors and nurses in this study will involve a face-to-face semi-
structured interview with myself at their place of work. The interview should take no more 
than one hour to complete (subject to pilot). 
I would be extremely grateful if you could display and/or circulate the enclosed 
poster within your organisation as you see fit to help me recruit doctors and nurses.  
Doctors and nurses may also be asked if they would like to participate in this study if they 
contact the pharmacy department for medicines advice during normal working hours. 
Depending on the number of nurses and doctors agreeing to take part, it is possible that 
not all of them will need to be interviewed. 
The information they provide will only be identifiable by myself and my supervisors. No data 
that they provide will be identifiable in any reports or publications.   
If you require any further information, please do not hesitate to contact either myself or my 
supervisors via email or telephone. Contact details are also provided in the information 
sheet.  
Yours sincerely, 
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APPENDIX 24 Recruitment poster 
 
***Are you a doctor or a nurse? *** 
 
Do you work out of hours? 
 
Do you find yourself looking for advice or 
information about medicines out of 
hours?  
 
Do you need medicines advice out of 
hours? 
 
 
 
 
 
 
 
 
You are invited to participate in a research project. 
 
The aims are to find out the perceptions of hospital doctors’ and nurses’ needs, 
access and provision of medicines advice out of hours. 
 
 
You would be required to participate in ONE face-to-face interview within the 
organisation which will take no more than ONE hour to complete (subject to pilot). 
 
 
If you are interested in receiving more 
information regarding this study, please 
contact the researcher XXXX 
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APPENDIX 25 Email to MI services  
 
How can UK Medicines Information (UKMI) better support healthcare professionals 
providing a 24/7 NHS service in England?  
 
Dear [insert Medicines Information Pharmacist name], 
 
I would like to invite you to take part in a study which I am carrying out as part of my PhD 
research project at the University of Wolverhampton. This study is being supervised by 
Professors Paul Rutter and Ray Fitzpatrick. 
 
The objectives of this study are to: 
 
• Identify the perceptions of on-call pharmacists about the medicines advice they provide 
out of hours. 
• Identify the medicines information needs of nurses and doctors when working out of 
hours. 
• Identify how on-call pharmacists, nurses and doctors access information when needing 
medicines advice out of hours. 
• Identify the perceptions of on-call pharmacists, nurses and doctors about the current 
provision of medicines advice by pharmacy out of hours services. 
• Identify what would affect when and what on-call pharmacists document when 
providing medicines advice out of hours. 
 
I would like to recruit doctors and nurses to take part in a face-to-face semi-structured 
interview with myself within their organisation.  One of the ways I would like to recruit 
doctors and nurses is via your medicines information service. 
 
This will involve asking doctors and nurses from within your organisation if they would like 
to participate in this study. Recruitment will be over a 4 – 8 week period depending on 
numbers recruited. A ‘script’ will be provided for you to use. If the doctor/nurse is willing to 
be contacted by myself, their full name, job role, contact email and telephone number will 
need to be logged on a proforma which I will provide. At the end of the recruitment period 
you will need to email these details to me (via secure email).  
 
Please let me know if you would be willing to participate in this study. 
  
If you require any further information, please do not hesitate to contact either myself or my 
supervisors via email or telephone. Contact details are also provided in the information 
sheet.  
 
Yours sincerely, 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
231 
 
APPENDIX 26 Script and template for MI services  
Data collection form for MI pharmacists from ____________ to ____________ 
 
Medicines Information script for recruiting doctors/nurses when they contact service: 
 
A research project is aiming to find out what doctors and nurses’ think their medicines 
information needs are when working out of hours and how they deal with such questions.  
 
This would involve a short face-to-face interview here in the hospital, lasting no more than 
one hour at a day and time of your convenience. Any information you provide in the interview 
will be treated anonymously.  
 
If you would like to participate in an interview, then I need to record your name, email address 
and contact telephone number.  
 
My colleague will then contact you in due course. You can withdraw from participating in the 
interview at any stage. 
 
If the doctor or nurse consents to be contacted, please complete all sections where 
possible 
No. Consent 
(please 
tick) 
Full name of doctor/nurse Job Role 
(please tick) 
Contact details 
Y N  Nurse Doctor Email Tel No. 
1     
    
2     
    
3     
    
4     
    
5     
    
6     
    
7     
    
8     
    
9     
    
10     
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APPENDIX 27 Email to doctors and nurses who expressed an 
interest to participate  
 
Dear [name], 
Thank you for expressing an interest when you contacted your hospital medicines 
information service to participate in this study. 
Please find attached an information sheet about the study. 
If you are still interested in participating in this study, I would be grateful if you could let 
me know what day(s) and time(s) of the week would be best for me to conduct the 
interview.  
The interview would take place at your hospital and we would need a room/venue that 
allows the interview to be recorded clearly. 
I look forward to hearing from you soon. 
Yours sincerely, 
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APPENDIX 28 Information sheet for nurses  
Reasons for conducting the study 
I am carrying out this service evaluation as part of my PhD research project at the University of 
Wolverhampton. The aims are to find out the perceptions of hospital on-call pharmacists’, 
doctors’ and nurses’ needs, access and provision of medicines advice out of hours. 
 
Why have I been chosen? 
I am seeking the opinions of nurses.  
 
Do I have to be involved? 
No – it is your decision whether you want to be involved in the study. Before agreeing to 
participate in the study you will be asked to give written consent. Even after agreeing to take 
part in the study you can choose to withdraw at any time without giving a reason. 
 
Benefits of taking part of benefits of the study 
There are no intended personal benefits. The information obtained will however, help to 
contribute to understanding how UK medicines information (UKMi) services usually based in 
hospital pharmacy departments can better support healthcare professionals providing a 24/7 
NHS service in England. 
If you decide to take part, you will be contacted to participate in an interview which should take 
no more than one hour to complete (subject to pilot). Depending on the number of nurses 
agreeing to take part, it is possible that you will not need to be interviewed. 
 
What will happen if I decide not to take part?  
I would like to thank you for taking the time to read this information. No further action is needed 
on your part.  
 
What will happen to the information I provide and confidentiality? 
All contact information and data from interviews will be confidential. Interviews will be digitally 
recorded and transcripts manually entered onto a qualitative software package (NVivo). This 
software will be used to analyse data but may be additionally analysed using other commercially 
available software. All data transferred onto software packages will be password protected and 
only accessed by the researcher and the supervisory team. Any information that could identify 
you will be coded or not be entered. Any quotes you give that are used in reports will be 
anonymised. Recordings of all interviews will be destroyed at the end of the study.  
 
Results of the study 
The results will be included in a final thesis submitted as part of the researcher’s PhD to the 
University of Wolverhampton. The results may be made available for a peer reviewed journal or 
conference. No individual results will be made available. 
 
What should I do now if I want to take part? 
If you would like to take part in the study, please email me (XXXX) and provide any dates and 
times which would be suitable for me to conduct the interview with yourself within your 
organisation.  
 
Contact for further information 
If you have any questions about this study before deciding to take part, please contact the 
researcher Mark Cheeseman, either by telephone XXXX or email XXXX 
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APPENDIX 29 Interview schedule for doctors and nurses 
1. What are the types of information or advice about medicines that you need to find 
when working out of hours?  
(If the interviewee replies ‘don’t know’ or struggles to answer this question, I would 
prompt with, 
Doctor: For example, have you ever needed some information/advice when you’ve been 
asked to prescribe a medicine for a patient? 
Nurse: For example, have you ever needed some information/advice when you have 
had to administer a medicine that a doctor has prescribed for a patient? 
2. How does this compare to normal working hours? 
3. How do you access information on medicines when working out of hours?  
4. What sources would you typically use to find information on medicines out of hours? 
5. What barriers (if any) do you face when trying to access information on medicines 
out of hours? 
6. How does this (question 3, 3a and 3b) compare during normal working hours? 
7. Tell me what support does the pharmacy department provide you with during out of 
hours when you have questions related to medicines? 
a. Is there anything that you would change?  
b. How does this compare to normal working hrs? 
8. Do you have anything else you would like to tell me? 
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APPENDIX 30 Expressions of interest received from on-call 
pharmacists and those contacted to participate  
Trust 
(UIN) 
Number of expressions of interest (n=107) received from on-
call pharmacists to participate in semi-structured interviews 
Yes 
(n=30) 
No 
(n=2) 
None 
(n=75) 
223 4 0 11 
191 3 1 12 
253 2 0 6 
128 3 0 5 
225 6 0 15 
202 4 0 9 
311 3 0 6 
137 5 1 11 
 
Trust 
(UIN) 
Number of on-call pharmacists (n=30) contacted to participate 
in semi-structured interviews 
Contacted (n=12) Not contacted (n=18) 
223 2 2 
191 2 1 
253 0 2 
128 3 0 
225 1 5 
202 0 4 
311 1 2 
137 3 2 
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APPENDIX 31 Expressions of interest received from doctors 
and nurses via MI services or recruitment poster  
 
Trust (UIN) 
Number of expressions of interest received from doctors 
and nurses to participate in semi-structured interviews 
Recruitment poster (n=0) MI services (n=20) 
Yes No Yes No 
191 0 0 9 1 
128 0 0 10 0 
202 0 0 0 0 
137 0 0 N/A N/A 
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ABSTRACT
Objectives UK hospital pharmacy services have
historically been delivered during typical ‘office’ hours,
which include the provision of medicines advice via the
pharmacy’s medicines information department. Outside
office hours, an on-call service operates whereby
pharmacists handle requests for medicine supply and
advice. It is not known how this out-of-hours service
operates. The aim of this study was to quantify the
extent and scope of its provision across England.
Methods A piloted self-administered survey was sent
to every chief pharmacist in England representing acute
hospitals and mental health trusts (n=218).
Key findings Just over half (n=116/218, 53.2%) of
chief pharmacists returned a completed survey. Most
hospitals provided an on-call pharmacy service (87.1%,
n=101/116). Nearly all on-call pharmacy services
(91.1%, n=92/101) provided both supply of medication
and medicines advice. Two-thirds (66.2%) of
pharmacists who provided on-call services were junior.
The majority of trusts (83.1%, n=74/89) receive <20
calls for medicines advice per week. Hospital nurses/
midwives were seen as the most common users of the
on-call pharmacy service. Medicines advice was
documented by on-call pharmacists all (49.5%, n=47/
95) or some of the time (49.5%, n=47/95). Just under
half of trusts (41.1%, n=39/95) had a standard policy
for the documentation of medicines advice. Two-thirds
(66.7%, n=62/93) of respondents stated that advice was
documented using paper-based forms. Most trusts
(81.1%, n=77/95) provided training prior to pharmacists
being on-call, with medicines information pharmacists
involved in nearly 80% of cases (n=61/77) (respondents
could select more than one option).
Conclusions Medicines advice is an integral part of
the pharmacy on-call service, which was provided by
junior staff. Variability existed in resourcing the service
across trusts. In addition to existing standards for
documentation of medicines advice, professional
standards should be developed for on-call hospital
pharmacy service provision and training.
INTRODUCTION
The provision of UK hospital pharmacy services
has historically been delivered during typical
‘office’ hours, for example, 9:00–17:00. This is
increasingly at odds with the provision of services
by other areas of hospital practice, particularly
general medical and nursing services.1 Increasingly,
there is an expectation that pharmacy services
should extend their opening times, and although
some have achieved this, most continue to only
provide an on-call pharmacy service.2 3
In the UK, on-call is defined as a system that
exists as part of arrangements to provide appropri-
ate service cover across the National Health Service
(NHS). A member of staff, for example, a pharma-
cist, is on-call when, as part of an established
arrangement with their employer, they are available
outside their normal working hours—either at the
workplace (typically termed residency) or at home
—to work as and when required.4
Outside office hours, the on-call pharmacist
receives calls from other healthcare professionals,
usually within their organisation, that may involve
either the supply of medication or medicines
advice. On-call pharmacists are typically employed
from the pharmacy department of that hospital,
and their knowledge, experience and training in
medicines information (MI) can vary.
During normal working hours, a healthcare pro-
fessional can contact the hospital pharmacy MI
department for medicines advice. UK Medicines
Information (UKMi) is an NHS pharmacy-based
service provided by a network of >200 MI centres
based in the pharmacy departments of most hospi-
tals. The centres are mainly staffed by pharmacists
with particular skills in locating, assessing and
interpreting information about medicines handling
over a half a million enquiries each year during
normal office hours.5
Almost all UKMi research outputs have concen-
trated on enquiries received during normal office
hours; very little is known about what happens
outside these hours.6–8
It is not known how the provision of medicines
advice out of hours compares to normal office
hours, particularly as an MI pharmacist may not be
available during on-call periods. Therefore, the aim
of this study was to identify how hospital pharma-
cies in NHS England provide out-of-hours services
and how calls for medicines advice from healthcare
professionals are documented.
METHODS
A piloted self-administered survey was sent as a
hyperlink contained in an email and printed in a
postal letter to every chief pharmacist in England
representing acute and mental health trusts
(n=218) in October 2012. Each trust was assigned
a unique identification number to maintain ano-
nymity. The survey consisted of four sections:
section A asked for demographics of the organisa-
tion; section B quantified the provision of the
on-call pharmacy service; section C looked at the
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documentation of medicines advice questions; and section D
explored the training provided to pharmacists to help them
answer questions out of hours. Questions consisted of multiple
option, closed and open questions.
Returns were included for analysis up to 6 weeks from the
initial mailing. A reminder letter and email were sent to each
chief pharmacist approximately two weeks after the first posting
if they had not already replied. The survey data were transferred
and analysed using SPSS V.20. Quantitative data were subject to
basic descriptive statistics, for example, Pearson’s χ2 test.
Open-ended questions were subject to thematic analysis.
RESULTS
Just over half (n=116/218, 53.2%) of chief pharmacists
returned a completed survey. The majority of respondents were
from acute hospitals (76.7%, n=89/116 compared with 23.3%,
n=27/116 from mental health trusts). Response rates between
acute and mental health trusts were comparable (54.3% vs
50.0%). Hospital nurses/midwives were the most common users
of the on-call pharmacy service; junior doctors were second
highest users, followed by senior doctors and then allied health-
care professionals.
Provision of the on-call pharmacy service
Most hospitals provided an on-call pharmacy service (87.1%,
n=101/116); of these acute hospitals were the main providers
(86.1%, n=87/101). Nearly half of mental health trusts (48.1%,
n=13/27) did not provide an on-call pharmacy service but did
state a service-level agreement with another provider, for
example, local acute hospital, was in place in most cases. The
standard model of on-call services was for pharmacists to be at
home (94.1%, n=95/101), with just 10% (n=10/101) of phar-
macy services operating a residency programme (note that some
provided both models).
Those pharmacists involved in the provision of on-call ser-
vices are shown in table 1; two-thirds (66.2%) of the pharma-
cists were either band 6, 7 or 8a (see table 1 for definition of
bands). The majority of trusts (80%, n=76/95) did not routinely
have an on-call MI pharmacist available; seven trusts had a dedi-
cated on-call MI pharmacist that answered all calls for medicines
advice. However, a further 12 trusts did have an MI pharmacist
available out of hours to support the on-call pharmacist with
questions for medicines advice if necessary.
Nearly all on-call pharmacy services (91.1%, n=92/101) pro-
vided both supply of medication and medicines advice. Eight
trusts (7.9%) provided medicines advice only and one acute hos-
pital only supplied medication. Table 2 shows the number of
medicine advice calls handled in a typical week. Data suggest
that home-based on-call pharmacists handle a greater number of
medicine advice calls compared with resident pharmacists.
Table 3 shows the number of calls for medicines advice com-
pared with those for the supply of medication in a typical week.
The majority (83.1%, n=74/89) receive <20 calls for medicines
advice per week compared with 65.9% (n=56/85) for the
supply of medication. There are only a small number of trusts
(4.5%, n=4/89) that handle >50 calls per week for medicines
advice compared with nearly a fifth of trusts (17.6%, n=15/85)
handling the same number of calls per week for the supply of
medication.
Documentation of activity
Documentation of on-call pharmacist activity by trusts was high
for both supply of medication (94.6%, n=88/93) and for medi-
cines advice (91.8%, n=89/97). Just under half of the trusts
(41.1%, n=39/95), primarily acute hospitals, had a standard
policy for the documentation of medicines advice. Box 1 high-
lights the themed information received from chief pharmacists
regarding what their policies specified should be documented
out of hours.
For those trusts that did not have a policy, chief pharmacists
were asked what they thought should be documented out of
hours (see table 4).
A comparison between box 1 (themed policy standards) and
table 4 (chief pharmacists’ perceptions on documentation)
shows similarity, although policy standards expect that the
urgency of the answer required, patient details (where
Table 1 Job banding of pharmacists providing on-call services
Agenda for Change banding*
Number (%)†
n=101
Band 6 89 (21.9%)
Band 7 93 (22.9%)
Band 8a 87 (21.4%)
Band 8b 69 (17.0%)
Band 8c 35 (8.6%)
Band 8d 23 (5.7%)
Band 9 10 (2.5%)
*Agenda for Change is the pay system used within the National Health Service for all
staff (except doctors and dentists). Staff are placed in pay bands (bands 1–9) on the
basis of their knowledge, responsibility, skills and effort needed for the job. Newly
qualified pharmacists usually start at band 6, and typically chief pharmacists are
band 9.
†Respondents (n=101) were asked to indicate the Agenda for Change banding of
those pharmacists providing the on-call pharmacy service and so could select more
than one option.
Table 2 Location of the on-call pharmacist when not in the
hospital and number of medicines information advice calls
Location
Number of calls per week*†
n=92
≤20 >20
Residency 1 (12.5%) 2 (25%)
Home 44 (52%) 28 (34%)
*Respondents (n=92) could select more than option.†χ2=11.272, df=1, p=0.001.
Table 3 Comparison of the number of calls for supply of
medicines and medicines advice received during a typical week by
the on-call pharmacy service
Number of
calls
per week
Calls for supply of
medication
Calls for medicines
advice
Number of NHS
hospital trusts (%)
(n=85)
Number of NHS
hospital trusts (%)
(n=89)
<10 30 (35.3%) 45 (50.6%)
11–20 26 (30.6%) 29 (32.6%)
21–30 10 (11.8%) 4 (4.5%)
31–40 2 (2.4%) 5 (5.6%)
41–50 2 (2.4%) 2 (2.2%)
>50 15 (17.6%) 4 (4.5%)
NHS, National Health Service.
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appropriate), name of the pharmacist handling the calls and
follow-up to be documented. These were not identified by chief
pharmacists where policy standards do not exist.
Medicines advice was documented by on-call pharmacists all
(49.5%, n=47/95) or some of the time (49.5%, n=47/95). One
respondent claimed that medicines advice was never documented.
Two-thirds (66.7%, n=62/93) of the respondents stated that
advice was documented using paper-based forms, with nearly a
third (29%, n=27/93) using electronic-based forms or database
systems. More than half (57.9%, n=55/95) of trusts’ on-call
pharmacists had access to a bespoke database (MiDatabank) for
documenting medicines advice calls within their organisation,
and just over half of these (52.7%, 29/55) were able to access it
remotely when outside the organisation, yet recording directly
on to this database was very low (4.3%, n=4/93).
All on-call pharmacists had access to information resources to
enable them to answer requests for medicines advice.
Respondents were asked if their information resources had been
reviewed against a recommended list provided by UKMi.
In almost two-thirds of trusts (63.8%, n=60/94), this had been
done, although a fifth of respondents did not know if their
information resources had been reviewed against this recom-
mended list (21.3%, n=20/94).
Training provided to pharmacists to help them answer
questions out of hours
The majority of trusts (81.1%, n=77/95) provided specific train-
ing for on-call pharmacists to help them provide medicines
advice out of hours. Both MI (79.2%, n=61/77) and other
pharmacist staff (70.1%, n=54/77) delivered this training.
Although small numbers, all nine trusts’ resident pharmacists
received training compared with 79.8% (n=71/89) of trusts that
operated a home-based on-call service. Additionally, chief phar-
macists stated that before being put on-call, pharmacists should
spend time in the trust MI service and shadow or be buddied
with a senior colleague at the start of their on-call role. Table 5
shows the training provided compared with the training that
chief pharmacists felt should be provided. A small number of
chief pharmacists (44.4%, n=8/18) felt that no additional train-
ing was required (respondents could select more than one
option).
Nearly half (48.1%, n=37/77) of those trusts that provide
initial training never give any refresher training. Only 13.0%
(n=10/77) of trusts provide refresher training ranging from
every 3 to 12 months, which was generally identified through
staff appraisal. The remaining 38.9% (n=30/77) selected the
option other and submitted their own opinions. On-call phar-
macists trained by MI staff (57.4%, n=35/61) were more likely
to have their training refreshed compared with training pro-
vided by other pharmacy staff (44.4%, n=24/54, χ2=1.918,
df=1, p=0.166) but did not reach statistical significance.
DISCUSSION
This is the first study to investigate the provision of on-call phar-
macy services by acute hospital and mental health trusts in NHS
England that focuses on the provision of medicines advice. The
study found that on-call pharmacy services are almost univer-
sally provided by trusts through non-residency (home-based)
Box 1 Chief pharmacists’ thoughts on requirements to
documentation (data presented as themes drawn from 37
respondents)
▸ Time the enquiry was received
▸ Urgency of the answer required
▸ Date and time of the enquiry received
▸ Enquirer’s contact details (including name and role) and
location
▸ Patient’s details (where appropriate)
▸ Enquirer’s question
▸ Resources used to answer the enquiry
▸ Answer provided to the enquirer
▸ Name of the pharmacist handling the call
▸ Time taken to answer the enquiry and respond to the
enquirer
▸ Follow-up needed during normal working hours further to
the enquiry
Table 4 Chief pharmacists’ opinions (where no policy existed) on
the information that should be documented by on-call pharmacists
when providing advice out of hours to healthcare professionals
Number (%)*
n=56
Time of call 54 (13.1%)
Enquirer’s name 56 (13.6%)
Enquirer’s job role 52 (12.6%)
Enquirer’s contact details 50 (12.2%)
Enquirer’s question 55 (13.3%)
Resources searched 41 (10.0%)
Information found from resources accessed 35 (8.5%)
Medicines information advice provided 54 (13.1%)
Other† 15 (3.6%)
*Respondents (n=56) could select more than one type of information that should be
documented by on-call pharmacists.
†This included date/day that the enquiry was received, the amount of time it took the
on-call pharmacist to answer the enquiry and the reason for the enquiry.
Table 5 Provision of training to pharmacists before they begin
on-call specifically to help them provide medicines information (MI)
advice out of hours
Training
Training
provided by
trusts
Training that
should be
provided
Number (%)
n=77*
Number (%)
n=18*
No additional training should be
provided to that received as part of
the pharmacist’s ‘normal working
hours’ role
N/A 8 (13.4%)
Communication skills 25 (6.9%) 6 (10.0%)
Use of MI resources/databases 71 (19.8%) 12 (18.3%)
Critical evaluation/interpretation of
information/data
25 (6.9%) 6 (10.0%)
Use of information technology 54 (15.0%) 6 (10.0%)
Documentation of enquiries 53 (14.7%) 7 (11.7%)
Use of MiDatabank (MI electronic
enquiry answering database)
50 (13.9%) 5 (8.3%)
Questioning skills 33 (9.2%) 5 (8.3%)
Mock ‘on-call’ scenarios 33 (9.2%) 3 (5.0%)
Other (please specify) 16 (4.4%) 3 (5.0%)
*Respondents could select more than option.
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pharmacists and almost all trusts provide medicines advice. The
volume of calls for advice increased with the size of the organ-
isation, although this was less than that for medicine supply and
reflects the traditional model of on-call pharmacy services,
which have centred on medicine supply rather than advice.1
Hospital nurses were the most common users. This was
expected as they account for the largest staff group employed by
the NHS,9 and in an on-call situation there is typically less med-
ically qualified staff available, meaning nurses are more likely to
contact the on-call pharmacist for advice rather than a doctor.
This scenario may also explain why junior doctors were also
high users as fewer senior doctors are present at this time. In
normal working hours, it is common practice for junior doctors
to consult senior medical staff associated with prescribing
decisions.
The service was predominantly provided by relatively low
banded pharmacists (band 8A or lower) and suggests that as
pharmacists move up through the Agenda for Change banding
they are less likely to undertake on-call. This means that the
on-call service lacks senior (8B or higher) pharmacists participat-
ing in the service10 and implies that the knowledge, skills and
experience of pharmacists providing on-call services are less
than the pharmacy workforce during normal working hours.
Almost 50% of on-call staff were band 6 and 7 posts. These are
usually held by younger less experienced pharmacists who may
have limited skills and experience, which could affect the stand-
ard of medicines advice provided. While no empirical evidence
exists to support this view, data from medical literature have
shown that greater clinical experience is associated with better
diagnostic ability.11 It therefore seems reasonable that pharma-
cists with greater clinical experience will provide higher-quality
answers. This assumption is supported by the Department of
Health highlighting a specific role of MI departments to assist in
the safe and effective use of medicines ‘out of hours’.12 This
study was not designed to compare medicines advice provided
by pharmacists providing on-call services with that provided by
MI departments during ‘office hours’. This warrants further
research. What is known from these data though is that pharma-
cists had good access to information resources and most had
received training prior to starting on-call services. This should
provide some reassurance that answers are being provided to an
acceptable standard, although chief pharmacist perception was
that medicines advice was not documented all of the time. This
may be attributable to a lack of organisational procedure (eg, no
trust policy on documentation) or operational reasons such as
the individual on-call pharmacist, the type of question asked or
the time of day/night that the question is asked. Further research
is needed to explore the exact reasons for apparent poor docu-
mentation. Pharmacy departments lacking policy on documenta-
tion was unexpected given there are national standards for what
medicines advice should be documented,13 and professional
standards for data capture to demonstrate the impact of the
service on patient outcomes.14 Regardless of whether a policy
on documentation existed, data showed there was broad agree-
ment on what should be documented, although where policy
was lacking chief pharmacists placed little value on which
resources were used. This is concerning, as the basis of answers
stems from the resources used and acts as an audit trail to
follow-up advice given if required. A national report has previ-
ously recommended that computer technology should enable
on-call pharmacy services to be provided off-site and out of
hours.12 Although a bespoke enquiry answering database
(MiDatabank) is used by MI pharmacists to document medicines
advice during normal working hours,15 its uptake out of hours
is very low. Further research is needed to explore the exact
reasons for this.
LIMITATIONS
This study had a number of limitations. First, the response rate
was just over 50%, and although comparable to other published
studies involving this target group,16–18 the data cannot be said
to be truly representative and therefore need to be interpreted
with caution. The response rate may also have been affected
because at the time that the survey was sent the NHS England
was going through organisational change. With regard to the
quality of responses, chief pharmacists may not have always
been the best person to answer all questions posed because
some were related to the everyday rather than managerial
aspects of the service. However, the chief pharmacists may have
delegated the completion of the survey to more appropriate
staff without the researcher’s knowledge.
CONCLUSIONS
Medicines advice is provided by all trusts out of hours.
However, service provision varies and is provided by relatively
junior pharmacy staff. Further work is needed to determine the
appropriateness of medicines advice provided. In addition to
existing standards for documentation of medicines advice, pro-
fessional standards should be developed for on-call hospital
pharmacy service provision and training.
Key messages
What is already known on this subject
▸ UK hospital pharmacy services have historically been
delivered during typical ‘office’ hours, which include the
provision of medicines advice via the pharmacy’s medicines
information department.
▸ Outside normal ‘office’ hours, an on-call service is provided
by UK hospital pharmacy services whereby pharmacists
handle requests for medicine supply and advice from
clinicians.
▸ Almost all research has focused on the medicines advice
during normal office hours; very little is known about what
happens outside these hours.
What this study adds
▸ An out-of-hours pharmacy service for medicines advice is
almost universally provided in English hospital trusts.
▸ The service is provided by relatively junior staff.
▸ Variability exists across trusts with regard to levels of
training received and documentation of activity.
▸ Professional standards for on-call pharmacy services should
be considered.
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